ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,Count,ont,comparison,geneID,symbol
GO:0030335,positive regulation of cell migration,6/15,395/16992,6.367386271701143e-7,3.347439940459365e-4,1.4295553494398494e-4,6,bp,PCR,2625/596/3480/7060/51176/5979,GATA3/BCL2/IGF1R/THBS4/LEF1/RET
GO:0040017,positive regulation of locomotion,6/15,438/16992,1.1647320600067382e-6,3.347439940459365e-4,1.4295553494398494e-4,6,bp,PCR,2625/596/3480/7060/51176/5979,GATA3/BCL2/IGF1R/THBS4/LEF1/RET
GO:0046632,alpha-beta T cell differentiation,4/15,90/16992,9.606551149468223e-7,3.347439940459365e-4,1.4295553494398494e-4,4,bp,PCR,2625/596/4602/51176,GATA3/BCL2/MYB/LEF1
GO:0051272,positive regulation of cellular component movement,6/15,420/16992,9.116937492768976e-7,3.347439940459365e-4,1.4295553494398494e-4,6,bp,PCR,2625/596/3480/7060/51176/5979,GATA3/BCL2/IGF1R/THBS4/LEF1/RET
GO:2000147,positive regulation of cell motility,6/15,410/16992,7.919207569514424e-7,3.347439940459365e-4,1.4295553494398494e-4,6,bp,PCR,2625/596/3480/7060/51176/5979,GATA3/BCL2/IGF1R/THBS4/LEF1/RET
GO:0046631,alpha-beta T cell activation,4/15,116/16992,2.655863208424602e-6,6.360792384176922e-4,2.7164355272132337e-4,4,bp,PCR,2625/596/4602/51176,GATA3/BCL2/MYB/LEF1
GO:0030098,lymphocyte differentiation,5/15,316/16992,5.553473690619192e-6,9.975427116774723e-4,4.2600988968828803e-4,5,bp,PCR,2625/596/4602/51176/3087,GATA3/BCL2/MYB/LEF1/HHEX
GO:0060562,epithelial tube morphogenesis,5/15,309/16992,4.978697756881514e-6,9.975427116774723e-4,4.2600988968828803e-4,5,bp,PCR,2625/596/51176/3087/5979,GATA3/BCL2/LEF1/HHEX/RET
GO:0035239,tube morphogenesis,5/15,346/16992,8.634623189872925e-6,0.0013786615026497103,5.887702128299317e-4,5,bp,PCR,2625/596/51176/3087/5979,GATA3/BCL2/LEF1/HHEX/RET
GO:0002287,alpha-beta T cell activation involved in immune response,3/15,53/16992,1.2696796788640228e-5,0.0014034843834827698,5.993710548807493e-4,3,bp,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:0002293,alpha-beta T cell differentiation involved in immune response,3/15,53/16992,1.2696796788640228e-5,0.0014034843834827698,5.993710548807493e-4,3,bp,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",3/15,52/16992,1.198446259718005e-5,0.0014034843834827698,5.993710548807493e-4,3,bp,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:0042093,T-helper cell differentiation,3/15,50/16992,1.0640030570769201e-5,0.0014034843834827698,5.993710548807493e-4,3,bp,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:2001235,positive regulation of apoptotic signaling pathway,4/15,176/16992,1.388861325631655e-5,0.0014255669463804916,6.088016186791391e-4,4,bp,PCR,658/596/5979/53832,BMPR1B/BCL2/RET/IL20RA
GO:0002292,T cell differentiation involved in immune response,3/15,59/16992,1.756378129636937e-5,0.001579083291830369,6.743622013237411e-4,3,bp,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:0007409,axonogenesis,5/15,422/16992,2.2557155765493227e-5,0.001579083291830369,6.743622013237411e-4,5,bp,PCR,2625/658/596/4137/5979,GATA3/BMPR1B/BCL2/MAPT/RET
GO:0014031,mesenchymal cell development,3/15,62/16992,2.0400700949266987e-5,0.001579083291830369,6.743622013237411e-4,3,bp,PCR,596/51176/5979,BCL2/LEF1/RET
GO:0043367,"CD4-positive, alpha-beta T cell differentiation",3/15,63/16992,2.1409380552718913e-5,0.001579083291830369,6.743622013237411e-4,3,bp,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:0048608,reproductive structure development,5/15,421/16992,2.230099689884922e-5,0.001579083291830369,6.743622013237411e-4,5,bp,PCR,2625/658/596/51176/595,GATA3/BMPR1B/BCL2/LEF1/CCND1
GO:0048732,gland development,5/15,417/16992,2.1299022286775877e-5,0.001579083291830369,6.743622013237411e-4,5,bp,PCR,2625/596/51176/3087/595,GATA3/BCL2/LEF1/HHEX/CCND1
GO:0061458,reproductive system development,5/15,424/16992,2.3076373784577414e-5,0.001579083291830369,6.743622013237411e-4,5,bp,PCR,2625/658/596/51176/595,GATA3/BMPR1B/BCL2/LEF1/CCND1
GO:0033555,multicellular organismal response to stress,3/15,68/16992,2.694748293398951e-5,0.0017601605898246782,7.5169294500076e-4,3,bp,PCR,596/7060/5979,BCL2/THBS4/RET
GO:0008406,gonad development,4/15,214/16992,2.994533412167976e-5,0.0017789500470377824,7.597171573988405e-4,4,bp,PCR,2625/658/596/595,GATA3/BMPR1B/BCL2/CCND1
GO:0030217,T cell differentiation,4/15,216/16992,3.105635122512359e-5,0.0017789500470377824,7.597171573988405e-4,4,bp,PCR,2625/596/4602/51176,GATA3/BCL2/MYB/LEF1
GO:0035710,"CD4-positive, alpha-beta T cell activation",3/15,70/16992,2.9402617258922663e-5,0.0017789500470377824,7.597171573988405e-4,3,bp,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:0045137,development of primary sexual characteristics,4/15,219/16992,3.2779320559101154e-5,0.0017789500470377824,7.597171573988405e-4,4,bp,PCR,2625/658/596/595,GATA3/BMPR1B/BCL2/CCND1
GO:0061564,axon development,5/15,458/16992,3.342494869173286e-5,0.0017789500470377824,7.597171573988405e-4,5,bp,PCR,2625/658/596/4137/5979,GATA3/BMPR1B/BCL2/MAPT/RET
GO:0002521,leukocyte differentiation,5/15,464/16992,3.5575977067464626e-5,0.0018258099659266666,7.79729121441048e-4,5,bp,PCR,2625/596/4602/51176/3087,GATA3/BCL2/MYB/LEF1/HHEX
GO:0014041,regulation of neuron maturation,2/15,11/16992,3.982211986964511e-5,0.0019732546983682766,8.426967652995682e-4,2,bp,PCR,596/5979,BCL2/RET
hsa04151,PI3K-Akt signaling pathway,6/15,352/7430,3.7683660139440716e-5,0.0019858231577563113,0.001236784598251738,6,kg,PCR,596/3480/4602/7060/3667/595,BCL2/IGF1R/MYB/THBS4/IRS1/CCND1
hsa05215,Prostate cancer,4/15,97/7430,3.3372938345924784e-5,0.0019858231577563113,0.001236784598251738,4,kg,PCR,596/3480/51176/595,BCL2/IGF1R/LEF1/CCND1
hsa05216,Thyroid cancer,3/15,37/7430,4.9645578943907785e-5,0.0019858231577563113,0.001236784598251738,3,kg,PCR,51176/5979/595,LEF1/RET/CCND1
GO:0072189,ureter development,2/15,13/16992,5.6417415597250914e-5,0.0027023942071083187,0.0011540825716911329,2,bp,PCR,2625/5979,GATA3/RET
GO:0001656,metanephros development,3/15,88/16992,5.8382729218576844e-5,0.0027063219963579005,0.0011557599706088387,3,bp,PCR,2625/596/5979,GATA3/BCL2/RET
GO:0002286,T cell activation involved in immune response,3/15,92/16992,6.667059267062111e-5,0.0029939263021150795,0.0012785840633872405,3,bp,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:0001657,ureteric bud development,3/15,97/16992,7.806876589966293e-5,0.0030438453231415386,0.0012999024454393416,3,bp,PCR,2625/596/5979,GATA3/BCL2/RET
GO:0007548,sex differentiation,4/15,266/16992,6.995656726374403e-5,0.0030438453231415386,0.0012999024454393416,4,bp,PCR,2625/658/596/595,GATA3/BMPR1B/BCL2/CCND1
GO:0051899,membrane depolarization,3/15,97/16992,7.806876589966293e-5,0.0030438453231415386,0.0012999024454393416,3,bp,PCR,596/776/8912,BCL2/CACNA1D/CACNA1H
GO:0072163,mesonephric epithelium development,3/15,98/16992,8.049138641571223e-5,0.0030438453231415386,0.0012999024454393416,3,bp,PCR,2625/596/5979,GATA3/BCL2/RET
GO:0072164,mesonephric tubule development,3/15,98/16992,8.049138641571223e-5,0.0030438453231415386,0.0012999024454393416,3,bp,PCR,2625/596/5979,GATA3/BCL2/RET
GO:1901214,regulation of neuron death,4/15,269/16992,7.307038355518394e-5,0.0030438453231415386,0.0012999024454393416,4,bp,PCR,2625/596/4602/4137,GATA3/BCL2/MYB/MAPT
GO:0001823,mesonephros development,3/15,102/16992,9.067349974638943e-5,0.0033409697214246566,0.0014267921822441307,3,bp,PCR,2625/596/5979,GATA3/BCL2/RET
GO:0033599,regulation of mammary gland epithelial cell proliferation,2/15,17/16992,9.816831688000852e-5,0.0035266967839143056,0.001506108651080131,2,bp,PCR,2625/595,GATA3/CCND1
GO:0002320,lymphoid progenitor cell differentiation,2/15,19/16992,1.2330636612133166e-4,0.004027073820826218,0.0017197993169554152,2,bp,PCR,2625/596,GATA3/BCL2
GO:0032656,regulation of interleukin-13 production,2/15,19/16992,1.2330636612133166e-4,0.004027073820826218,0.0017197993169554152,2,bp,PCR,2625/51176,GATA3/LEF1
GO:0032674,regulation of interleukin-5 production,2/15,19/16992,1.2330636612133166e-4,0.004027073820826218,0.0017197993169554152,2,bp,PCR,2625/51176,GATA3/LEF1
GO:0070997,neuron death,4/15,304/16992,1.1733161224588804e-4,0.004027073820826218,0.0017197993169554152,4,bp,PCR,2625/596/4602/4137,GATA3/BCL2/MYB/MAPT
GO:0032634,interleukin-5 production,2/15,20/16992,1.3693720912394847e-4,0.004277799337198129,0.0018268739798458116,2,bp,PCR,2625/51176,GATA3/LEF1
GO:1903429,regulation of cell maturation,2/15,20/16992,1.3693720912394847e-4,0.004277799337198129,0.0018268739798458116,2,bp,PCR,596/5979,BCL2/RET
GO:0032616,interleukin-13 production,2/15,21/16992,1.512744746189048e-4,0.00462513659632694,0.001975207585729485,2,bp,PCR,2625/51176,GATA3/LEF1
GO:0000982,"transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding",4/15,367/16982,2.425144891410769e-4,0.005023514417922308,0.002406910719294899,4,mf,PCR,2625/4602/51176/3087,GATA3/MYB/LEF1/HHEX
GO:0000987,core promoter proximal region sequence-specific DNA binding,4/15,343/16982,1.8715640318927966e-4,0.005023514417922308,0.002406910719294899,4,mf,PCR,2625/4602/51176/3087,GATA3/MYB/LEF1/HHEX
GO:0001159,core promoter proximal region DNA binding,4/15,346/16982,1.9351616648112456e-4,0.005023514417922308,0.002406910719294899,4,mf,PCR,2625/4602/51176/3087,GATA3/MYB/LEF1/HHEX
GO:0008301,"DNA binding, bending",2/15,19/16982,1.2345100263864677e-4,0.005023514417922308,0.002406910719294899,2,mf,PCR,51176/3087,LEF1/HHEX
GO:0019199,transmembrane receptor protein kinase activity,3/15,80/16982,4.397390377344094e-5,0.005023514417922308,0.002406910719294899,3,mf,PCR,658/3480/5979,BMPR1B/IGF1R/RET
GO:0051721,protein phosphatase 2A binding,2/15,26/16982,2.3379242239066132e-4,0.005023514417922308,0.002406910719294899,2,mf,PCR,596/4137,BCL2/MAPT
GO:0071837,HMG box domain binding,2/15,17/16982,9.828352588810275e-5,0.005023514417922308,0.002406910719294899,2,mf,PCR,2625/3087,GATA3/HHEX
GO:0001654,eye development,4/15,337/16992,1.7450047180982503e-4,0.005224107874806636,0.002231003839147544,4,bp,PCR,2625/658/596/5979,GATA3/BMPR1B/BCL2/RET
GO:0030879,mammary gland development,3/15,131/16992,1.9040611216386536e-4,0.005583950677132133,0.0023846780535238133,3,bp,PCR,2625/51176/595,GATA3/LEF1/CCND1
GO:0048799,animal organ maturation,2/15,24/16992,1.9851390315685588e-4,0.005593421153654939,0.002388722508574757,2,bp,PCR,2625/5979,GATA3/RET
GO:1902107,positive regulation of leukocyte differentiation,3/15,132/16992,1.9473079849514045e-4,0.005593421153654939,0.002388722508574757,3,bp,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:0005158,insulin receptor binding,2/15,31/16982,3.33650656456784e-4,0.005730923425484508,0.0027458507882539207,2,mf,PCR,3480/3667,IGF1R/IRS1
GO:0043548,phosphatidylinositol 3-kinase binding,2/15,32/16982,3.5571248847834875e-4,0.005730923425484508,0.0027458507882539207,2,mf,PCR,3480/3667,IGF1R/IRS1
GO:0008584,male gonad development,3/15,137/16992,2.1731362903060856e-4,0.005892069526735557,0.0025162630729859943,3,bp,PCR,2625/596/595,GATA3/BCL2/CCND1
GO:0046546,development of primary male sexual characteristics,3/15,137/16992,2.1731362903060856e-4,0.005892069526735557,0.0025162630729859943,3,bp,PCR,2625/596/595,GATA3/BCL2/CCND1
GO:0051569,regulation of histone H3-K4 methylation,2/15,26/16992,2.335189996100791e-4,0.005992264329280065,0.002559052194975115,2,bp,PCR,2625/4602,GATA3/MYB
GO:0072006,nephron development,3/15,139/16992,2.2680217698957633e-4,0.005992264329280065,0.002559052194975115,3,bp,PCR,2625/596/5979,GATA3/BCL2/RET
GO:0072073,kidney epithelium development,3/15,140/16992,2.316456803668159e-4,0.005992264329280065,0.002559052194975115,3,bp,PCR,2625/596/5979,GATA3/BCL2/RET
hsa04934,Cushing's syndrome,4/15,154/7430,2.027499291602506e-4,0.006082497874807517,0.003788222360625735,4,kg,PCR,776/51176/595/8912,CACNA1D/LEF1/CCND1/CACNA1H
GO:0032673,regulation of interleukin-4 production,2/15,27/16992,2.520719323571401e-4,0.006142819901867184,0.0026233483520408515,2,bp,PCR,2625/51176,GATA3/LEF1
GO:0033598,mammary gland epithelial cell proliferation,2/15,27/16992,2.520719323571401e-4,0.006142819901867184,0.0026233483520408515,2,bp,PCR,2625/595,GATA3/CCND1
GO:2001233,regulation of apoptotic signaling pathway,4/15,371/16992,2.5221042046636317e-4,0.006142819901867184,0.0026233483520408515,4,bp,PCR,658/596/5979/53832,BMPR1B/BCL2/RET/IL20RA
GO:0010212,response to ionizing radiation,3/15,147/16992,2.6744041573647956e-4,0.006241248477119906,0.002665383190243493,3,bp,PCR,2625/596/595,GATA3/BCL2/CCND1
GO:0016331,morphogenesis of embryonic epithelium,3/15,146/16992,2.621215301368176e-4,0.006241248477119906,0.002665383190243493,3,bp,PCR,2625/3087/5979,GATA3/HHEX/RET
GO:0042391,regulation of membrane potential,4/15,379/16992,2.7362467227456786e-4,0.006241248477119906,0.002665383190243493,4,bp,PCR,596/4137/776/8912,BCL2/MAPT/CACNA1D/CACNA1H
GO:0048754,branching morphogenesis of an epithelial tube,3/15,148/16992,2.728288239578772e-4,0.006241248477119906,0.002665383190243493,3,bp,PCR,596/51176/3087,BCL2/LEF1/HHEX
GO:0002285,lymphocyte activation involved in immune response,3/15,156/16992,3.184866756937109e-4,0.006591228483664875,0.0028148454059822164,3,bp,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:0010039,response to iron ion,2/15,32/16992,3.5529711892043104e-4,0.006591228483664875,0.0028148454059822164,2,bp,PCR,596/595,BCL2/CCND1
GO:0014065,phosphatidylinositol 3-kinase signaling,3/15,163/16992,3.6226721755098563e-4,0.006591228483664875,0.0028148454059822164,3,bp,PCR,2625/3480/3667,GATA3/IGF1R/IRS1
GO:0030307,positive regulation of cell growth,3/15,154/16992,3.066415688721123e-4,0.006591228483664875,0.0028148454059822164,3,bp,PCR,596/4137/51176,BCL2/MAPT/LEF1
GO:0032633,interleukin-4 production,2/15,32/16992,3.5529711892043104e-4,0.006591228483664875,0.0028148454059822164,2,bp,PCR,2625/51176,GATA3/LEF1
GO:0042493,response to drug,4/15,408/16992,3.623570286774705e-4,0.006591228483664875,0.0028148454059822164,4,bp,PCR,2625/596/5979/595,GATA3/BCL2/RET/CCND1
GO:0046661,male sex differentiation,3/15,159/16992,3.368034555221787e-4,0.006591228483664875,0.0028148454059822164,3,bp,PCR,2625/596/595,GATA3/BCL2/CCND1
GO:0048265,response to pain,2/15,30/16992,3.119192650472853e-4,0.006591228483664875,0.0028148454059822164,2,bp,PCR,7060/5979,THBS4/RET
GO:0048469,cell maturation,3/15,155/16992,3.125277753615354e-4,0.006591228483664875,0.0028148454059822164,3,bp,PCR,2625/596/5979,GATA3/BCL2/RET
GO:0048863,stem cell differentiation,3/15,163/16992,3.6226721755098563e-4,0.006591228483664875,0.0028148454059822164,3,bp,PCR,51176/3087/5979,LEF1/HHEX/RET
GO:0050769,positive regulation of neurogenesis,4/15,392/16992,3.111836490961773e-4,0.006591228483664875,0.0028148454059822164,4,bp,PCR,596/4602/4137/5979,BCL2/MYB/MAPT/RET
GO:0071353,cellular response to interleukin-4,2/15,31/16992,0.00033326094870225233,0.006591228483664875,0.0028148454059822164,2,bp,PCR,2625/51176,GATA3/LEF1
GO:0071772,response to BMP,3/15,158/16992,3.306241251570684e-4,0.006591228483664875,0.0028148454059822164,3,bp,PCR,2625/658/51176,GATA3/BMPR1B/LEF1
GO:0071773,cellular response to BMP stimulus,3/15,158/16992,3.306241251570684e-4,0.006591228483664875,0.0028148454059822164,3,bp,PCR,2625/658/51176,GATA3/BMPR1B/LEF1
GO:1903708,positive regulation of hemopoiesis,3/15,163/16992,3.6226721755098563e-4,0.006591228483664875,0.0028148454059822164,3,bp,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:2001236,regulation of extrinsic apoptotic signaling pathway,3/15,154/16992,3.066415688721123e-4,0.006591228483664875,0.0028148454059822164,3,bp,PCR,658/596/5979,BMPR1B/BCL2/RET
GO:0010165,response to X-ray,2/15,34/16992,4.0144860754045777e-4,0.00712199566710664,0.0030415144664858594,2,bp,PCR,2625/595,GATA3/CCND1
GO:0070670,response to interleukin-4,2/15,34/16992,4.0144860754045777e-4,0.00712199566710664,0.0030415144664858594,2,bp,PCR,2625/51176,GATA3/LEF1
GO:0001755,neural crest cell migration,2/15,35/16992,4.255617730611355e-4,0.007457710584010386,0.00318488464306344,2,bp,PCR,51176/5979,LEF1/RET
GO:0048009,insulin-like growth factor receptor signaling pathway,2/15,36/16992,4.5036511938068637e-4,0.0077972852596391124,0.003329903165490681,2,bp,PCR,3480/3667,IGF1R/IRS1
GO:0061138,morphogenesis of a branching epithelium,3/15,180/16992,4.84313504594966e-4,0.008285220310749597,0.0035382803656499396,3,bp,PCR,596/51176/3087,BCL2/LEF1/HHEX
GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation",2/15,38/16992,5.020380612685407e-4,0.008388705744684801,0.0035824747823691465,2,bp,PCR,2625/4602,GATA3/MYB
GO:0048762,mesenchymal cell differentiation,3/15,182/16992,5.00198454719087e-4,0.008388705744684801,0.0035824747823691465,3,bp,PCR,596/51176/5979,BCL2/LEF1/RET
GO:0005245,voltage-gated calcium channel activity,2/15,41/16982,5.853790022324117e-4,0.00848799553236997,0.004066843594456755,2,mf,PCR,776/8912,CACNA1D/CACNA1H
GO:0002573,myeloid leukocyte differentiation,3/15,185/16992,5.246488880222707e-4,0.008600014317200083,0.003672716072906016,3,bp,PCR,2625/51176/3087,GATA3/LEF1/HHEX
GO:0010720,positive regulation of cell development,4/15,453/16992,5.386230261294415e-4,0.008600014317200083,0.003672716072906016,4,bp,PCR,596/4602/4137/5979,BCL2/MYB/MAPT/RET
GO:0042110,T cell activation,4/15,453/16992,5.386230261294415e-4,0.008600014317200083,0.003672716072906016,4,bp,PCR,2625/596/4602/51176,GATA3/BCL2/MYB/LEF1
GO:0051962,positive regulation of nervous system development,4/15,453/16992,5.386230261294415e-4,0.008600014317200083,0.003672716072906016,4,bp,PCR,596/4602/4137/5979,BCL2/MYB/MAPT/RET
GO:0043235,receptor complex,4/15,321/18122,1.1302427167248153e-4,0.008702868918781078,0.005710700042399067,4,cc,PCR,658/3480/5979/3667,BMPR1B/IGF1R/RET/IRS1
GO:0090184,positive regulation of kidney development,2/15,40/16992,5.564588583537373e-4,0.008787158015981544,0.003752637529441629,2,bp,PCR,2625/5979,GATA3/RET
GO:0001763,morphogenesis of a branching structure,3/15,193/16992,5.935744755599174e-4,0.009271375232386971,0.003959426993723477,3,bp,PCR,596/51176/3087,BCL2/LEF1/HHEX
GO:0043523,regulation of neuron apoptotic process,3/15,194/16992,6.025775803544546e-4,0.009310795515799474,0.003976261792265389,3,bp,PCR,2625/596/4602,GATA3/BCL2/MYB
GO:0010817,regulation of hormone levels,4/15,474/16992,6.389664161168434e-4,0.00933648757660281,0.003987233825703724,4,bp,PCR,2625/776/3667/8912,GATA3/CACNA1D/IRS1/CACNA1H
GO:0016055,Wnt signaling pathway,4/15,470/16992,6.188999316094616e-4,0.00933648757660281,0.003987233825703724,4,bp,PCR,2625/51176/3087/595,GATA3/LEF1/HHEX/CCND1
GO:0042551,neuron maturation,2/15,43/16992,6.432235699956007e-4,0.00933648757660281,0.003987233825703724,2,bp,PCR,596/5979,BCL2/RET
GO:0048483,autonomic nervous system development,2/15,43/16992,6.432235699956007e-4,0.00933648757660281,0.003987233825703724,2,bp,PCR,2625/5979,GATA3/RET
GO:0061647,histone H3-K9 modification,2/15,42/16992,6.136189540765245e-4,0.00933648757660281,0.003987233825703724,2,bp,PCR,2625/4602,GATA3/MYB
GO:0198738,cell-cell signaling by wnt,4/15,471/16992,6.238736325427341e-4,0.00933648757660281,0.003987233825703724,4,bp,PCR,2625/51176/3087/595,GATA3/LEF1/HHEX/CCND1
GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation",2/15,44/16992,6.735098101359613e-4,0.009678335971653764,0.004133223361150163,2,bp,PCR,2625/4602,GATA3/MYB
GO:0010035,response to inorganic substance,4/15,485/16992,6.965466427814655e-4,0.009828474647116085,0.004197341478422648,4,bp,PCR,596/4602/595/8912,BCL2/MYB/CCND1/CACNA1H
GO:0048066,developmental pigmentation,2/15,45/16992,7.044766100577292e-4,0.009828474647116085,0.004197341478422648,2,bp,PCR,596/51176,BCL2/LEF1
GO:0048538,thymus development,2/15,45/16992,7.044766100577292e-4,0.009828474647116085,0.004197341478422648,2,bp,PCR,2625/596,GATA3/BCL2
GO:0048015,phosphatidylinositol-mediated signaling,3/15,206/16992,7.175240065437695e-4,0.00991424997503266,0.0042339726297066565,3,bp,PCR,2625/3480/3667,GATA3/IGF1R/IRS1
GO:0045058,T cell selection,2/15,46/16992,7.361229064582538e-4,0.010074367776957244,0.00430235242571591,2,bp,PCR,2625/596,GATA3/BCL2
GO:0048017,inositol lipid-mediated signaling,3/15,209/16992,7.482956536562449e-4,0.010144347682113433,0.004332237994851944,3,bp,PCR,2625/3480/3667,GATA3/IGF1R/IRS1
GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,2/15,47/16992,7.684476371711097e-4,0.010320179949671819,0.004407328799515563,2,bp,PCR,596/5979,BCL2/RET
GO:0097191,extrinsic apoptotic signaling pathway,3/15,213/16992,7.906214060838323e-4,0.01051965704205988,0.0044925173464607625,3,bp,PCR,658/596/5979,BMPR1B/BCL2/RET
GO:0086010,membrane depolarization during action potential,2/15,48/16992,8.014497411651232e-4,0.010565901633525523,0.004512266529205861,2,bp,PCR,776/8912,CACNA1D/CACNA1H
GO:0051402,neuron apoptotic process,3/15,219/16992,8.569332835944059e-4,0.011194664804774195,0.004780785687421424,3,bp,PCR,2625/596/4602,GATA3/BCL2/MYB
GO:0007411,axon guidance,3/15,221/16992,8.798008825241775e-4,0.01138985466835354,0.004864143333443295,3,bp,PCR,2625/658/5979,GATA3/BMPR1B/RET
GO:0051568,histone H3-K4 methylation,2/15,51/16992,9.045096995303511e-4,0.011502481754204553,0.004912241777607776,2,bp,PCR,2625/4602,GATA3/MYB
GO:0097485,neuron projection guidance,3/15,223/16992,9.030547490146634e-4,0.011502481754204553,0.004912241777607776,3,bp,PCR,2625/658/5979,GATA3/BMPR1B/RET
GO:0048747,muscle fiber development,2/15,52/16992,9.402107090076782e-4,0.011748545989948119,0.005017325797267519,2,bp,PCR,596/51176,BCL2/LEF1
GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,2/15,52/16992,9.402107090076782e-4,0.011748545989948119,0.005017325797267519,2,bp,PCR,658/5979,BMPR1B/RET
GO:0010332,response to gamma radiation,2/15,53/16992,9.765838036045042e-4,0.011994452357091219,0.005122342397673648,2,bp,PCR,2625/596,GATA3/BCL2
GO:0046637,regulation of alpha-beta T cell differentiation,2/15,53/16992,9.765838036045042e-4,0.011994452357091219,0.005122342397673648,2,bp,PCR,2625/4602,GATA3/MYB
hsa04510,Focal adhesion,4/15,199/7430,5.404443141147488e-4,0.012322351196372802,0.007674446797740957,4,kg,PCR,596/3480/7060/595,BCL2/IGF1R/THBS4/CCND1
hsa05210,Colorectal cancer,3/15,86/7430,6.161175598186401e-4,0.012322351196372802,0.007674446797740957,3,kg,PCR,596/51176/595,BCL2/LEF1/CCND1
GO:0090183,regulation of kidney development,2/15,55/16992,0.0010513420323235174,0.012695617650831046,0.005421781555458741,2,bp,PCR,2625/5979,GATA3/RET
GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,2/15,55/16992,0.0010513420323235174,0.012695617650831046,0.005421781555458741,2,bp,PCR,596/53832,BCL2/IL20RA
GO:0001541,ovarian follicle development,2/15,56/16992,0.0010897250613490675,0.012839194118371342,0.005483097220825911,2,bp,PCR,658/596,BMPR1B/BCL2
GO:0060485,mesenchyme development,3/15,238/16992,0.0010900359655123895,0.012839194118371342,0.005483097220825911,3,bp,PCR,596/51176/5979,BCL2/LEF1/RET
GO:0071695,anatomical structure maturation,2/15,56/16992,0.0010897250613490675,0.012839194118371342,0.005483097220825911,2,bp,PCR,2625/5979,GATA3/RET
GO:1902105,regulation of leukocyte differentiation,3/15,239/16992,0.001103306078600851,0.012889844186580674,0.005504727803374379,3,bp,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:0042063,gliogenesis,3/15,242/16992,0.0011437320718002096,0.013043991961721438,0.0055705580439392,3,bp,PCR,4602/4137/51176,MYB/MAPT/LEF1
GO:0045927,positive regulation of growth,3/15,242/16992,0.0011437320718002096,0.013043991961721438,0.0055705580439392,3,bp,PCR,596/4137/51176,BCL2/MAPT/LEF1
GO:0051146,striated muscle cell differentiation,3/15,242/16992,0.0011437320718002096,0.013043991961721438,0.0055705580439392,3,bp,PCR,596/51176/8912,BCL2/LEF1/CACNA1H
GO:0014032,neural crest cell development,2/15,58/16992,0.00116849369444013,0.013221460148901312,0.00564634748328716,2,bp,PCR,51176/5979,LEF1/RET
GO:0021700,developmental maturation,3/15,247/16992,0.001213179750492096,0.013619838292633921,0.005816478573494177,3,bp,PCR,2625/596/5979,GATA3/BCL2/RET
GO:0031060,regulation of histone methylation,2/15,60/16992,0.0012499254349870048,0.013816483462125584,0.0059004577214366305,2,bp,PCR,2625/4602,GATA3/MYB
GO:0043966,histone H3 acetylation,2/15,60/16992,0.0012499254349870048,0.013816483462125584,0.0059004577214366305,2,bp,PCR,2625/51176,GATA3/LEF1
GO:0048864,stem cell development,2/15,62/16992,0.0013340119075985228,0.014522538721356646,0.006201985184449273,2,bp,PCR,51176/5979,LEF1/RET
GO:0051881,regulation of mitochondrial membrane potential,2/15,62/16992,0.0013340119075985228,0.014522538721356646,0.006201985184449273,2,bp,PCR,596/4137,BCL2/MAPT
GO:0032835,glomerulus development,2/15,63/16992,0.0013770480560262525,0.014657911529701665,0.006259797400883472,2,bp,PCR,596/5979,BCL2/RET
GO:0033673,negative regulation of kinase activity,3/15,257/16992,0.0013599809553361088,0.014657911529701665,0.006259797400883472,3,bp,PCR,3480/4137/3087,IGF1R/MAPT/HHEX
GO:0042113,B cell activation,3/15,258/16992,0.0013752498141690493,0.014657911529701665,0.006259797400883472,3,bp,PCR,596/51176/3087,BCL2/LEF1/HHEX
GO:0060675,ureteric bud morphogenesis,2/15,64/16992,0.0014207447548277186,0.015011839799172292,0.006410945759013622,2,bp,PCR,2625/596,GATA3/BCL2
GO:0034976,response to endoplasmic reticulum stress,3/15,263/16992,0.0014532238863082122,0.015242939595802196,0.006509639075817808,3,bp,PCR,596/7060/595,BCL2/THBS4/CCND1
GO:0072171,mesonephric tubule morphogenesis,2/15,65/16992,0.0014651009621207093,0.015256160018604777,0.006515284980292705,2,bp,PCR,2625/596,GATA3/BCL2
GO:0001822,kidney development,3/15,265/16992,0.0014851796380040045,0.015281944863176774,0.006526296637902106,3,bp,PCR,2625/596/5979,GATA3/BCL2/RET
GO:0014033,neural crest cell differentiation,2/15,66/16992,0.0015101156371406417,0.015281944863176774,0.006526296637902106,2,bp,PCR,51176/5979,LEF1/RET
GO:0034103,regulation of tissue remodeling,2/15,66/16992,0.0015101156371406417,0.015281944863176774,0.006526296637902106,2,bp,PCR,7060/53832,THBS4/IL20RA
GO:0061180,mammary gland epithelium development,2/15,66/16992,0.0015101156371406417,0.015281944863176774,0.006526296637902106,2,bp,PCR,2625/595,GATA3/CCND1
hsa01522,Endocrine resistance,3/15,98/7430,9.0240785319237e-4,0.0154698489118692,0.00963473046265538,3,kg,PCR,596/3480/595,BCL2/IGF1R/CCND1
GO:0033077,T cell differentiation in thymus,2/15,68/16992,0.001602116232885177,0.015987784907333328,0.006827732191316216,2,bp,PCR,2625/596,GATA3/BCL2
GO:1901216,positive regulation of neuron death,2/15,68/16992,0.001602116232885177,0.015987784907333328,0.006827732191316216,2,bp,PCR,4602/4137,MYB/MAPT
GO:0038034,signal transduction in absence of ligand,2/15,69/16992,0.00164910007765993,0.016120794636716458,0.006884535232908981,2,bp,PCR,596/5979,BCL2/RET
GO:0071300,cellular response to retinoic acid,2/15,69/16992,0.00164910007765993,0.016120794636716458,0.006884535232908981,2,bp,PCR,4602/5979,MYB/RET
GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,2/15,69/16992,0.00164910007765993,0.016120794636716458,0.006884535232908981,2,bp,PCR,596/5979,BCL2/RET
GO:0072001,renal system development,3/15,280/16992,0.001739076199041817,0.01688548985150737,0.007211105434149214,3,bp,PCR,2625/596/5979,GATA3/BCL2/RET
GO:0001077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",3/15,256/16982,0.0013470906316752004,0.01718723737524783,0.008234901392133263,3,mf,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:0004714,transmembrane receptor protein tyrosine kinase activity,2/15,64/16982,0.0014223920586411997,0.01718723737524783,0.008234901392133263,2,mf,PCR,3480/5979,IGF1R/RET
GO:0014812,muscle cell migration,2/15,74/16992,0.001893813351762072,0.017649464320371254,0.007537367834140161,2,bp,PCR,596/7060,BCL2/THBS4
GO:0016525,negative regulation of angiogenesis,2/15,74/16992,0.001893813351762072,0.017649464320371254,0.007537367834140161,2,bp,PCR,7060/3087,THBS4/HHEX
GO:0043627,response to estrogen,2/15,74/16992,0.001893813351762072,0.017649464320371254,0.007537367834140161,2,bp,PCR,2625/595,GATA3/CCND1
GO:0045582,positive regulation of T cell differentiation,2/15,73/16992,0.0018435682686587876,0.017649464320371254,0.007537367834140161,2,bp,PCR,2625/4602,GATA3/MYB
GO:0046634,regulation of alpha-beta T cell activation,2/15,74/16992,0.001893813351762072,0.017649464320371254,0.007537367834140161,2,bp,PCR,2625/4602,GATA3/MYB
GO:0050678,regulation of epithelial cell proliferation,3/15,289/16992,0.0019037348431854865,0.017649464320371254,0.007537367834140161,3,bp,PCR,2625/7060/595,GATA3/THBS4/CCND1
GO:0072078,nephron tubule morphogenesis,2/15,73/16992,0.0018435682686587876,0.017649464320371254,0.007537367834140161,2,bp,PCR,2625/596,GATA3/BCL2
GO:0046879,hormone secretion,3/15,291/16992,0.0019416073351555803,0.017686992410487146,0.007553394553942063,3,bp,PCR,2625/776/3667,GATA3/CACNA1D/IRS1
GO:0060070,canonical Wnt signaling pathway,3/15,290/16992,0.0019226123708266404,0.017686992410487146,0.007553394553942063,3,bp,PCR,2625/51176/595,GATA3/LEF1/CCND1
GO:0072088,nephron epithelium morphogenesis,2/15,75/16992,0.0019447075858434024,0.017686992410487146,0.007553394553942063,2,bp,PCR,2625/596,GATA3/BCL2
GO:0043010,camera-type eye development,3/15,292/16992,0.0019607200098143373,0.017720469522661653,0.007567691265950074,3,bp,PCR,2625/658/5979,GATA3/BMPR1B/RET
GO:0005891,voltage-gated calcium channel complex,2/15,39/18122,4.655478370351217e-4,0.017923591725852183,0.011761208514571495,2,cc,PCR,776/8912,CACNA1D/CACNA1H
GO:2000181,negative regulation of blood vessel morphogenesis,2/15,76/16992,0.001996249941260959,0.017928819784949986,0.007656669182599598,2,bp,PCR,7060/3087,THBS4/HHEX
GO:0061333,renal tubule morphogenesis,2/15,77/16992,0.0020484393894798767,0.01817041606594187,0.007759845120641769,2,bp,PCR,2625/596,GATA3/BCL2
GO:0072028,nephron morphogenesis,2/15,77/16992,0.0020484393894798767,0.01817041606594187,0.007759845120641769,2,bp,PCR,2625/596,GATA3/BCL2
GO:0051251,positive regulation of lymphocyte activation,3/15,301/16992,0.0021380758045034033,0.0188491713562662,0.008049713878110973,3,bp,PCR,2625/596/4602,GATA3/BCL2/MYB
GO:0048477,oogenesis,2/15,79/16992,0.0021547554557113553,0.018880387743031815,0.008063045126313994,2,bp,PCR,658/596,BMPR1B/BCL2
GO:0009914,hormone transport,3/15,303/16992,0.0021788057801382116,0.018975417612476425,0.008103628515601771,3,bp,PCR,2625/776/3667,GATA3/CACNA1D/IRS1
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,2/15,81/16992,0.002263647578361419,0.019595551627140717,0.008368462512268277,2,bp,PCR,658/596,BMPR1B/BCL2
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,2/15,83/16992,0.0023751075689032704,0.019728494661930635,0.008425237071314918,2,bp,PCR,3087/595,HHEX/CCND1
GO:0001701,in utero embryonic development,3/15,311/16992,0.002346583943609015,0.019728494661930635,0.008425237071314918,3,bp,PCR,2625/51176/3087,GATA3/LEF1/HHEX
GO:0022602,ovulation cycle process,2/15,82/16992,0.0023190571012402022,0.019728494661930635,0.008425237071314918,2,bp,PCR,658/596,BMPR1B/BCL2
GO:0030111,regulation of Wnt signaling pathway,3/15,311/16992,0.002346583943609015,0.019728494661930635,0.008425237071314918,3,bp,PCR,51176/3087/595,LEF1/HHEX/CCND1
GO:0031058,positive regulation of histone modification,2/15,82/16992,0.0023190571012402022,0.019728494661930635,0.008425237071314918,2,bp,PCR,2625/4602,GATA3/MYB
GO:0072676,lymphocyte migration,2/15,83/16992,0.0023751075689032704,0.019728494661930635,0.008425237071314918,2,bp,PCR,2625/5979,GATA3/RET
GO:1901343,negative regulation of vasculature development,2/15,83/16992,0.0023751075689032704,0.019728494661930635,0.008425237071314918,2,bp,PCR,7060/3087,THBS4/HHEX
GO:0001655,urogenital system development,3/15,315/16992,0.002433417132300498,0.019868297835885316,0.008484941316574107,3,bp,PCR,2625/596/5979,GATA3/BCL2/RET
GO:0010038,response to metal ion,3/15,315/16992,0.002433417132300498,0.019868297835885316,0.008484941316574107,3,bp,PCR,596/595/8912,BCL2/CCND1/CACNA1H
GO:0045621,positive regulation of lymphocyte differentiation,2/15,84/16992,0.0024317979605374906,0.019868297835885316,0.008484941316574107,2,bp,PCR,2625/4602,GATA3/MYB
GO:0001667,ameboidal-type cell migration,3/15,316/16992,0.0024554348953948575,0.01993480194735825,0.00851334251570147,3,bp,PCR,2625/51176/5979,GATA3/LEF1/RET
GO:0045666,positive regulation of neuron differentiation,3/15,318/16992,0.002499843561989909,0.020181321340334263,0.00861862091448916,3,bp,PCR,596/4137/5979,BCL2/MAPT/RET
GO:1904029,regulation of cyclin-dependent protein kinase activity,2/15,86/16992,0.002547094437962124,0.020447903393025546,0.008732467258641097,2,bp,PCR,3087/595,HHEX/CCND1
GO:0051098,regulation of binding,3/15,321/16992,0.0025673932011932962,0.020496355722859814,0.008753159276582993,3,bp,PCR,2625/596/51176,GATA3/BCL2/LEF1
GO:1903706,regulation of hemopoiesis,3/15,324/16992,0.0026360728275574563,0.020928379299447873,0.008937658961709782,3,bp,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:0042100,B cell proliferation,2/15,88/16992,0.0026649383889768437,0.021041299258020466,0.008985882479893003,2,bp,PCR,596/51176,BCL2/LEF1
GO:0002696,positive regulation of leukocyte activation,3/15,327/16992,0.0027058891570004083,0.02116517007071584,0.009038782662145065,3,bp,PCR,2625/596/4602,GATA3/BCL2/MYB
GO:0009791,post-embryonic development,2/15,89/16992,0.0027248131267101116,0.02116517007071584,0.009038782662145065,2,bp,PCR,2625/596,GATA3/BCL2
GO:1905269,positive regulation of chromatin organization,2/15,89/16992,0.0027248131267101116,0.02116517007071584,0.009038782662145065,2,bp,PCR,2625/4602,GATA3/MYB
GO:0003002,regionalization,3/15,331/16992,0.002800757293759688,0.021638108769530495,0.009240755530627608,3,bp,PCR,658/51176/3087,BMPR1B/LEF1/HHEX
GO:0030099,myeloid cell differentiation,3/15,333/16992,0.0028489584817603325,0.021892798600479133,0.009349523190916262,3,bp,PCR,2625/51176/3087,GATA3/LEF1/HHEX
GO:0033138,positive regulation of peptidyl-serine phosphorylation,2/15,92/16992,0.002908236221307598,0.021985532743728796,0.009389126168987941,2,bp,PCR,596/5979,BCL2/RET
GO:0050867,positive regulation of cell activation,3/15,336/16992,0.0029222246026807236,0.021985532743728796,0.009389126168987941,3,bp,PCR,2625/596/4602,GATA3/BCL2/MYB
GO:0060993,kidney morphogenesis,2/15,92/16992,0.002908236221307598,0.021985532743728796,0.009389126168987941,2,bp,PCR,2625/596,GATA3/BCL2
GO:0072080,nephron tubule development,2/15,92/16992,0.002908236221307598,0.021985532743728796,0.009389126168987941,2,bp,PCR,2625/596,GATA3/BCL2
GO:0008585,female gonad development,2/15,93/16992,0.002970640173152052,0.02223338504593489,0.009494973799055078,2,bp,PCR,658/596,BMPR1B/BCL2
GO:0061326,renal tubule development,2/15,94/16992,0.0030336739011373845,0.02258750982349441,0.00964620607779163,2,bp,PCR,2625/596,GATA3/BCL2
GO:0050673,epithelial cell proliferation,3/15,343/16992,0.0030977125594633882,0.022827758707430198,0.009748806597393552,3,bp,PCR,2625/7060/595,GATA3/THBS4/CCND1
GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,2/15,95/16992,0.0030973363964896645,0.022827758707430198,0.009748806597393552,2,bp,PCR,596/595,BCL2/CCND1
GO:0002244,hematopoietic progenitor cell differentiation,2/15,96/16992,0.003161626651523705,0.02306222080324652,0.009848935815326317,2,bp,PCR,2625/596,GATA3/BCL2
GO:0018958,phenol-containing compound metabolic process,2/15,96/16992,0.003161626651523705,0.02306222080324652,0.009848935815326317,2,bp,PCR,2625/596,GATA3/BCL2
GO:0043473,pigmentation,2/15,97/16992,0.003226543659642106,0.023299212255807566,0.009950145218573648,2,bp,PCR,596/51176,BCL2/LEF1
GO:0046545,development of primary female sexual characteristics,2/15,97/16992,0.003226543659642106,0.023299212255807566,0.009950145218573648,2,bp,PCR,658/596,BMPR1B/BCL2
GO:1902807,negative regulation of cell cycle G1/S phase transition,2/15,98/16992,0.0032920864153343225,0.023653640894177107,0.010101507263894265,2,bp,PCR,596/595,BCL2/CCND1
GO:0007517,muscle organ development,3/15,353/16992,0.0033595529773547354,0.023899394200290865,0.010206458498164725,3,bp,PCR,596/51176/8912,BCL2/LEF1/CACNA1H
GO:0051348,negative regulation of transferase activity,3/15,353/16992,0.0033595529773547354,0.023899394200290865,0.010206458498164725,3,bp,PCR,3480/4137/3087,IGF1R/MAPT/HHEX
hsa04152,AMPK signaling pathway,3/15,120/7430,0.0016222915119101925,0.024334372678652887,0.015155618071792588,3,kg,PCR,3480/3667/595,IGF1R/IRS1/CCND1
GO:0014902,myotube differentiation,2/15,102/16992,0.0035604948416168352,0.025204094026617694,0.010763642689461318,2,bp,PCR,596/8912,BCL2/CACNA1H
GO:0042692,muscle cell differentiation,3/15,362/16992,0.0036065881845364395,0.025281303517945677,0.010796615720589188,3,bp,PCR,596/51176/8912,BCL2/LEF1/CACNA1H
GO:0051047,positive regulation of secretion,3/15,362/16992,0.0036065881845364395,0.025281303517945677,0.010796615720589188,3,bp,PCR,2625/4602/8912,GATA3/MYB/CACNA1H
hsa04068,FoxO signaling pathway,3/15,132/7430,0.002132894484129249,0.02559473380955099,0.015940579828755443,3,kg,PCR,3480/3667/595,IGF1R/IRS1/CCND1
hsa04140,Autophagy - animal,3/15,128/7430,0.0019528902557894895,0.02559473380955099,0.015940579828755443,3,kg,PCR,596/3480/3667,BCL2/IGF1R/IRS1
hsa04010,MAPK signaling pathway,4/15,295/7430,0.0023483711341597746,0.025618594190833902,0.015955440241659714,4,kg,PCR,3480/4137/776/8912,IGF1R/MAPT/CACNA1D/CACNA1H
GO:0042698,ovulation cycle,2/15,104/16992,0.0036984274766504767,0.025799224679353083,0.011017798767947002,2,bp,PCR,658/596,BMPR1B/BCL2
GO:0018205,peptidyl-lysine modification,3/15,366/16992,0.0037198864666684902,0.025823559674408792,0.011028191253840478,3,bp,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:0018108,peptidyl-tyrosine phosphorylation,3/15,367/16992,0.0037485506041046415,0.025897438548549853,0.011059741913932218,3,bp,PCR,3480/7060/5979,IGF1R/THBS4/RET
GO:0018212,peptidyl-tyrosine modification,3/15,369/16992,0.0038062878760765305,0.026144104245668865,0.011165082793264438,3,bp,PCR,3480/7060/5979,IGF1R/THBS4/RET
GO:0032526,response to retinoic acid,2/15,106/16992,0.0038388350701712808,0.026144104245668865,0.011165082793264438,2,bp,PCR,4602/5979,MYB/RET
GO:0034968,histone lysine methylation,2/15,106/16992,0.0038388350701712808,0.026144104245668865,0.011165082793264438,2,bp,PCR,2625/4602,GATA3/MYB
GO:0001503,ossification,3/15,373/16992,0.003923404420859237,0.02659401958856002,0.011357223323539898,3,bp,PCR,658/596/51176,BMPR1B/BCL2/LEF1
GO:0001558,regulation of cell growth,3/15,379/16992,0.0041032097314533085,0.027456301741017028,0.011725468933826267,3,bp,PCR,596/4137/51176,BCL2/MAPT/LEF1
GO:0006816,calcium ion transport,3/15,379/16992,0.0041032097314533085,0.027456301741017028,0.011725468933826267,3,bp,PCR,596/776/8912,BCL2/CACNA1D/CACNA1H
GO:0051101,regulation of DNA binding,2/15,110/16992,0.004127043267960806,0.027456301741017028,0.011725468933826267,2,bp,PCR,2625/51176,GATA3/LEF1
GO:0072009,nephron epithelium development,2/15,110/16992,0.004127043267960806,0.027456301741017028,0.011725468933826267,2,bp,PCR,2625/596,GATA3/BCL2
hsa04340,Hedgehog signaling pathway,2/15,47/7430,0.0039024157616791844,0.02754646420008836,0.017156131212335734,2,kg,PCR,596/595,BCL2/CCND1
hsa04390,Hippo signaling pathway,3/15,154/7430,0.0033083611652394277,0.02754646420008836,0.017156131212335734,3,kg,PCR,658/51176/595,BMPR1B/LEF1/CCND1
hsa04630,Jak-STAT signaling pathway,3/15,162/7430,0.0038175961689323806,0.02754646420008836,0.017156131212335734,3,kg,PCR,596/595/53832,BCL2/CCND1/IL20RA
hsa04930,Type II diabetes mellitus,2/15,46/7430,0.0037407110105500906,0.02754646420008836,0.017156131212335734,2,kg,PCR,776/3667,CACNA1D/IRS1
hsa05224,Breast cancer,3/15,147/7430,0.0028993080590054804,0.02754646420008836,0.017156131212335734,3,kg,PCR,3480/51176/595,IGF1R/LEF1/CCND1
hsa05226,Gastric cancer,3/15,149/7430,0.0030127610393211727,0.02754646420008836,0.017156131212335734,3,kg,PCR,596/51176/595,BCL2/LEF1/CCND1
GO:0043900,regulation of multi-organism process,3/15,382/16992,0.004194983381137347,0.02768947214200145,0.01182504652147152,3,bp,PCR,596/51176/8912,BCL2/LEF1/CACNA1H
GO:0046660,female sex differentiation,2/15,111/16992,0.004200629733442113,0.02768947214200145,0.01182504652147152,2,bp,PCR,658/596,BMPR1B/BCL2
GO:0048545,response to steroid hormone,3/15,383/16992,0.004225853164237175,0.02772854336533708,0.011841732250662212,3,bp,PCR,596/51176/595,BCL2/LEF1/CCND1
GO:0007292,female gamete generation,2/15,112/16992,0.004274827982937777,0.02788177815984938,0.011907172594361198,2,bp,PCR,658/596,BMPR1B/BCL2
GO:0045785,positive regulation of cell adhesion,3/15,385/16992,0.004288011811640023,0.02788177815984938,0.011907172594361198,3,bp,PCR,2625/4602/5979,GATA3/MYB/RET
hsa05225,Hepatocellular carcinoma,3/15,168/7430,0.00422952374807514,0.0281968249871676,0.017561180474464033,3,kg,PCR,3480/51176/595,IGF1R/LEF1/CCND1
GO:0034704,calcium channel complex,2/15,60/18122,0.0011009308891098545,0.0282572261538196,0.018541993921850183,2,cc,PCR,776/8912,CACNA1D/CACNA1H
GO:0030183,B cell differentiation,2/15,115/16992,0.0045010835476542235,0.029062124767508274,0.012411250587449968,2,bp,PCR,596/3087,BCL2/HHEX
GO:0050708,regulation of protein secretion,3/15,392/16992,0.004509988742626545,0.029062124767508274,0.012411250587449968,3,bp,PCR,2625/776/3667,GATA3/CACNA1D/IRS1
GO:0022407,regulation of cell-cell adhesion,3/15,394/16992,0.004574680685540917,0.029347393505010255,0.012533077254090013,3,bp,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:0016202,regulation of striated muscle tissue development,2/15,117/16992,0.004654961401871941,0.029598139533141502,0.012640160676717941,2,bp,PCR,596/51176,BCL2/LEF1
GO:0018022,peptidyl-lysine methylation,2/15,117/16992,0.004654961401871941,0.029598139533141502,0.012640160676717941,2,bp,PCR,2625/4602,GATA3/MYB
GO:0045580,regulation of T cell differentiation,2/15,118/16992,0.0047328096171812915,0.02996056132109919,0.012794936270886589,2,bp,PCR,2625/4602,GATA3/MYB
GO:0043434,response to peptide hormone,3/15,401/16992,0.004805580586729806,0.03019119877566734,0.012893432140214673,3,bp,PCR,3480/3087/3667,IGF1R/HHEX/IRS1
GO:1901861,regulation of muscle tissue development,2/15,119/16992,0.004811262713728477,0.03019119877566734,0.012893432140214673,2,bp,PCR,596/51176,BCL2/LEF1
GO:0010975,regulation of neuron projection development,3/15,402/16992,0.004839137533353084,0.030234089719253836,0.012911749116452395,3,bp,PCR,2625/4137/5979,GATA3/MAPT/RET
GO:0001838,embryonic epithelial tube formation,2/15,120/16992,0.0048903197096745055,0.030421599232910237,0.01299182679763152,2,bp,PCR,2625/5979,GATA3/RET
GO:0044708,single-organism behavior,3/15,405/16992,0.004940669482192228,0.03060233640478548,0.013069012287287064,3,bp,PCR,596/4137/7060,BCL2/MAPT/THBS4
GO:0008286,insulin receptor signaling pathway,2/15,122/16992,0.005050241477732057,0.031013662408123786,0.01324467288132159,2,bp,PCR,3480/3667,IGF1R/IRS1
GO:0048634,regulation of muscle organ development,2/15,122/16992,0.005050241477732057,0.031013662408123786,0.01324467288132159,2,bp,PCR,596/51176,BCL2/LEF1
GO:0000978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,3/15,331/16982,0.0028054200060287004,0.03129122314416627,0.01499252796744083,3,mf,PCR,4602/51176/3087,MYB/LEF1/HHEX
GO:0001525,angiogenesis,3/15,411/16992,0.005147625454368076,0.031343804143758154,0.013385662979021357,3,bp,PCR,7060/51176/3087,THBS4/LEF1/HHEX
GO:0030856,regulation of epithelial cell differentiation,2/15,123/16992,0.005131104291487743,0.031343804143758154,0.013385662979021357,2,bp,PCR,2625/595,GATA3/CCND1
GO:0033135,regulation of peptidyl-serine phosphorylation,2/15,124/16992,0.005212567087928738,0.031472516409048724,0.013440630748617666,2,bp,PCR,596/5979,BCL2/RET
GO:0035270,endocrine system development,2/15,124/16992,0.005212567087928738,0.031472516409048724,0.013440630748617666,2,bp,PCR,2625/3087,GATA3/HHEX
GO:0023061,signal release,3/15,414/16992,0.005253059610332419,0.03158429564873509,0.013488367112194673,3,bp,PCR,2625/776/3667,GATA3/CACNA1D/IRS1
GO:0042542,response to hydrogen peroxide,2/15,125/16992,0.005294628890532594,0.031701590482063904,0.013538458961317994,2,bp,PCR,596/4602,BCL2/MYB
GO:0002791,regulation of peptide secretion,3/15,419/16992,0.0054316984813021635,0.0319971918396824,0.013664698269446466,3,bp,PCR,2625/776/3667,GATA3/CACNA1D/IRS1
GO:0007389,pattern specification process,3/15,421/16992,0.005504178626964815,0.0319971918396824,0.013664698269446466,3,bp,PCR,658/51176/3087,BMPR1B/LEF1/HHEX
GO:0009411,response to UV,2/15,128/16992,0.005544398585999247,0.0319971918396824,0.013664698269446466,2,bp,PCR,596/595,BCL2/CCND1
GO:0034762,regulation of transmembrane transport,3/15,422/16992,0.005540638977672915,0.0319971918396824,0.013664698269446466,3,bp,PCR,596/776/8912,BCL2/CACNA1D/CACNA1H
GO:0048565,digestive tract development,2/15,127/16992,0.0054605456134408595,0.0319971918396824,0.013664698269446466,2,bp,PCR,596/5979,BCL2/RET
GO:0048568,embryonic organ development,3/15,420/16992,0.005467865187954957,0.0319971918396824,0.013664698269446466,3,bp,PCR,2625/51176/3087,GATA3/LEF1/HHEX
GO:0072175,epithelial tube formation,2/15,128/16992,0.005544398585999247,0.0319971918396824,0.013664698269446466,2,bp,PCR,2625/5979,GATA3/RET
GO:0090288,negative regulation of cellular response to growth factor stimulus,2/15,126/16992,0.005377288723837425,0.0319971918396824,0.013664698269446466,2,bp,PCR,2625/3087,GATA3/HHEX
GO:1903747,regulation of establishment of protein localization to mitochondrion,2/15,128/16992,0.005544398585999247,0.0319971918396824,0.013664698269446466,2,bp,PCR,596/4137,BCL2/MAPT
GO:0061351,neural precursor cell proliferation,2/15,129/16992,0.00562884666922662,0.032354610654714615,0.013817337297512083,2,bp,PCR,51176/3087,LEF1/HHEX
GO:0001889,liver development,2/15,130/16992,0.005713888891893853,0.0324539855243141,0.013859776259513694,2,bp,PCR,3087/595,HHEX/CCND1
GO:0031056,regulation of histone modification,2/15,130/16992,0.005713888891893853,0.0324539855243141,0.013859776259513694,2,bp,PCR,2625/4602,GATA3/MYB
GO:0045471,response to ethanol,2/15,130/16992,0.005713888891893853,0.0324539855243141,0.013859776259513694,2,bp,PCR,2625/595,GATA3/CCND1
GO:0070838,divalent metal ion transport,3/15,428/16992,0.005762496188020711,0.032601208748762836,0.013922649306324388,3,bp,PCR,596/776/8912,BCL2/CACNA1D/CACNA1H
GO:0009314,response to radiation,3/15,432/16992,0.0059133616146695225,0.03268269477030809,0.01395744866944264,3,bp,PCR,2625/596/595,GATA3/BCL2/CCND1
GO:0016570,histone modification,3/15,432/16992,0.0059133616146695225,0.03268269477030809,0.01395744866944264,3,bp,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:0016571,histone methylation,2/15,132/16992,0.0058857518759096944,0.03268269477030809,0.01395744866944264,2,bp,PCR,2625/4602,GATA3/MYB
GO:0042326,negative regulation of phosphorylation,3/15,432/16992,0.0059133616146695225,0.03268269477030809,0.01395744866944264,3,bp,PCR,3480/4137/3087,IGF1R/MAPT/HHEX
GO:0051249,regulation of lymphocyte activation,3/15,430/16992,0.0058376319090317035,0.03268269477030809,0.01395744866944264,3,bp,PCR,2625/596/4602,GATA3/BCL2/MYB
GO:0072511,divalent inorganic cation transport,3/15,432/16992,0.0059133616146695225,0.03268269477030809,0.01395744866944264,3,bp,PCR,596/776/8912,BCL2/CACNA1D/CACNA1H
GO:0001508,action potential,2/15,133/16992,0.005972570700075656,0.03275795456491877,0.013989589064460056,2,bp,PCR,776/8912,CACNA1D/CACNA1H
GO:0061008,hepaticobiliary system development,2/15,133/16992,0.005972570700075656,0.03275795456491877,0.013989589064460056,2,bp,PCR,3087/595,HHEX/CCND1
GO:0001228,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding",3/15,355/16982,0.0034191688094501087,0.03292693274302363,0.01577624363731078,3,mf,PCR,2625/4602/51176,GATA3/MYB/LEF1
GO:0035326,enhancer binding,2/15,97/16982,0.0032302527869857473,0.03292693274302363,0.01577624363731078,2,mf,PCR,2625/51176,GATA3/LEF1
GO:0042826,histone deacetylase binding,2/15,103/16982,0.0036333167164715728,0.03292693274302363,0.01577624363731078,2,mf,PCR,51176/595,LEF1/CCND1
GO:0055002,striated muscle cell development,2/15,136/16992,0.006236564900224882,0.03407583179324394,0.014552400787797104,2,bp,PCR,596/51176,BCL2/LEF1
GO:0055123,digestive system development,2/15,138/16992,0.006415499493578335,0.03478895385763044,0.014856946195655094,2,bp,PCR,596/5979,BCL2/RET
GO:0060041,retina development in camera-type eye,2/15,138/16992,0.006415499493578335,0.03478895385763044,0.014856946195655094,2,bp,PCR,658/5979,BMPR1B/RET
GO:2000045,regulation of G1/S transition of mitotic cell cycle,2/15,139/16992,0.00650584543980592,0.03514624021428988,0.015009528656141082,2,bp,PCR,596/595,BCL2/CCND1
GO:1901652,response to peptide,3/15,448/16992,0.006540746134891251,0.03520244268104392,0.01503353044211157,3,bp,PCR,3480/3087/3667,IGF1R/HHEX/IRS1
GO:0001078,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",2/15,117/16982,0.004660284698647938,0.03556533059494479,0.017040376183421826,2,mf,PCR,2625/3087,GATA3/HHEX
GO:0005262,calcium channel activity,2/15,115/16982,0.004506233569503702,0.03556533059494479,0.017040376183421826,2,mf,PCR,776/8912,CACNA1D/CACNA1H
GO:0019903,protein phosphatase binding,2/15,111/16982,0.0042054410165155605,0.03556533059494479,0.017040376183421826,2,mf,PCR,596/4137,BCL2/MAPT
GO:0030902,hindbrain development,2/15,142/16992,0.0067803863512845754,0.03598321531182676,0.01536696665333114,2,bp,PCR,596/51176,BCL2/LEF1
GO:0035148,tube formation,2/15,142/16992,0.0067803863512845754,0.03598321531182676,0.01536696665333114,2,bp,PCR,2625/5979,GATA3/RET
GO:0035264,multicellular organism growth,2/15,142/16992,0.0067803863512845754,0.03598321531182676,0.01536696665333114,2,bp,PCR,596/3087,BCL2/HHEX
GO:0050900,leukocyte migration,3/15,454/16992,0.006785978670497601,0.03598321531182676,0.01536696665333114,3,bp,PCR,2625/7060/5979,GATA3/THBS4/RET
GO:0045619,regulation of lymphocyte differentiation,2/15,143/16992,0.006873064483976199,0.036311006115712495,0.01550695276376983,2,bp,PCR,2625/4602,GATA3/MYB
GO:0016573,histone acetylation,2/15,145/16992,0.007060161751904228,0.03662618208478836,0.015641551591716377,2,bp,PCR,2625/51176,GATA3/LEF1
GO:0035107,appendage morphogenesis,2/15,145/16992,0.007060161751904228,0.03662618208478836,0.015641551591716377,2,bp,PCR,658/51176,BMPR1B/LEF1
GO:0035108,limb morphogenesis,2/15,145/16992,0.007060161751904228,0.03662618208478836,0.015641551591716377,2,bp,PCR,658/51176,BMPR1B/LEF1
GO:0048771,tissue remodeling,2/15,144/16992,0.006966323269345433,0.03662618208478836,0.015641551591716377,2,bp,PCR,7060/53832,THBS4/IL20RA
GO:0051384,response to glucocorticoid,2/15,145/16992,0.007060161751904228,0.03662618208478836,0.015641551591716377,2,bp,PCR,596/595,BCL2/CCND1
hsa05213,Endometrial cancer,2/15,58/7430,0.0058913757629398215,0.03720868902909361,0.023173832640926723,2,kg,PCR,51176/595,LEF1/CCND1
GO:0030509,BMP signaling pathway,2/15,148/16992,0.007345145843462444,0.03783145009697323,0.016156272502315053,2,bp,PCR,658/51176,BMPR1B/LEF1
GO:1901615,organic hydroxy compound metabolic process,3/15,467/16992,0.007336190217998686,0.03783145009697323,0.016156272502315053,3,bp,PCR,2625/596/8912,GATA3/BCL2/CACNA1H
GO:0008361,regulation of cell size,2/15,150/16992,0.007538016253351021,0.03827607546312868,0.016346153898841902,2,bp,PCR,4137/5979,MAPT/RET
GO:0018393,internal peptidyl-lysine acetylation,2/15,150/16992,0.007538016253351021,0.03827607546312868,0.016346153898841902,2,bp,PCR,2625/51176,GATA3/LEF1
GO:0050770,regulation of axonogenesis,2/15,150/16992,0.007538016253351021,0.03827607546312868,0.016346153898841902,2,bp,PCR,4137/5979,MAPT/RET
GO:2001242,regulation of intrinsic apoptotic signaling pathway,2/15,150/16992,0.007538016253351021,0.03827607546312868,0.016346153898841902,2,bp,PCR,596/53832,BCL2/IL20RA
GO:0055001,muscle cell development,2/15,151/16992,0.007635312912088121,0.03840331872902158,0.016400494318587394,2,bp,PCR,596/51176,BCL2/LEF1
GO:0071900,regulation of protein serine/threonine kinase activity,3/15,474/16992,0.007643249239039786,0.03840331872902158,0.016400494318587394,3,bp,PCR,3480/3087/595,IGF1R/HHEX/CCND1
GO:1902806,regulation of cell cycle G1/S phase transition,2/15,151/16992,0.007635312912088121,0.03840331872902158,0.016400494318587394,2,bp,PCR,596/595,BCL2/CCND1
GO:2001252,positive regulation of chromosome organization,2/15,152/16992,0.0077331826087242836,0.03871980281789825,0.016535651791257135,2,bp,PCR,2625/4602,GATA3/MYB
hsa04213,Longevity regulating pathway - multiple species,2/15,62/7430,0.006708306385677446,0.03954394483091759,0.02462824634206271,2,kg,PCR,3480/3667,IGF1R/IRS1
hsa04927,Cortisol synthesis and secretion,2/15,63/7430,0.006920190345410578,0.03954394483091759,0.02462824634206271,2,kg,PCR,776/8912,CACNA1D/CACNA1H
GO:0006475,internal protein amino acid acetylation,2/15,155/16992,0.008030220459426411,0.03965438762953867,0.016934774924382702,2,bp,PCR,2625/51176,GATA3/LEF1
GO:0016049,cell growth,3/15,482/16992,0.008003506625667695,0.03965438762953867,0.016934774924382702,3,bp,PCR,596/4137/51176,BCL2/MAPT/LEF1
GO:0018394,peptidyl-lysine acetylation,2/15,155/16992,0.008030220459426411,0.03965438762953867,0.016934774924382702,2,bp,PCR,2625/51176,GATA3/LEF1
GO:2000377,regulation of reactive oxygen species metabolic process,2/15,155/16992,0.008030220459426411,0.03965438762953867,0.016934774924382702,2,bp,PCR,596/4137,BCL2/MAPT
hsa04115,p53 signaling pathway,2/15,72/7430,0.008962470121402773,0.03983320053956788,0.024808396827274735,2,kg,PCR,596/595,BCL2/CCND1
hsa04520,Adherens junction,2/15,72/7430,0.008962470121402773,0.03983320053956788,0.024808396827274735,2,kg,PCR,3480/51176,IGF1R/LEF1
hsa05214,Glioma,2/15,71/7430,0.008723657329229832,0.03983320053956788,0.024808396827274735,2,kg,PCR,3480/595,IGF1R/CCND1
hsa05218,Melanoma,2/15,72/7430,0.008962470121402773,0.03983320053956788,0.024808396827274735,2,kg,PCR,3480/595,IGF1R/CCND1
hsa05221,Acute myeloid leukemia,2/15,66/7430,0.007574021863691222,0.03983320053956788,0.024808396827274735,2,kg,PCR,51176/595,LEF1/CCND1
hsa05412,Arrhythmogenic right ventricular cardiomyopathy (ARVC),2/15,72/7430,0.008962470121402773,0.03983320053956788,0.024808396827274735,2,kg,PCR,776/51176,CACNA1D/LEF1
GO:1902275,regulation of chromatin organization,2/15,156/16992,0.00813037284622814,0.04001145815078711,0.017087265210349697,2,bp,PCR,2625/4602,GATA3/MYB
GO:0002694,regulation of leukocyte activation,3/15,489/16992,0.008326953143607466,0.04012203738800184,0.017134489101714154,3,bp,PCR,2625/596/4602,GATA3/BCL2/MYB
GO:0006338,chromatin remodeling,2/15,159/16992,0.008434236113715663,0.04012203738800184,0.017134489101714154,2,bp,PCR,2625/4602,GATA3/MYB
GO:0009306,protein secretion,3/15,489/16992,0.008326953143607466,0.04012203738800184,0.017134489101714154,3,bp,PCR,2625/776/3667,GATA3/CACNA1D/IRS1
GO:0021548,pons development,1/15,10/16992,0.008795018634113139,0.04012203738800184,0.017134489101714154,1,bp,PCR,596,BCL2
GO:0021932,hindbrain radial glia guided cell migration,1/15,10/16992,0.008795018634113139,0.04012203738800184,0.017134489101714154,1,bp,PCR,51176,LEF1
GO:0031960,response to corticosteroid,2/15,161/16992,0.008639640640686577,0.04012203738800184,0.017134489101714154,2,bp,PCR,596/595,BCL2/CCND1
GO:0032930,positive regulation of superoxide anion generation,1/15,10/16992,0.008795018634113139,0.04012203738800184,0.017134489101714154,1,bp,PCR,4137,MAPT
GO:0033327,Leydig cell differentiation,1/15,10/16992,0.008795018634113139,0.04012203738800184,0.017134489101714154,1,bp,PCR,595,CCND1
GO:0043902,positive regulation of multi-organism process,2/15,162/16992,0.008743188791989823,0.04012203738800184,0.017134489101714154,2,bp,PCR,51176/8912,LEF1/CACNA1H
GO:0048340,paraxial mesoderm morphogenesis,1/15,10/16992,0.008795018634113139,0.04012203738800184,0.017134489101714154,1,bp,PCR,51176,LEF1
GO:0048514,blood vessel morphogenesis,3/15,492/16992,0.008467934570272468,0.04012203738800184,0.017134489101714154,3,bp,PCR,7060/51176/3087,THBS4/LEF1/HHEX
GO:0048639,positive regulation of developmental growth,2/15,159/16992,0.008434236113715663,0.04012203738800184,0.017134489101714154,2,bp,PCR,596/4137,BCL2/MAPT
GO:0048742,regulation of skeletal muscle fiber development,1/15,10/16992,0.008795018634113139,0.04012203738800184,0.017134489101714154,1,bp,PCR,596,BCL2
GO:0050679,positive regulation of epithelial cell proliferation,2/15,161/16992,0.008639640640686577,0.04012203738800184,0.017134489101714154,2,bp,PCR,7060/595,THBS4/CCND1
GO:0051451,myoblast migration,1/15,10/16992,0.008795018634113139,0.04012203738800184,0.017134489101714154,1,bp,PCR,7060,THBS4
GO:0051574,positive regulation of histone H3-K9 methylation,1/15,10/16992,0.008795018634113139,0.04012203738800184,0.017134489101714154,1,bp,PCR,4602,MYB
GO:0060252,positive regulation of glial cell proliferation,1/15,10/16992,0.008795018634113139,0.04012203738800184,0.017134489101714154,1,bp,PCR,4602,MYB
GO:0070509,calcium ion import,2/15,159/16992,0.008434236113715663,0.04012203738800184,0.017134489101714154,2,bp,PCR,776/8912,CACNA1D/CACNA1H
GO:0072537,fibroblast activation,1/15,10/16992,0.008795018634113139,0.04012203738800184,0.017134489101714154,1,bp,PCR,4602,MYB
GO:0086070,SA node cell to atrial cardiac muscle cell communication,1/15,10/16992,0.008795018634113139,0.04012203738800184,0.017134489101714154,1,bp,PCR,776,CACNA1D
GO:0090193,positive regulation of glomerulus development,1/15,10/16992,0.008795018634113139,0.04012203738800184,0.017134489101714154,1,bp,PCR,5979,RET
GO:0099624,atrial cardiac muscle cell membrane repolarization,1/15,10/16992,0.008795018634113139,0.04012203738800184,0.017134489101714154,1,bp,PCR,776,CACNA1D
GO:2000615,regulation of histone H3-K9 acetylation,1/15,10/16992,0.008795018634113139,0.04012203738800184,0.017134489101714154,1,bp,PCR,2625,GATA3
GO:0002699,positive regulation of immune effector process,2/15,164/16992,0.008951972185876277,0.04070881022501332,0.017385075897288042,2,bp,PCR,2625/4602,GATA3/MYB
GO:0006986,response to unfolded protein,2/15,168/16992,0.009376261170947867,0.041983575577998825,0.01792947629342806,2,bp,PCR,7060/595,THBS4/CCND1
GO:0007494,midgut development,1/15,11/16992,0.009670538285537655,0.041983575577998825,0.01792947629342806,1,bp,PCR,5979,RET
GO:0032352,positive regulation of hormone metabolic process,1/15,11/16992,0.009670538285537655,0.041983575577998825,0.01792947629342806,1,bp,PCR,2625,GATA3
GO:0032754,positive regulation of interleukin-5 production,1/15,11/16992,0.009670538285537655,0.041983575577998825,0.01792947629342806,1,bp,PCR,2625,GATA3
GO:0035745,T-helper 2 cell cytokine production,1/15,11/16992,0.009670538285537655,0.041983575577998825,0.01792947629342806,1,bp,PCR,2625,GATA3
GO:0043374,"CD8-positive, alpha-beta T cell differentiation",1/15,11/16992,0.009670538285537655,0.041983575577998825,0.01792947629342806,1,bp,PCR,596,BCL2
GO:0045793,positive regulation of cell size,1/15,11/16992,0.009670538285537655,0.041983575577998825,0.01792947629342806,1,bp,PCR,5979,RET
GO:0045837,negative regulation of membrane potential,1/15,11/16992,0.009670538285537655,0.041983575577998825,0.01792947629342806,1,bp,PCR,4137,MAPT
GO:0048484,enteric nervous system development,1/15,11/16992,0.009670538285537655,0.041983575577998825,0.01792947629342806,1,bp,PCR,5979,RET
GO:0048736,appendage development,2/15,169/16992,0.009483728435293375,0.041983575577998825,0.01792947629342806,2,bp,PCR,658/51176,BMPR1B/LEF1
GO:0050796,regulation of insulin secretion,2/15,169/16992,0.009483728435293375,0.041983575577998825,0.01792947629342806,2,bp,PCR,776/3667,CACNA1D/IRS1
GO:0060033,anatomical structure regression,1/15,11/16992,0.009670538285537655,0.041983575577998825,0.01792947629342806,1,bp,PCR,51176,LEF1
GO:0060173,limb development,2/15,169/16992,0.009483728435293375,0.041983575577998825,0.01792947629342806,2,bp,PCR,658/51176,BMPR1B/LEF1
GO:0090009,primitive streak formation,1/15,11/16992,0.009670538285537655,0.041983575577998825,0.01792947629342806,1,bp,PCR,3087,HHEX
GO:1990000,amyloid fibril formation,1/15,11/16992,0.009670538285537655,0.041983575577998825,0.01792947629342806,1,bp,PCR,4137,MAPT
GO:0001227,"transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding",2/15,180/16982,0.01071440753455806,0.04243645464544011,0.020332529993459515,2,mf,PCR,2625/3087,GATA3/HHEX
GO:0003682,chromatin binding,3/15,482/16982,0.008016450215569824,0.04243645464544011,0.020332529993459515,3,mf,PCR,2625/51176/3087,GATA3/LEF1/HHEX
GO:0004713,protein tyrosine kinase activity,2/15,181/16982,0.010828612564698512,0.04243645464544011,0.020332529993459515,2,mf,PCR,3480/5979,IGF1R/RET
GO:0005068,transmembrane receptor protein tyrosine kinase adaptor activity,1/15,11/16982,0.009676209402266656,0.04243645464544011,0.020332529993459515,1,mf,PCR,3667,IRS1
GO:0008190,eukaryotic initiation factor 4E binding,1/15,10/16982,0.008800178449918206,0.04243645464544011,0.020332529993459515,1,mf,PCR,3087,HHEX
GO:0008331,high voltage-gated calcium channel activity,1/15,12/16982,0.010551517684569633,0.04243645464544011,0.020332529993459515,1,mf,PCR,776,CACNA1D
GO:0015085,calcium ion transmembrane transporter activity,2/15,135/16982,0.006154975725110443,0.04243645464544011,0.020332529993459515,2,mf,PCR,776/8912,CACNA1D/CACNA1H
GO:0015267,channel activity,3/15,466/16982,0.007304774926551761,0.04243645464544011,0.020332529993459515,3,mf,PCR,596/776/8912,BCL2/CACNA1D/CACNA1H
GO:0019902,phosphatase binding,2/15,155/16982,0.008039312317559173,0.04243645464544011,0.020332529993459515,2,mf,PCR,596/4137,BCL2/MAPT
GO:0022803,passive transmembrane transporter activity,3/15,467/16982,0.007348089288458913,0.04243645464544011,0.020332529993459515,3,mf,PCR,596/776/8912,BCL2/CACNA1D/CACNA1H
GO:0022843,voltage-gated cation channel activity,2/15,132/16982,0.005892456244501069,0.04243645464544011,0.020332529993459515,2,mf,PCR,776/8912,CACNA1D/CACNA1H
GO:0031994,insulin-like growth factor I binding,1/15,12/16982,0.010551517684569633,0.04243645464544011,0.020332529993459515,1,mf,PCR,3480,IGF1R
GO:0034452,dynactin binding,1/15,10/16982,0.008800178449918206,0.04243645464544011,0.020332529993459515,1,mf,PCR,4137,MAPT
GO:0043560,insulin receptor substrate binding,1/15,11/16982,0.009676209402266656,0.04243645464544011,0.020332529993459515,1,mf,PCR,3480,IGF1R
GO:0045295,gamma-catenin binding,1/15,10/16982,0.008800178449918206,0.04243645464544011,0.020332529993459515,1,mf,PCR,51176,LEF1
GO:0051400,BH domain binding,1/15,10/16982,0.008800178449918206,0.04243645464544011,0.020332529993459515,1,mf,PCR,596,BCL2
GO:0070016,armadillo repeat domain binding,1/15,10/16982,0.008800178449918206,0.04243645464544011,0.020332529993459515,1,mf,PCR,51176,LEF1
GO:0072509,divalent inorganic cation transmembrane transporter activity,2/15,176/16982,0.0102630619480167,0.04243645464544011,0.020332529993459515,2,mf,PCR,776/8912,CACNA1D/CACNA1H
GO:0031099,regeneration,2/15,173/16992,0.009919149673650896,0.042933186991073305,0.018335016676406066,2,bp,PCR,596/595,BCL2/CCND1
GO:0006479,protein methylation,2/15,177/16992,0.010363409934281757,0.04443885042776798,0.01897802424597204,2,bp,PCR,2625/4602,GATA3/MYB
GO:0006705,mineralocorticoid biosynthetic process,1/15,12/16992,0.010545336114035408,0.04443885042776798,0.01897802424597204,1,bp,PCR,8912,CACNA1H
GO:0008212,mineralocorticoid metabolic process,1/15,12/16992,0.010545336114035408,0.04443885042776798,0.01897802424597204,1,bp,PCR,8912,CACNA1H
GO:0008213,protein alkylation,2/15,177/16992,0.010363409934281757,0.04443885042776798,0.01897802424597204,2,bp,PCR,2625/4602,GATA3/MYB
GO:0033197,response to vitamin E,1/15,12/16992,0.010545336114035408,0.04443885042776798,0.01897802424597204,1,bp,PCR,595,CCND1
GO:0040037,negative regulation of fibroblast growth factor receptor signaling pathway,1/15,12/16992,0.010545336114035408,0.04443885042776798,0.01897802424597204,1,bp,PCR,2625,GATA3
GO:0043970,histone H3-K9 acetylation,1/15,12/16992,0.010545336114035408,0.04443885042776798,0.01897802424597204,1,bp,PCR,2625,GATA3
GO:0072178,nephric duct morphogenesis,1/15,12/16992,0.010545336114035408,0.04443885042776798,0.01897802424597204,1,bp,PCR,2625,GATA3
GO:1900121,negative regulation of receptor binding,1/15,12/16992,0.010545336114035408,0.04443885042776798,0.01897802424597204,1,bp,PCR,51176,LEF1
GO:1903900,regulation of viral life cycle,2/15,179/16992,0.010588836225769222,0.04449168905388998,0.01900058947252526,2,bp,PCR,596/51176,BCL2/LEF1
GO:0006473,protein acetylation,2/15,180/16992,0.010702370188928483,0.04457769843910212,0.01903732058015349,2,bp,PCR,2625/51176,GATA3/LEF1
GO:0007369,gastrulation,2/15,180/16992,0.010702370188928483,0.04457769843910212,0.01903732058015349,2,bp,PCR,51176/3087,LEF1/HHEX
GO:0010001,glial cell differentiation,2/15,180/16992,0.010702370188928483,0.04457769843910212,0.01903732058015349,2,bp,PCR,4137/51176,MAPT/LEF1
GO:0001134,"transcription factor activity, transcription factor recruiting",1/15,14/16982,0.012299968453077015,0.04525579086319065,0.021683355331909862,1,mf,PCR,4602,MYB
GO:0005244,voltage-gated ion channel activity,2/15,195/16982,0.012484356100190525,0.04525579086319065,0.021683355331909862,2,mf,PCR,776/8912,CACNA1D/CACNA1H
GO:0022832,voltage-gated channel activity,2/15,195/16982,0.012484356100190525,0.04525579086319065,0.021683355331909862,2,mf,PCR,776/8912,CACNA1D/CACNA1H
GO:0043393,regulation of protein binding,2/15,182/16992,0.010931075157342105,0.04539871387601331,0.01938794285588819,2,bp,PCR,596/51176,BCL2/LEF1
GO:0010623,programmed cell death involved in cell development,1/15,13/16992,0.01141941267223845,0.04545622163436745,0.019412502078772462,1,bp,PCR,596,BCL2
GO:0030278,regulation of ossification,2/15,184/16992,0.01116195673667431,0.04545622163436745,0.019412502078772462,2,bp,PCR,658/596,BMPR1B/BCL2
GO:0032928,regulation of superoxide anion generation,1/15,13/16992,0.01141941267223845,0.04545622163436745,0.019412502078772462,1,bp,PCR,4137,MAPT
GO:0033033,negative regulation of myeloid cell apoptotic process,1/15,13/16992,0.01141941267223845,0.04545622163436745,0.019412502078772462,1,bp,PCR,596,BCL2
GO:0035743,"CD4-positive, alpha-beta T cell cytokine production",1/15,13/16992,0.01141941267223845,0.04545622163436745,0.019412502078772462,1,bp,PCR,2625,GATA3
GO:0035966,response to topologically incorrect protein,2/15,186/16992,0.011395007606780517,0.04545622163436745,0.019412502078772462,2,bp,PCR,7060/595,THBS4/CCND1
GO:0036445,neuronal stem cell division,1/15,13/16992,0.01141941267223845,0.04545622163436745,0.019412502078772462,1,bp,PCR,51176,LEF1
GO:0042415,norepinephrine metabolic process,1/15,13/16992,0.01141941267223845,0.04545622163436745,0.019412502078772462,1,bp,PCR,2625,GATA3
GO:0046628,positive regulation of insulin receptor signaling pathway,1/15,13/16992,0.01141941267223845,0.04545622163436745,0.019412502078772462,1,bp,PCR,3667,IRS1
GO:0048311,mitochondrion distribution,1/15,13/16992,0.01141941267223845,0.04545622163436745,0.019412502078772462,1,bp,PCR,4137,MAPT
GO:0055057,neuroblast division,1/15,13/16992,0.01141941267223845,0.04545622163436745,0.019412502078772462,1,bp,PCR,51176,LEF1
GO:0070365,hepatocyte differentiation,1/15,13/16992,0.01141941267223845,0.04545622163436745,0.019412502078772462,1,bp,PCR,3087,HHEX
GO:0071481,cellular response to X-ray,1/15,13/16992,0.01141941267223845,0.04545622163436745,0.019412502078772462,1,bp,PCR,2625,GATA3
GO:0072182,regulation of nephron tubule epithelial cell differentiation,1/15,13/16992,0.01141941267223845,0.04545622163436745,0.019412502078772462,1,bp,PCR,2625,GATA3
GO:1901722,regulation of cell proliferation involved in kidney development,1/15,13/16992,0.01141941267223845,0.04545622163436745,0.019412502078772462,1,bp,PCR,2625,GATA3
hsa01521,EGFR tyrosine kinase inhibitor resistance,2/15,79/7430,0.010715734905584109,0.045924578166789035,0.028602149560017737,2,kg,PCR,596/3480,BCL2/IGF1R
GO:0042445,hormone metabolic process,2/15,188/16992,0.011630220463610777,0.04604029423197985,0.019661935712005463,2,bp,PCR,2625/8912,GATA3/CACNA1H
GO:0097305,response to alcohol,2/15,188/16992,0.011630220463610777,0.04604029423197985,0.019661935712005463,2,bp,PCR,2625/595,GATA3/CCND1
GO:0004675,transmembrane receptor protein serine/threonine kinase activity,1/15,16/16982,0.01404553517960161,0.04628642275095985,0.022177160809897283,1,mf,PCR,658,BMPR1B
GO:0005159,insulin-like growth factor receptor binding,1/15,16/16982,0.01404553517960161,0.04628642275095985,0.022177160809897283,1,mf,PCR,3667,IRS1
GO:0034185,apolipoprotein binding,1/15,16/16982,0.01404553517960161,0.04628642275095985,0.022177160809897283,1,mf,PCR,4137,MAPT
GO:0070742,C2H2 zinc finger domain binding,1/15,15/16982,0.01317311204532201,0.04628642275095985,0.022177160809897283,1,mf,PCR,51176,LEF1
GO:0002726,positive regulation of T cell cytokine production,1/15,14/16992,0.01229276851238914,0.046453312744509624,0.019838319107826328,1,bp,PCR,2625,GATA3
GO:0016973,poly(A)+ mRNA export from nucleus,1/15,14/16992,0.01229276851238914,0.046453312744509624,0.019838319107826328,1,bp,PCR,3087,HHEX
GO:0021535,cell migration in hindbrain,1/15,14/16992,0.01229276851238914,0.046453312744509624,0.019838319107826328,1,bp,PCR,51176,LEF1
GO:0030852,regulation of granulocyte differentiation,1/15,14/16992,0.01229276851238914,0.046453312744509624,0.019838319107826328,1,bp,PCR,51176,LEF1
GO:0032736,positive regulation of interleukin-13 production,1/15,14/16992,0.01229276851238914,0.046453312744509624,0.019838319107826328,1,bp,PCR,2625,GATA3
GO:0032869,cellular response to insulin stimulus,2/15,194/16992,0.012348758154768737,0.046453312744509624,0.019838319107826328,2,bp,PCR,3480/3667,IGF1R/IRS1
GO:0033151,V(D)J recombination,1/15,14/16992,0.01229276851238914,0.046453312744509624,0.019838319107826328,1,bp,PCR,51176,LEF1
GO:0035637,multicellular organismal signaling,2/15,192/16992,0.01210710300154616,0.046453312744509624,0.019838319107826328,2,bp,PCR,776/8912,CACNA1D/CACNA1H
GO:0035864,response to potassium ion,1/15,14/16992,0.01229276851238914,0.046453312744509624,0.019838319107826328,1,bp,PCR,8912,CACNA1H
GO:0035988,chondrocyte proliferation,1/15,14/16992,0.01229276851238914,0.046453312744509624,0.019838319107826328,1,bp,PCR,658,BMPR1B
GO:0046321,positive regulation of fatty acid oxidation,1/15,14/16992,0.01229276851238914,0.046453312744509624,0.019838319107826328,1,bp,PCR,3667,IRS1
GO:0048266,behavioral response to pain,1/15,14/16992,0.01229276851238914,0.046453312744509624,0.019838319107826328,1,bp,PCR,7060,THBS4
GO:0048853,forebrain morphogenesis,1/15,14/16992,0.01229276851238914,0.046453312744509624,0.019838319107826328,1,bp,PCR,3087,HHEX
GO:0070585,protein localization to mitochondrion,2/15,194/16992,0.012348758154768737,0.046453312744509624,0.019838319107826328,2,bp,PCR,596/4137,BCL2/MAPT
GO:0072216,positive regulation of metanephros development,1/15,14/16992,0.01229276851238914,0.046453312744509624,0.019838319107826328,1,bp,PCR,5979,RET
GO:0072655,establishment of protein localization to mitochondrion,2/15,192/16992,0.01210710300154616,0.046453312744509624,0.019838319107826328,2,bp,PCR,596/4137,BCL2/MAPT
GO:0090192,regulation of glomerulus development,1/15,14/16992,0.01229276851238914,0.046453312744509624,0.019838319107826328,1,bp,PCR,5979,RET
GO:2001241,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,1/15,14/16992,0.01229276851238914,0.046453312744509624,0.019838319107826328,1,bp,PCR,5979,RET
GO:2001275,positive regulation of glucose import in response to insulin stimulus,1/15,14/16992,0.01229276851238914,0.046453312744509624,0.019838319107826328,1,bp,PCR,3667,IRS1
GO:0071229,cellular response to acid chemical,2/15,195/16992,0.012470386032342077,0.046788367437273014,0.019981407329546327,2,bp,PCR,4602/5979,MYB/RET
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,2/15,196/16992,0.012592546238893531,0.047123669128359386,0.020124601034196627,2,bp,PCR,4137/51176,MAPT/LEF1
GO:0022898,regulation of transmembrane transporter activity,2/15,197/16992,0.012715237871921045,0.047213945276357985,0.020163154302543097,2,bp,PCR,596/776,BCL2/CACNA1D
GO:0060541,respiratory system development,2/15,197/16992,0.012715237871921045,0.047213945276357985,0.020163154302543097,2,bp,PCR,51176/3087,LEF1/HHEX
GO:0090276,regulation of peptide hormone secretion,2/15,197/16992,0.012715237871921045,0.047213945276357985,0.020163154302543097,2,bp,PCR,776/3667,CACNA1D/IRS1
GO:0002830,positive regulation of type 2 immune response,1/15,15/16992,0.013165404186338825,0.047296714539422226,0.020198501685882986,1,bp,PCR,2625,GATA3
GO:0007158,neuron cell-cell adhesion,1/15,15/16992,0.013165404186338825,0.047296714539422226,0.020198501685882986,1,bp,PCR,5979,RET
GO:0030073,insulin secretion,2/15,199/16992,0.0129622118123717,0.047296714539422226,0.020198501685882986,2,bp,PCR,776/3667,CACNA1D/IRS1
GO:0030178,negative regulation of Wnt signaling pathway,2/15,198/16992,0.012838460029917866,0.047296714539422226,0.020198501685882986,2,bp,PCR,51176/595,LEF1/CCND1
GO:0043923,positive regulation by host of viral transcription,1/15,15/16992,0.013165404186338825,0.047296714539422226,0.020198501685882986,1,bp,PCR,51176,LEF1
GO:0045725,positive regulation of glycogen biosynthetic process,1/15,15/16992,0.013165404186338825,0.047296714539422226,0.020198501685882986,1,bp,PCR,3667,IRS1
GO:0046184,aldehyde biosynthetic process,1/15,15/16992,0.013165404186338825,0.047296714539422226,0.020198501685882986,1,bp,PCR,8912,CACNA1H
GO:0051571,positive regulation of histone H3-K4 methylation,1/15,15/16992,0.013165404186338825,0.047296714539422226,0.020198501685882986,1,bp,PCR,4602,MYB
GO:0071599,otic vesicle development,1/15,15/16992,0.013165404186338825,0.047296714539422226,0.020198501685882986,1,bp,PCR,2625,GATA3
GO:0072160,nephron tubule epithelial cell differentiation,1/15,15/16992,0.013165404186338825,0.047296714539422226,0.020198501685882986,1,bp,PCR,2625,GATA3
GO:0072176,nephric duct development,1/15,15/16992,0.013165404186338825,0.047296714539422226,0.020198501685882986,1,bp,PCR,2625,GATA3
GO:0090136,epithelial cell-cell adhesion,1/15,15/16992,0.013165404186338825,0.047296714539422226,0.020198501685882986,1,bp,PCR,7060,THBS4
GO:1901991,negative regulation of mitotic cell cycle phase transition,2/15,200/16992,0.013086492319763688,0.047296714539422226,0.020198501685882986,2,bp,PCR,596/595,BCL2/CCND1
GO:0001894,tissue homeostasis,2/15,202/16992,0.013336635916249184,0.047673497043905666,0.02035941015756291,2,bp,PCR,596/53832,BCL2/IL20RA
GO:0009952,anterior/posterior pattern specification,2/15,202/16992,0.013336635916249184,0.047673497043905666,0.02035941015756291,2,bp,PCR,51176/3087,LEF1/HHEX
GO:1901617,organic hydroxy compound biosynthetic process,2/15,203/16992,0.013462497211264789,0.04800399129674318,0.020500550801011815,2,bp,PCR,2625/8912,GATA3/CACNA1H
GO:0001649,osteoblast differentiation,2/15,204/16992,0.013588883643060903,0.048215372333527205,0.020590823038088388,2,bp,PCR,658/51176,BMPR1B/LEF1
GO:0045444,fat cell differentiation,2/15,204/16992,0.013588883643060903,0.048215372333527205,0.020590823038088388,2,bp,PCR,2625/595,GATA3/CCND1
GO:0043583,ear development,2/15,205/16992,0.01371579431707315,0.04842652686396589,0.02068099854352424,2,bp,PCR,2625/596,GATA3/BCL2
GO:0051924,regulation of calcium ion transport,2/15,205/16992,0.01371579431707315,0.04842652686396589,0.02068099854352424,2,bp,PCR,596/776,BCL2/CACNA1D
GO:0006590,thyroid hormone generation,1/15,16/16992,0.014037320245548268,0.048489493252050146,0.020707888924986442,1,bp,PCR,2625,GATA3
GO:0031998,regulation of fatty acid beta-oxidation,1/15,16/16992,0.014037320245548268,0.048489493252050146,0.020707888924986442,1,bp,PCR,3667,IRS1
GO:0045064,T-helper 2 cell differentiation,1/15,16/16992,0.014037320245548268,0.048489493252050146,0.020707888924986442,1,bp,PCR,2625,GATA3
GO:0048070,regulation of developmental pigmentation,1/15,16/16992,0.014037320245548268,0.048489493252050146,0.020707888924986442,1,bp,PCR,596,BCL2
GO:0070875,positive regulation of glycogen metabolic process,1/15,16/16992,0.014037320245548268,0.048489493252050146,0.020707888924986442,1,bp,PCR,3667,IRS1
GO:0072224,metanephric glomerulus development,1/15,16/16992,0.014037320245548268,0.048489493252050146,0.020707888924986442,1,bp,PCR,5979,RET
GO:1904950,negative regulation of establishment of protein localization,2/15,207/16992,0.013971184818428876,0.048489493252050146,0.020707888924986442,2,bp,PCR,4137/3667,MAPT/IRS1
GO:1905314,semi-lunar valve development,1/15,16/16992,0.014037320245548268,0.048489493252050146,0.020707888924986442,1,bp,PCR,2625,GATA3
GO:2000811,negative regulation of anoikis,1/15,16/16992,0.014037320245548268,0.048489493252050146,0.020707888924986442,1,bp,PCR,596,BCL2
GO:1901988,negative regulation of cell cycle phase transition,2/15,208/16992,0.014099662861581324,0.04858804683955003,0.020749977150831538,2,bp,PCR,596/595,BCL2/CCND1
GO:0002363,alpha-beta T cell lineage commitment,1/15,17/16992,0.014908517241089991,0.04902411733511743,0.020936205110334737,1,bp,PCR,596,BCL2
GO:0006704,glucocorticoid biosynthetic process,1/15,17/16992,0.014908517241089991,0.04902411733511743,0.020936205110334737,1,bp,PCR,8912,CACNA1H
GO:0010224,response to UV-B,1/15,17/16992,0.014908517241089991,0.04902411733511743,0.020936205110334737,1,bp,PCR,596,BCL2
GO:0010523,negative regulation of calcium ion transport into cytosol,1/15,17/16992,0.014908517241089991,0.04902411733511743,0.020936205110334737,1,bp,PCR,596,BCL2
GO:0021542,dentate gyrus development,1/15,17/16992,0.014908517241089991,0.04902411733511743,0.020936205110334737,1,bp,PCR,51176,LEF1
GO:0032409,regulation of transporter activity,2/15,211/16992,0.014488217476489016,0.04902411733511743,0.020936205110334737,2,bp,PCR,596/776,BCL2/CACNA1D
GO:0033630,positive regulation of cell adhesion mediated by integrin,1/15,17/16992,0.014908517241089991,0.04902411733511743,0.020936205110334737,1,bp,PCR,5979,RET
GO:0034643,"establishment of mitochondrion localization, microtubule-mediated",1/15,17/16992,0.014908517241089991,0.04902411733511743,0.020936205110334737,1,bp,PCR,4137,MAPT
GO:0036037,"CD8-positive, alpha-beta T cell activation",1/15,17/16992,0.014908517241089991,0.04902411733511743,0.020936205110334737,1,bp,PCR,596,BCL2
GO:0043543,protein acylation,2/15,211/16992,0.014488217476489016,0.04902411733511743,0.020936205110334737,2,bp,PCR,2625/51176,GATA3/LEF1
GO:0045063,T-helper 1 cell differentiation,1/15,17/16992,0.014908517241089991,0.04902411733511743,0.020936205110334737,1,bp,PCR,51176,LEF1
GO:0047497,mitochondrion transport along microtubule,1/15,17/16992,0.014908517241089991,0.04902411733511743,0.020936205110334737,1,bp,PCR,4137,MAPT
GO:0050870,positive regulation of T cell activation,2/15,211/16992,0.014488217476489016,0.04902411733511743,0.020936205110334737,2,bp,PCR,2625/4602,GATA3/MYB
GO:0060572,morphogenesis of an epithelial bud,1/15,17/16992,0.014908517241089991,0.04902411733511743,0.020936205110334737,1,bp,PCR,3087,HHEX
GO:0060749,mammary gland alveolus development,1/15,17/16992,0.014908517241089991,0.04902411733511743,0.020936205110334737,1,bp,PCR,595,CCND1
GO:0061377,mammary gland lobule development,1/15,17/16992,0.014908517241089991,0.04902411733511743,0.020936205110334737,1,bp,PCR,595,CCND1
GO:0071636,positive regulation of transforming growth factor beta production,1/15,17/16992,0.014908517241089991,0.04902411733511743,0.020936205110334737,1,bp,PCR,4602,MYB
GO:0072643,interferon-gamma secretion,1/15,17/16992,0.014908517241089991,0.04902411733511743,0.020936205110334737,1,bp,PCR,2625,GATA3
GO:1902043,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,1/15,17/16992,0.014908517241089991,0.04902411733511743,0.020936205110334737,1,bp,PCR,658,BMPR1B
GO:2000116,regulation of cysteine-type endopeptidase activity,2/15,210/16992,0.01435818007975136,0.04902411733511743,0.020936205110334737,2,bp,PCR,4137/51176,MAPT/LEF1
GO:0045765,regulation of angiogenesis,2/15,215/16992,0.015013538280390783,0.049256745454158805,0.021035551111434334,2,bp,PCR,7060/3087,THBS4/HHEX
GO:0001774,microglial cell activation,1/15,18/16992,0.015778995723645495,0.05049981482155585,0.021566415442234966,1,bp,PCR,4137,MAPT
GO:0032026,response to magnesium ion,1/15,18/16992,0.015778995723645495,0.05049981482155585,0.021566415442234966,1,bp,PCR,595,CCND1
GO:0032703,negative regulation of interleukin-2 production,1/15,18/16992,0.015778995723645495,0.05049981482155585,0.021566415442234966,1,bp,PCR,2625,GATA3
GO:0035455,response to interferon-alpha,1/15,18/16992,0.015778995723645495,0.05049981482155585,0.021566415442234966,1,bp,PCR,2625,GATA3
GO:0048339,paraxial mesoderm development,1/15,18/16992,0.015778995723645495,0.05049981482155585,0.021566415442234966,1,bp,PCR,51176,LEF1
GO:0070734,histone H3-K27 methylation,1/15,18/16992,0.015778995723645495,0.05049981482155585,0.021566415442234966,1,bp,PCR,2625,GATA3
GO:0090185,negative regulation of kidney development,1/15,18/16992,0.015778995723645495,0.05049981482155585,0.021566415442234966,1,bp,PCR,2625,GATA3
GO:1903039,positive regulation of leukocyte cell-cell adhesion,2/15,220/16992,0.015681758205963795,0.05049981482155585,0.021566415442234966,2,bp,PCR,2625/4602,GATA3/MYB
GO:1905276,regulation of epithelial tube formation,1/15,18/16992,0.015778995723645495,0.05049981482155585,0.021566415442234966,1,bp,PCR,2625,GATA3
GO:1905331,negative regulation of morphogenesis of an epithelium,1/15,18/16992,0.015778995723645495,0.05049981482155585,0.021566415442234966,1,bp,PCR,2625,GATA3
GO:2000696,regulation of epithelial cell differentiation involved in kidney development,1/15,18/16992,0.015778995723645495,0.05049981482155585,0.021566415442234966,1,bp,PCR,2625,GATA3
GO:0010821,regulation of mitochondrion organization,2/15,221/16992,0.015816935898415284,0.05050874863560614,0.021570230710587394,2,bp,PCR,596/4137,BCL2/MAPT
GO:0001818,negative regulation of cytokine production,2/15,222/16992,0.01595262277597791,0.05082908853454602,0.021707034842794078,2,bp,PCR,2625/51176,GATA3/LEF1
GO:0003215,cardiac right ventricle morphogenesis,1/15,19/16992,0.016648756243507923,0.051672273697453315,0.022067124906138727,1,bp,PCR,2625,GATA3
GO:0006582,melanin metabolic process,1/15,19/16992,0.016648756243507923,0.051672273697453315,0.022067124906138727,1,bp,PCR,596,BCL2
GO:0032332,positive regulation of chondrocyte differentiation,1/15,19/16992,0.016648756243507923,0.051672273697453315,0.022067124906138727,1,bp,PCR,658,BMPR1B
GO:0042180,cellular ketone metabolic process,2/15,225/16992,0.016362729755100846,0.051672273697453315,0.022067124906138727,2,bp,PCR,3667/8912,IRS1/CACNA1H
GO:0045624,positive regulation of T-helper cell differentiation,1/15,19/16992,0.016648756243507923,0.051672273697453315,0.022067124906138727,1,bp,PCR,4602,MYB
GO:0051654,establishment of mitochondrion localization,1/15,19/16992,0.016648756243507923,0.051672273697453315,0.022067124906138727,1,bp,PCR,4137,MAPT
GO:0060046,regulation of acrosome reaction,1/15,19/16992,0.016648756243507923,0.051672273697453315,0.022067124906138727,1,bp,PCR,8912,CACNA1H
GO:0060438,trachea development,1/15,19/16992,0.016648756243507923,0.051672273697453315,0.022067124906138727,1,bp,PCR,51176,LEF1
GO:0060713,labyrinthine layer morphogenesis,1/15,19/16992,0.016648756243507923,0.051672273697453315,0.022067124906138727,1,bp,PCR,51176,LEF1
GO:0072079,nephron tubule formation,1/15,19/16992,0.016648756243507923,0.051672273697453315,0.022067124906138727,1,bp,PCR,2625,GATA3
GO:0080111,DNA demethylation,1/15,19/16992,0.016648756243507923,0.051672273697453315,0.022067124906138727,1,bp,PCR,2625,GATA3
GO:2001273,regulation of glucose import in response to insulin stimulus,1/15,19/16992,0.016648756243507923,0.051672273697453315,0.022067124906138727,1,bp,PCR,3667,IRS1
GO:0000302,response to reactive oxygen species,2/15,228/16992,0.016777387889794746,0.05173627982325118,0.022094459317258498,2,bp,PCR,596/4602,BCL2/MYB
GO:0048872,homeostasis of number of cells,2/15,228/16992,0.016777387889794746,0.05173627982325118,0.022094459317258498,2,bp,PCR,2625/596,GATA3/BCL2
GO:2000146,negative regulation of cell motility,2/15,228/16992,0.016777387889794746,0.05173627982325118,0.022094459317258498,2,bp,PCR,2625/596,GATA3/BCL2
GO:0008016,regulation of heart contraction,2/15,229/16992,0.016916614564076973,0.052053908198241135,0.022230105467951934,2,bp,PCR,776/8912,CACNA1D/CACNA1H
GO:0007281,germ cell development,2/15,231/16992,0.0171965736345487,0.05244391180580173,0.022396660134624335,2,bp,PCR,658/596,BMPR1B/BCL2
GO:0010971,positive regulation of G2/M transition of mitotic cell cycle,1/15,20/16992,0.017517799350580954,0.05244391180580173,0.022396660134624335,1,bp,PCR,595,CCND1
GO:0031116,positive regulation of microtubule polymerization,1/15,20/16992,0.017517799350580954,0.05244391180580173,0.022396660134624335,1,bp,PCR,4137,MAPT
GO:0042403,thyroid hormone metabolic process,1/15,20/16992,0.017517799350580954,0.05244391180580173,0.022396660134624335,1,bp,PCR,2625,GATA3
GO:0043369,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment",1/15,20/16992,0.017517799350580954,0.05244391180580173,0.022396660134624335,1,bp,PCR,596,BCL2
GO:0043496,regulation of protein homodimerization activity,1/15,20/16992,0.017517799350580954,0.05244391180580173,0.022396660134624335,1,bp,PCR,596,BCL2
GO:0043586,tongue development,1/15,20/16992,0.017517799350580954,0.05244391180580173,0.022396660134624335,1,bp,PCR,51176,LEF1
GO:0044321,response to leptin,1/15,20/16992,0.017517799350580954,0.05244391180580173,0.022396660134624335,1,bp,PCR,595,CCND1
GO:0051900,regulation of mitochondrial depolarization,1/15,20/16992,0.017517799350580954,0.05244391180580173,0.022396660134624335,1,bp,PCR,596,BCL2
GO:0060065,uterus development,1/15,20/16992,0.017517799350580954,0.05244391180580173,0.022396660134624335,1,bp,PCR,2625,GATA3
GO:0060231,mesenchymal to epithelial transition,1/15,20/16992,0.017517799350580954,0.05244391180580173,0.022396660134624335,1,bp,PCR,2625,GATA3
GO:0072111,cell proliferation involved in kidney development,1/15,20/16992,0.017517799350580954,0.05244391180580173,0.022396660134624335,1,bp,PCR,2625,GATA3
GO:2000114,regulation of establishment of cell polarity,1/15,20/16992,0.017517799350580954,0.05244391180580173,0.022396660134624335,1,bp,PCR,2625,GATA3
GO:0030506,ankyrin binding,1/15,19/16982,0.016658487353123363,0.05251044926528017,0.025159271517303027,1,mf,PCR,776,CACNA1D
GO:0070064,proline-rich region binding,1/15,19/16982,0.016658487353123363,0.05251044926528017,0.025159271517303027,1,mf,PCR,595,CCND1
GO:0001502,cartilage condensation,1/15,21/16992,0.018386125594379132,0.05284172495824563,0.022566549940048496,1,bp,PCR,658,BMPR1B
GO:0002438,acute inflammatory response to antigenic stimulus,1/15,21/16992,0.018386125594379132,0.05284172495824563,0.022566549940048496,1,bp,PCR,2625,GATA3
GO:0009713,catechol-containing compound biosynthetic process,1/15,21/16992,0.018386125594379132,0.05284172495824563,0.022566549940048496,1,bp,PCR,2625,GATA3
GO:0010976,positive regulation of neuron projection development,2/15,236/16992,0.01790521419560284,0.05284172495824563,0.022566549940048496,2,bp,PCR,4137/5979,MAPT/RET
GO:0030072,peptide hormone secretion,2/15,237/16992,0.01804843416378314,0.05284172495824563,0.022566549940048496,2,bp,PCR,776/3667,CACNA1D/IRS1
GO:0031290,retinal ganglion cell axon guidance,1/15,21/16992,0.018386125594379132,0.05284172495824563,0.022566549940048496,1,bp,PCR,658,BMPR1B
GO:0032469,endoplasmic reticulum calcium ion homeostasis,1/15,21/16992,0.018386125594379132,0.05284172495824563,0.022566549940048496,1,bp,PCR,596,BCL2
GO:0033141,positive regulation of peptidyl-serine phosphorylation of STAT protein,1/15,21/16992,0.018386125594379132,0.05284172495824563,0.022566549940048496,1,bp,PCR,5979,RET
GO:0042423,catecholamine biosynthetic process,1/15,21/16992,0.018386125594379132,0.05284172495824563,0.022566549940048496,1,bp,PCR,2625,GATA3
GO:0044381,glucose import in response to insulin stimulus,1/15,21/16992,0.018386125594379132,0.05284172495824563,0.022566549940048496,1,bp,PCR,3667,IRS1
GO:0045061,thymic T cell selection,1/15,21/16992,0.018386125594379132,0.05284172495824563,0.022566549940048496,1,bp,PCR,2625,GATA3
GO:0045956,positive regulation of calcium ion-dependent exocytosis,1/15,21/16992,0.018386125594379132,0.05284172495824563,0.022566549940048496,1,bp,PCR,8912,CACNA1H
GO:0048485,sympathetic nervous system development,1/15,21/16992,0.018386125594379132,0.05284172495824563,0.022566549940048496,1,bp,PCR,2625,GATA3
GO:0051412,response to corticosterone,1/15,21/16992,0.018386125594379132,0.05284172495824563,0.022566549940048496,1,bp,PCR,595,CCND1
GO:0051647,nucleus localization,1/15,21/16992,0.018386125594379132,0.05284172495824563,0.022566549940048496,1,bp,PCR,3087,HHEX
GO:0072593,reactive oxygen species metabolic process,2/15,236/16992,0.01790521419560284,0.05284172495824563,0.022566549940048496,2,bp,PCR,596/4137,BCL2/MAPT
GO:0090287,regulation of cellular response to growth factor stimulus,2/15,236/16992,0.01790521419560284,0.05284172495824563,0.022566549940048496,2,bp,PCR,2625/3087,GATA3/HHEX
GO:1900120,regulation of receptor binding,1/15,21/16992,0.018386125594379132,0.05284172495824563,0.022566549940048496,1,bp,PCR,51176,LEF1
GO:1901342,regulation of vasculature development,2/15,239/16992,0.018336359051056586,0.05284172495824563,0.022566549940048496,2,bp,PCR,7060/3087,THBS4/HHEX
GO:1902751,positive regulation of cell cycle G2/M phase transition,1/15,21/16992,0.018386125594379132,0.05284172495824563,0.022566549940048496,1,bp,PCR,595,CCND1
GO:0006469,negative regulation of protein kinase activity,2/15,240/16992,0.01848106224820574,0.053008555789763774,0.022637796597760156,2,bp,PCR,3480/3087,IGF1R/HHEX
GO:0000082,G1/S transition of mitotic cell cycle,2/15,241/16992,0.018626258134664328,0.053212590337003256,0.02272493144817266,2,bp,PCR,596/595,BCL2/CCND1
GO:0045165,cell fate commitment,2/15,241/16992,0.018626258134664328,0.053212590337003256,0.02272493144817266,2,bp,PCR,2625/596,GATA3/BCL2
GO:0002724,regulation of T cell cytokine production,1/15,22/16992,0.01925373552402876,0.05341238986106048,0.022810257692559982,1,bp,PCR,2625,GATA3
GO:0021854,hypothalamus development,1/15,22/16992,0.01925373552402876,0.05341238986106048,0.022810257692559982,1,bp,PCR,51176,LEF1
GO:0032753,positive regulation of interleukin-4 production,1/15,22/16992,0.01925373552402876,0.05341238986106048,0.022810257692559982,1,bp,PCR,2625,GATA3
GO:0032878,regulation of establishment or maintenance of cell polarity,1/15,22/16992,0.01925373552402876,0.05341238986106048,0.022810257692559982,1,bp,PCR,2625,GATA3
GO:0035162,embryonic hemopoiesis,1/15,22/16992,0.01925373552402876,0.05341238986106048,0.022810257692559982,1,bp,PCR,2625,GATA3
GO:0048103,somatic stem cell division,1/15,22/16992,0.01925373552402876,0.05341238986106048,0.022810257692559982,1,bp,PCR,51176,LEF1
GO:0051271,negative regulation of cellular component movement,2/15,243/16992,0.018918124542156113,0.05341238986106048,0.022810257692559982,2,bp,PCR,2625/596,GATA3/BCL2
GO:0060669,embryonic placenta morphogenesis,1/15,22/16992,0.01925373552402876,0.05341238986106048,0.022810257692559982,1,bp,PCR,51176,LEF1
GO:0061213,positive regulation of mesonephros development,1/15,22/16992,0.01925373552402876,0.05341238986106048,0.022810257692559982,1,bp,PCR,2625,GATA3
GO:0070841,inclusion body assembly,1/15,22/16992,0.01925373552402876,0.05341238986106048,0.022810257692559982,1,bp,PCR,4137,MAPT
GO:0071157,negative regulation of cell cycle arrest,1/15,22/16992,0.01925373552402876,0.05341238986106048,0.022810257692559982,1,bp,PCR,595,CCND1
GO:0086012,membrane depolarization during cardiac muscle cell action potential,1/15,22/16992,0.01925373552402876,0.05341238986106048,0.022810257692559982,1,bp,PCR,776,CACNA1D
GO:0090140,regulation of mitochondrial fission,1/15,22/16992,0.01925373552402876,0.05341238986106048,0.022810257692559982,1,bp,PCR,4137,MAPT
GO:0098743,cell aggregation,1/15,22/16992,0.01925373552402876,0.05341238986106048,0.022810257692559982,1,bp,PCR,658,BMPR1B
GO:2000679,positive regulation of transcription regulatory region DNA binding,1/15,22/16992,0.01925373552402876,0.05341238986106048,0.022810257692559982,1,bp,PCR,2625,GATA3
GO:0050851,antigen receptor-mediated signaling pathway,2/15,246/16992,0.019359597889837907,0.053602586064926926,0.022891482749772842,2,bp,PCR,2625/596,GATA3/BCL2
GO:1902911,protein kinase complex,2/15,96/18122,0.002787934962303282,0.05366774802433818,0.03521602057646251,2,cc,PCR,3667/595,IRS1/CCND1
GO:0032868,response to insulin,2/15,247/16992,0.01950773191546522,0.05380539493766511,0.022978094164493836,2,bp,PCR,3480/3667,IGF1R/IRS1
GO:0034599,cellular response to oxidative stress,2/15,247/16992,0.01950773191546522,0.05380539493766511,0.022978094164493836,2,bp,PCR,596/4602,BCL2/MYB
GO:0006700,C21-steroid hormone biosynthetic process,1/15,23/16992,0.020120629688268,0.05384235542279537,0.02299387848330931,1,bp,PCR,8912,CACNA1H
GO:0010769,regulation of cell morphogenesis involved in differentiation,2/15,250/16992,0.019955050781604148,0.05384235542279537,0.02299387848330931,2,bp,PCR,4137/5979,MAPT/RET
GO:0022409,positive regulation of cell-cell adhesion,2/15,249/16992,0.019805459212774663,0.05384235542279537,0.02299387848330931,2,bp,PCR,2625/4602,GATA3/MYB
GO:0031112,positive regulation of microtubule polymerization or depolymerization,1/15,23/16992,0.020120629688268,0.05384235542279537,0.02299387848330931,1,bp,PCR,4137,MAPT
GO:0032967,positive regulation of collagen biosynthetic process,1/15,23/16992,0.020120629688268,0.05384235542279537,0.02299387848330931,1,bp,PCR,4602,MYB
GO:0033139,regulation of peptidyl-serine phosphorylation of STAT protein,1/15,23/16992,0.020120629688268,0.05384235542279537,0.02299387848330931,1,bp,PCR,5979,RET
GO:0033688,regulation of osteoblast proliferation,1/15,23/16992,0.020120629688268,0.05384235542279537,0.02299387848330931,1,bp,PCR,596,BCL2
GO:0046883,regulation of hormone secretion,2/15,249/16992,0.019805459212774663,0.05384235542279537,0.02299387848330931,2,bp,PCR,776/3667,CACNA1D/IRS1
GO:0051570,regulation of histone H3-K9 methylation,1/15,23/16992,0.020120629688268,0.05384235542279537,0.02299387848330931,1,bp,PCR,4602,MYB
GO:0051882,mitochondrial depolarization,1/15,23/16992,0.020120629688268,0.05384235542279537,0.02299387848330931,1,bp,PCR,596,BCL2
GO:0060326,cell chemotaxis,2/15,250/16992,0.019955050781604148,0.05384235542279537,0.02299387848330931,2,bp,PCR,7060/51176,THBS4/LEF1
GO:0072215,regulation of metanephros development,1/15,23/16992,0.020120629688268,0.05384235542279537,0.02299387848330931,1,bp,PCR,5979,RET
GO:0090596,sensory organ morphogenesis,2/15,248/16992,0.0196563526404113,0.05384235542279537,0.02299387848330931,2,bp,PCR,2625/596,GATA3/BCL2
GO:0099623,regulation of cardiac muscle cell membrane repolarization,1/15,23/16992,0.020120629688268,0.05384235542279537,0.02299387848330931,1,bp,PCR,776,CACNA1D
GO:2000027,regulation of organ morphogenesis,2/15,248/16992,0.0196563526404113,0.05384235542279537,0.02299387848330931,2,bp,PCR,2625/596,GATA3/BCL2
GO:2000209,regulation of anoikis,1/15,23/16992,0.020120629688268,0.05384235542279537,0.02299387848330931,1,bp,PCR,596,BCL2
GO:0002360,T cell lineage commitment,1/15,24/16992,0.02098680863544644,0.054610418537851285,0.023321886977670805,1,bp,PCR,596,BCL2
GO:0008211,glucocorticoid metabolic process,1/15,24/16992,0.02098680863544644,0.054610418537851285,0.023321886977670805,1,bp,PCR,8912,CACNA1H
GO:0010714,positive regulation of collagen metabolic process,1/15,24/16992,0.02098680863544644,0.054610418537851285,0.023321886977670805,1,bp,PCR,4602,MYB
GO:0014002,astrocyte development,1/15,24/16992,0.02098680863544644,0.054610418537851285,0.023321886977670805,1,bp,PCR,4137,MAPT
GO:0030318,melanocyte differentiation,1/15,24/16992,0.02098680863544644,0.054610418537851285,0.023321886977670805,1,bp,PCR,596,BCL2
GO:0030878,thyroid gland development,1/15,24/16992,0.02098680863544644,0.054610418537851285,0.023321886977670805,1,bp,PCR,3087,HHEX
GO:0032943,mononuclear cell proliferation,2/15,257/16992,0.021015700383738175,0.054610418537851285,0.023321886977670805,2,bp,PCR,596/51176,BCL2/LEF1
GO:0040013,negative regulation of locomotion,2/15,257/16992,0.021015700383738175,0.054610418537851285,0.023321886977670805,2,bp,PCR,2625/596,GATA3/BCL2
GO:0042554,superoxide anion generation,1/15,24/16992,0.02098680863544644,0.054610418537851285,0.023321886977670805,1,bp,PCR,4137,MAPT
GO:0044253,positive regulation of multicellular organismal metabolic process,1/15,24/16992,0.02098680863544644,0.054610418537851285,0.023321886977670805,1,bp,PCR,4602,MYB
GO:0044843,cell cycle G1/S phase transition,2/15,254/16992,0.020558250035773266,0.054610418537851285,0.023321886977670805,2,bp,PCR,596/595,BCL2/CCND1
GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,1/15,24/16992,0.02098680863544644,0.054610418537851285,0.023321886977670805,1,bp,PCR,3087,HHEX
GO:0046651,lymphocyte proliferation,2/15,255/16992,0.02071025385586748,0.054610418537851285,0.023321886977670805,2,bp,PCR,596/51176,BCL2/LEF1
GO:0048643,positive regulation of skeletal muscle tissue development,1/15,24/16992,0.02098680863544644,0.054610418537851285,0.023321886977670805,1,bp,PCR,596,BCL2
GO:0060251,regulation of glial cell proliferation,1/15,24/16992,0.02098680863544644,0.054610418537851285,0.023321886977670805,1,bp,PCR,4602,MYB
GO:0060561,apoptotic process involved in morphogenesis,1/15,24/16992,0.02098680863544644,0.054610418537851285,0.023321886977670805,1,bp,PCR,51176,LEF1
GO:0060047,heart contraction,2/15,259/16992,0.021323059804417916,0.05530909194756055,0.02362026195321232,2,bp,PCR,776/8912,CACNA1D/CACNA1H
GO:0003015,heart process,2/15,262/16992,0.021787670879173094,0.055578258719891034,0.023735212125917646,2,bp,PCR,776/8912,CACNA1D/CACNA1H
GO:0033032,regulation of myeloid cell apoptotic process,1/15,25/16992,0.021852272913527093,0.055578258719891034,0.023735212125917646,1,bp,PCR,596,BCL2
GO:0035510,DNA dealkylation,1/15,25/16992,0.021852272913527093,0.055578258719891034,0.023735212125917646,1,bp,PCR,2625,GATA3
GO:0043372,"positive regulation of CD4-positive, alpha-beta T cell differentiation",1/15,25/16992,0.021852272913527093,0.055578258719891034,0.023735212125917646,1,bp,PCR,4602,MYB
GO:0043921,modulation by host of viral transcription,1/15,25/16992,0.021852272913527093,0.055578258719891034,0.023735212125917646,1,bp,PCR,51176,LEF1
GO:0052472,modulation by host of symbiont transcription,1/15,25/16992,0.021852272913527093,0.055578258719891034,0.023735212125917646,1,bp,PCR,51176,LEF1
GO:0060037,pharyngeal system development,1/15,25/16992,0.021852272913527093,0.055578258719891034,0.023735212125917646,1,bp,PCR,2625,GATA3
GO:0060384,innervation,1/15,25/16992,0.021852272913527093,0.055578258719891034,0.023735212125917646,1,bp,PCR,5979,RET
GO:0060571,morphogenesis of an epithelial fold,1/15,25/16992,0.021852272913527093,0.055578258719891034,0.023735212125917646,1,bp,PCR,3087,HHEX
GO:0090322,regulation of superoxide metabolic process,1/15,25/16992,0.021852272913527093,0.055578258719891034,0.023735212125917646,1,bp,PCR,4137,MAPT
GO:1904030,negative regulation of cyclin-dependent protein kinase activity,1/15,25/16992,0.021852272913527093,0.055578258719891034,0.023735212125917646,1,bp,PCR,3087,HHEX
hsa04211,Longevity regulating pathway,2/15,89/7430,0.01346241185881979,0.055706531829599136,0.034694418946504726,2,kg,PCR,3480/3667,IGF1R/IRS1
GO:0050792,regulation of viral process,2/15,265/16992,0.022256548141314014,0.056506465864078155,0.024131611616860834,2,bp,PCR,596/51176,BCL2/LEF1
GO:0002063,chondrocyte development,1/15,26/16992,0.02271702307008394,0.05657601759395255,0.024161314329761815,1,bp,PCR,658,BMPR1B
GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,1/15,26/16992,0.02271702307008394,0.05657601759395255,0.024161314329761815,1,bp,PCR,3087,HHEX
GO:0032350,regulation of hormone metabolic process,1/15,26/16992,0.02271702307008394,0.05657601759395255,0.024161314329761815,1,bp,PCR,2625,GATA3
GO:0033687,osteoblast proliferation,1/15,26/16992,0.02271702307008394,0.05657601759395255,0.024161314329761815,1,bp,PCR,596,BCL2
GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,1/15,26/16992,0.02271702307008394,0.05657601759395255,0.024161314329761815,1,bp,PCR,2625,GATA3
GO:0045992,negative regulation of embryonic development,1/15,26/16992,0.02271702307008394,0.05657601759395255,0.024161314329761815,1,bp,PCR,2625,GATA3
GO:0052312,modulation of transcription in other organism involved in symbiotic interaction,1/15,26/16992,0.02271702307008394,0.05657601759395255,0.024161314329761815,1,bp,PCR,51176,LEF1
GO:0061217,regulation of mesonephros development,1/15,26/16992,0.02271702307008394,0.05657601759395255,0.024161314329761815,1,bp,PCR,2625,GATA3
GO:0080154,regulation of fertilization,1/15,26/16992,0.02271702307008394,0.05657601759395255,0.024161314329761815,1,bp,PCR,8912,CACNA1H
GO:1900078,positive regulation of cellular response to insulin stimulus,1/15,26/16992,0.02271702307008394,0.05657601759395255,0.024161314329761815,1,bp,PCR,3667,IRS1
GO:2000352,negative regulation of endothelial cell apoptotic process,1/15,26/16992,0.02271702307008394,0.05657601759395255,0.024161314329761815,1,bp,PCR,2625,GATA3
GO:0048018,receptor agonist activity,1/15,21/16982,0.018396863289351528,0.056756280360765354,0.027193571715502827,1,mf,PCR,4137,MAPT
GO:0005088,Ras guanyl-nucleotide exchange factor activity,2/15,250/16982,0.0199770786168534,0.0572390929362096,0.027424901152739267,2,mf,PCR,5979/3667,RET/IRS1
GO:0005248,voltage-gated sodium channel activity,1/15,23/16982,0.020132370618942685,0.0572390929362096,0.027424901152739267,1,mf,PCR,8912,CACNA1H
GO:0017025,TBP-class protein binding,1/15,23/16982,0.020132370618942685,0.0572390929362096,0.027424901152739267,1,mf,PCR,3087,HHEX
GO:1905030,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,1/15,23/16982,0.020132370618942685,0.0572390929362096,0.027424901152739267,1,mf,PCR,8912,CACNA1H
GO:0002828,regulation of type 2 immune response,1/15,27/16992,0.02358105965230395,0.05723983567628509,0.02444480401367924,1,bp,PCR,2625,GATA3
GO:0005979,regulation of glycogen biosynthetic process,1/15,27/16992,0.02358105965230395,0.05723983567628509,0.02444480401367924,1,bp,PCR,3667,IRS1
GO:0010506,regulation of autophagy,2/15,272/16992,0.02336705904251125,0.05723983567628509,0.02444480401367924,2,bp,PCR,596/4137,BCL2/MAPT
GO:0010948,negative regulation of cell cycle process,2/15,271/16992,0.02320701092931981,0.05723983567628509,0.02444480401367924,2,bp,PCR,596/595,BCL2/CCND1
GO:0010962,regulation of glucan biosynthetic process,1/15,27/16992,0.02358105965230395,0.05723983567628509,0.02444480401367924,1,bp,PCR,3667,IRS1
GO:0021846,cell proliferation in forebrain,1/15,27/16992,0.02358105965230395,0.05723983567628509,0.02444480401367924,1,bp,PCR,3087,HHEX
GO:0022412,cellular process involved in reproduction in multicellular organism,2/15,273/16992,0.0235275728406381,0.05723983567628509,0.02444480401367924,2,bp,PCR,658/596,BMPR1B/BCL2
GO:0031069,hair follicle morphogenesis,1/15,27/16992,0.02358105965230395,0.05723983567628509,0.02444480401367924,1,bp,PCR,596,BCL2
GO:0048753,pigment granule organization,1/15,27/16992,0.02358105965230395,0.05723983567628509,0.02444480401367924,1,bp,PCR,596,BCL2
GO:0050996,positive regulation of lipid catabolic process,1/15,27/16992,0.02358105965230395,0.05723983567628509,0.02444480401367924,1,bp,PCR,3667,IRS1
GO:0070588,calcium ion transmembrane transport,2/15,272/16992,0.02336705904251125,0.05723983567628509,0.02444480401367924,2,bp,PCR,776/8912,CACNA1D/CACNA1H
GO:0070661,leukocyte proliferation,2/15,270/16992,0.023047429330390206,0.05723983567628509,0.02444480401367924,2,bp,PCR,596/51176,BCL2/LEF1
GO:0071634,regulation of transforming growth factor beta production,1/15,27/16992,0.02358105965230395,0.05723983567628509,0.02444480401367924,1,bp,PCR,4602,MYB
GO:0090023,positive regulation of neutrophil chemotaxis,1/15,27/16992,0.02358105965230395,0.05723983567628509,0.02444480401367924,1,bp,PCR,7060,THBS4
GO:1903522,regulation of blood circulation,2/15,273/16992,0.0235275728406381,0.05723983567628509,0.02444480401367924,2,bp,PCR,776/8912,CACNA1D/CACNA1H
GO:0045930,negative regulation of mitotic cell cycle,2/15,274/16992,0.023688551495303932,0.05740379173482588,0.024514822972862685,2,bp,PCR,596/595,BCL2/CCND1
GO:0071813,lipoprotein particle binding,1/15,24/16982,0.0209990499302648,0.057450230941290495,0.02752606346370362,1,mf,PCR,4137,MAPT
GO:0071814,protein-lipid complex binding,1/15,24/16982,0.0209990499302648,0.057450230941290495,0.02752606346370362,1,mf,PCR,4137,MAPT
hsa04713,Circadian entrainment,2/15,96/7430,0.015549325661994287,0.05830997123247857,0.03631585927636824,2,kg,PCR,776/8912,CACNA1D/CACNA1H
hsa04925,Aldosterone synthesis and secretion,2/15,96/7430,0.015549325661994287,0.05830997123247857,0.03631585927636824,2,kg,PCR,776/8912,CACNA1D/CACNA1H
hsa05222,Small cell lung cancer,2/15,93/7430,0.014638672077365177,0.05830997123247857,0.03631585927636824,2,kg,PCR,596/595,BCL2/CCND1
GO:0018105,peptidyl-serine phosphorylation,2/15,277/16992,0.024174268328506516,0.058482194592700106,0.02497536493978256,2,bp,PCR,596/5979,BCL2/RET
GO:0043027,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,1/15,25/16982,0.02186501373796912,0.05871161096306522,0.028130427031305305,1,mf,PCR,51176,LEF1
GO:0001782,B cell homeostasis,1/15,28/16992,0.024444383206988052,0.058740098107762255,0.025085505033751163,1,bp,PCR,596,BCL2
GO:0042501,serine phosphorylation of STAT protein,1/15,28/16992,0.024444383206988052,0.058740098107762255,0.025085505033751163,1,bp,PCR,5979,RET
GO:0046320,regulation of fatty acid oxidation,1/15,28/16992,0.024444383206988052,0.058740098107762255,0.025085505033751163,1,bp,PCR,3667,IRS1
GO:0071604,transforming growth factor beta production,1/15,28/16992,0.024444383206988052,0.058740098107762255,0.025085505033751163,1,bp,PCR,4602,MYB
GO:0043414,macromolecule methylation,2/15,279/16992,0.024500388687850982,0.05877639156000311,0.025101004489969464,2,bp,PCR,2625/4602,GATA3/MYB
hsa04066,HIF-1 signaling pathway,2/15,100/7430,0.01680093217231608,0.059297407666997926,0.03693084161716537,2,kg,PCR,596/3480,BCL2/IGF1R
hsa04933,AGE-RAGE signaling pathway in diabetic complications,2/15,99/7430,0.016484054739542356,0.059297407666997926,0.03693084161716537,2,kg,PCR,596/595,BCL2/CCND1
GO:0034399,nuclear periphery,2/15,122/18122,0.00445699375214068,0.059435956284353546,0.039001037616527276,2,cc,PCR,4602/4137,MYB/MAPT
GO:0043025,neuronal cell body,3/15,422/18122,0.004631373216962614,0.059435956284353546,0.039001037616527276,3,cc,PCR,658/4137/5979,BMPR1B/MAPT/RET
GO:0097193,intrinsic apoptotic signaling pathway,2/15,281/16992,0.024828348670709332,0.05946389506634885,0.025394609254427266,2,bp,PCR,596/53832,BCL2/IL20RA
GO:0001569,branching involved in blood vessel morphogenesis,1/15,30/16992,0.02616889341901496,0.05968999975099126,0.025491169362215075,1,bp,PCR,51176,LEF1
GO:0001702,gastrulation with mouth forming second,1/15,29/16992,0.02530699428054939,0.05968999975099126,0.025491169362215075,1,bp,PCR,3087,HHEX
GO:0002369,T cell cytokine production,1/15,29/16992,0.02530699428054939,0.05968999975099126,0.025491169362215075,1,bp,PCR,2625,GATA3
GO:0006959,humoral immune response,2/15,288/16992,0.025990600901894312,0.05968999975099126,0.025491169362215075,2,bp,PCR,2625/596,GATA3/BCL2
GO:0010831,positive regulation of myotube differentiation,1/15,30/16992,0.02616889341901496,0.05968999975099126,0.025491169362215075,1,bp,PCR,596,BCL2
GO:0030851,granulocyte differentiation,1/15,29/16992,0.02530699428054939,0.05968999975099126,0.025491169362215075,1,bp,PCR,51176,LEF1
GO:0032965,regulation of collagen biosynthetic process,1/15,30/16992,0.02616889341901496,0.05968999975099126,0.025491169362215075,1,bp,PCR,4602,MYB
GO:0033028,myeloid cell apoptotic process,1/15,30/16992,0.02616889341901496,0.05968999975099126,0.025491169362215075,1,bp,PCR,596,BCL2
GO:0033044,regulation of chromosome organization,2/15,288/16992,0.025990600901894312,0.05968999975099126,0.025491169362215075,2,bp,PCR,2625/4602,GATA3/MYB
GO:0035066,positive regulation of histone acetylation,1/15,29/16992,0.02530699428054939,0.05968999975099126,0.025491169362215075,1,bp,PCR,2625,GATA3
GO:0043552,positive regulation of phosphatidylinositol 3-kinase activity,1/15,30/16992,0.02616889341901496,0.05968999975099126,0.025491169362215075,1,bp,PCR,3667,IRS1
GO:0043903,"regulation of symbiosis, encompassing mutualism through parasitism",2/15,287/16992,0.025823200718393613,0.05968999975099126,0.025491169362215075,2,bp,PCR,596/51176,BCL2/LEF1
GO:0045622,regulation of T-helper cell differentiation,1/15,30/16992,0.02616889341901496,0.05968999975099126,0.025491169362215075,1,bp,PCR,4602,MYB
GO:0045923,positive regulation of fatty acid metabolic process,1/15,30/16992,0.02616889341901496,0.05968999975099126,0.025491169362215075,1,bp,PCR,3667,IRS1
GO:0046627,negative regulation of insulin receptor signaling pathway,1/15,30/16992,0.02616889341901496,0.05968999975099126,0.025491169362215075,1,bp,PCR,3667,IRS1
GO:0048638,regulation of developmental growth,2/15,285/16992,0.025489761235425783,0.05968999975099126,0.025491169362215075,2,bp,PCR,596/4137,BCL2/MAPT
GO:0048730,epidermis morphogenesis,1/15,30/16992,0.02616889341901496,0.05968999975099126,0.025491169362215075,1,bp,PCR,596,BCL2
GO:0060306,regulation of membrane repolarization,1/15,30/16992,0.02616889341901496,0.05968999975099126,0.025491169362215075,1,bp,PCR,776,CACNA1D
GO:0060325,face morphogenesis,1/15,29/16992,0.02530699428054939,0.05968999975099126,0.025491169362215075,1,bp,PCR,51176,LEF1
GO:0060441,epithelial tube branching involved in lung morphogenesis,1/15,29/16992,0.02530699428054939,0.05968999975099126,0.025491169362215075,1,bp,PCR,3087,HHEX
GO:0061036,positive regulation of cartilage development,1/15,30/16992,0.02616889341901496,0.05968999975099126,0.025491169362215075,1,bp,PCR,658,BMPR1B
GO:0070873,regulation of glycogen metabolic process,1/15,30/16992,0.02616889341901496,0.05968999975099126,0.025491169362215075,1,bp,PCR,3667,IRS1
GO:0071624,positive regulation of granulocyte chemotaxis,1/15,30/16992,0.02616889341901496,0.05968999975099126,0.025491169362215075,1,bp,PCR,7060,THBS4
GO:0086019,cell-cell signaling involved in cardiac conduction,1/15,30/16992,0.02616889341901496,0.05968999975099126,0.025491169362215075,1,bp,PCR,776,CACNA1D
GO:1900739,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,1/15,29/16992,0.02530699428054939,0.05968999975099126,0.025491169362215075,1,bp,PCR,596,BCL2
GO:1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,1/15,29/16992,0.02530699428054939,0.05968999975099126,0.025491169362215075,1,bp,PCR,596,BCL2
GO:1902624,positive regulation of neutrophil migration,1/15,30/16992,0.02616889341901496,0.05968999975099126,0.025491169362215075,1,bp,PCR,7060,THBS4
GO:1902742,apoptotic process involved in development,1/15,30/16992,0.02616889341901496,0.05968999975099126,0.025491169362215075,1,bp,PCR,51176,LEF1
GO:2000516,"positive regulation of CD4-positive, alpha-beta T cell activation",1/15,29/16992,0.02530699428054939,0.05968999975099126,0.025491169362215075,1,bp,PCR,4602,MYB
GO:2000758,positive regulation of peptidyl-lysine acetylation,1/15,30/16992,0.02616889341901496,0.05968999975099126,0.025491169362215075,1,bp,PCR,2625,GATA3
GO:0001662,behavioral fear response,1/15,31/16992,0.027030081168025633,0.06078595718067736,0.025959208172241077,1,bp,PCR,596,BCL2
GO:0001844,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,1/15,31/16992,0.027030081168025633,0.06078595718067736,0.025959208172241077,1,bp,PCR,596,BCL2
GO:0002209,behavioral defense response,1/15,31/16992,0.027030081168025633,0.06078595718067736,0.025959208172241077,1,bp,PCR,596,BCL2
GO:0018209,peptidyl-serine modification,2/15,294/16992,0.027004476932597762,0.06078595718067736,0.025959208172241077,2,bp,PCR,596/5979,BCL2/RET
GO:0032689,negative regulation of interferon-gamma production,1/15,31/16992,0.027030081168025633,0.06078595718067736,0.025959208172241077,1,bp,PCR,2625,GATA3
GO:0035418,protein localization to synapse,1/15,31/16992,0.027030081168025633,0.06078595718067736,0.025959208172241077,1,bp,PCR,4137,MAPT
GO:0043368,positive T cell selection,1/15,31/16992,0.027030081168025633,0.06078595718067736,0.025959208172241077,1,bp,PCR,596,BCL2
GO:0048741,skeletal muscle fiber development,1/15,31/16992,0.027030081168025633,0.06078595718067736,0.025959208172241077,1,bp,PCR,596,BCL2
GO:0048873,homeostasis of number of cells within a tissue,1/15,31/16992,0.027030081168025633,0.06078595718067736,0.025959208172241077,1,bp,PCR,596,BCL2
GO:0009416,response to light stimulus,2/15,296/16992,0.02734602563987352,0.06140037319452851,0.026221600243497144,2,bp,PCR,596/595,BCL2/CCND1
GO:0002711,positive regulation of T cell mediated immunity,1/15,32/16992,0.027890558072835248,0.06147044777709241,0.026251526245500405,1,bp,PCR,2625,GATA3
GO:0014911,positive regulation of smooth muscle cell migration,1/15,32/16992,0.027890558072835248,0.06147044777709241,0.026251526245500405,1,bp,PCR,596,BCL2
GO:0031113,regulation of microtubule polymerization,1/15,32/16992,0.027890558072835248,0.06147044777709241,0.026251526245500405,1,bp,PCR,4137,MAPT
GO:0040018,positive regulation of multicellular organism growth,1/15,32/16992,0.027890558072835248,0.06147044777709241,0.026251526245500405,1,bp,PCR,596,BCL2
GO:0043276,anoikis,1/15,32/16992,0.027890558072835248,0.06147044777709241,0.026251526245500405,1,bp,PCR,596,BCL2
GO:0051385,response to mineralocorticoid,1/15,32/16992,0.027890558072835248,0.06147044777709241,0.026251526245500405,1,bp,PCR,595,CCND1
GO:0051567,histone H3-K9 methylation,1/15,32/16992,0.027890558072835248,0.06147044777709241,0.026251526245500405,1,bp,PCR,4602,MYB
GO:0071375,cellular response to peptide hormone stimulus,2/15,298/16992,0.027689358581010386,0.06147044777709241,0.026251526245500405,2,bp,PCR,3480/3667,IGF1R/IRS1
GO:0090022,regulation of neutrophil chemotaxis,1/15,32/16992,0.027890558072835248,0.06147044777709241,0.026251526245500405,1,bp,PCR,7060,THBS4
GO:0097421,liver regeneration,1/15,32/16992,0.027890558072835248,0.06147044777709241,0.026251526245500405,1,bp,PCR,595,CCND1
GO:1900077,negative regulation of cellular response to insulin stimulus,1/15,32/16992,0.027890558072835248,0.06147044777709241,0.026251526245500405,1,bp,PCR,3667,IRS1
GO:1905332,positive regulation of morphogenesis of an epithelium,1/15,32/16992,0.027890558072835248,0.06147044777709241,0.026251526245500405,1,bp,PCR,2625,GATA3
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,2/15,301/16992,0.028207689332518753,0.062074195361147694,0.026509362264622284,2,bp,PCR,2625/51176,GATA3/LEF1
GO:0002931,response to ischemia,1/15,33/16992,0.028750324678312844,0.06222020566677042,0.026571717323171196,1,bp,PCR,596,BCL2
GO:0010907,positive regulation of glucose metabolic process,1/15,33/16992,0.028750324678312844,0.06222020566677042,0.026571717323171196,1,bp,PCR,3667,IRS1
GO:0014009,glial cell proliferation,1/15,33/16992,0.028750324678312844,0.06222020566677042,0.026571717323171196,1,bp,PCR,4602,MYB
GO:0042596,fear response,1/15,33/16992,0.028750324678312844,0.06222020566677042,0.026571717323171196,1,bp,PCR,596,BCL2
GO:0045737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,1/15,33/16992,0.028750324678312844,0.06222020566677042,0.026571717323171196,1,bp,PCR,595,CCND1
GO:0048854,brain morphogenesis,1/15,33/16992,0.028750324678312844,0.06222020566677042,0.026571717323171196,1,bp,PCR,3087,HHEX
GO:0051204,protein insertion into mitochondrial membrane,1/15,33/16992,0.028750324678312844,0.06222020566677042,0.026571717323171196,1,bp,PCR,596,BCL2
GO:0090218,positive regulation of lipid kinase activity,1/15,33/16992,0.028750324678312844,0.06222020566677042,0.026571717323171196,1,bp,PCR,3667,IRS1
GO:0099622,cardiac muscle cell membrane repolarization,1/15,33/16992,0.028750324678312844,0.06222020566677042,0.026571717323171196,1,bp,PCR,776,CACNA1D
GO:1901099,negative regulation of signal transduction in absence of ligand,1/15,33/16992,0.028750324678312844,0.06222020566677042,0.026571717323171196,1,bp,PCR,596,BCL2
GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,1/15,33/16992,0.028750324678312844,0.06222020566677042,0.026571717323171196,1,bp,PCR,596,BCL2
GO:0050863,regulation of T cell activation,2/15,305/16992,0.028904981770195338,0.0624608403064221,0.026674482583338162,2,bp,PCR,2625/4602,GATA3/MYB
GO:0008207,C21-steroid hormone metabolic process,1/15,34/16992,0.02960938152894288,0.0628488644861018,0.026840191916930267,1,bp,PCR,8912,CACNA1H
GO:0014904,myotube cell development,1/15,34/16992,0.02960938152894288,0.0628488644861018,0.026840191916930267,1,bp,PCR,596,BCL2
GO:0017145,stem cell division,1/15,34/16992,0.02960938152894288,0.0628488644861018,0.026840191916930267,1,bp,PCR,51176,LEF1
GO:0019228,neuronal action potential,1/15,34/16992,0.02960938152894288,0.0628488644861018,0.026840191916930267,1,bp,PCR,8912,CACNA1H
GO:0031062,positive regulation of histone methylation,1/15,34/16992,0.02960938152894288,0.0628488644861018,0.026840191916930267,1,bp,PCR,4602,MYB
GO:0032885,regulation of polysaccharide biosynthetic process,1/15,34/16992,0.02960938152894288,0.0628488644861018,0.026840191916930267,1,bp,PCR,3667,IRS1
GO:0042092,type 2 immune response,1/15,34/16992,0.02960938152894288,0.0628488644861018,0.026840191916930267,1,bp,PCR,2625,GATA3
GO:0042149,cellular response to glucose starvation,1/15,34/16992,0.02960938152894288,0.0628488644861018,0.026840191916930267,1,bp,PCR,596,BCL2
GO:0045124,regulation of bone resorption,1/15,34/16992,0.02960938152894288,0.0628488644861018,0.026840191916930267,1,bp,PCR,53832,IL20RA
GO:0050931,pigment cell differentiation,1/15,34/16992,0.02960938152894288,0.0628488644861018,0.026840191916930267,1,bp,PCR,596,BCL2
GO:0060323,head morphogenesis,1/15,34/16992,0.02960938152894288,0.0628488644861018,0.026840191916930267,1,bp,PCR,51176,LEF1
GO:1901985,positive regulation of protein acetylation,1/15,34/16992,0.02960938152894288,0.0628488644861018,0.026840191916930267,1,bp,PCR,2625,GATA3
GO:0002720,positive regulation of cytokine production involved in immune response,1/15,35/16992,0.030467729168821456,0.06372944223522042,0.02721625083187453,1,bp,PCR,2625,GATA3
GO:0003179,heart valve morphogenesis,1/15,35/16992,0.030467729168821456,0.06372944223522042,0.02721625083187453,1,bp,PCR,2625,GATA3
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,2/15,312/16992,0.030142108003502827,0.06372944223522042,0.02721625083187453,2,bp,PCR,658/51176,BMPR1B/LEF1
GO:0007340,acrosome reaction,1/15,35/16992,0.030467729168821456,0.06372944223522042,0.02721625083187453,1,bp,PCR,8912,CACNA1H
GO:0009615,response to virus,2/15,313/16992,0.030320579736798133,0.06372944223522042,0.02721625083187453,2,bp,PCR,2625/596,GATA3/BCL2
GO:0010712,regulation of collagen metabolic process,1/15,35/16992,0.030467729168821456,0.06372944223522042,0.02721625083187453,1,bp,PCR,4602,MYB
GO:0030501,positive regulation of bone mineralization,1/15,35/16992,0.030467729168821456,0.06372944223522042,0.02721625083187453,1,bp,PCR,658,BMPR1B
GO:0040019,positive regulation of embryonic development,1/15,35/16992,0.030467729168821456,0.06372944223522042,0.02721625083187453,1,bp,PCR,2625,GATA3
GO:0086091,regulation of heart rate by cardiac conduction,1/15,35/16992,0.030467729168821456,0.06372944223522042,0.02721625083187453,1,bp,PCR,776,CACNA1D
GO:1902622,regulation of neutrophil migration,1/15,35/16992,0.030467729168821456,0.06372944223522042,0.02721625083187453,1,bp,PCR,7060,THBS4
GO:0048511,rhythmic process,2/15,315/16992,0.0306788198341867,0.06407770945018355,0.027364981584043522,2,bp,PCR,658/596,BMPR1B/BCL2
hsa04928,"Parathyroid hormone synthesis, secretion and action",2/15,106/7430,0.018757128549347243,0.0643101550263334,0.04005281584973396,2,kg,PCR,2625/596,GATA3/BCL2
GO:1901990,regulation of mitotic cell cycle phase transition,2/15,316/16992,0.030858586617236346,0.06435963565888045,0.02748538079268015,2,bp,PCR,596/595,BCL2/CCND1
GO:0005520,insulin-like growth factor binding,1/15,28/16982,0.02445861762280399,0.06448181009648325,0.030895095944594518,1,mf,PCR,3480,IGF1R
GO:0031346,positive regulation of cell projection organization,2/15,318/16992,0.031219409706150367,0.06486246976883196,0.027700120774441662,2,bp,PCR,4137/5979,MAPT/RET
GO:0032964,collagen biosynthetic process,1/15,36/16992,0.03132536814166276,0.06486246976883196,0.027700120774441662,1,bp,PCR,4602,MYB
GO:0044246,regulation of multicellular organismal metabolic process,1/15,36/16992,0.03132536814166276,0.06486246976883196,0.027700120774441662,1,bp,PCR,4602,MYB
GO:1904031,positive regulation of cyclin-dependent protein kinase activity,1/15,36/16992,0.03132536814166276,0.06486246976883196,0.027700120774441662,1,bp,PCR,595,CCND1
GO:1904036,negative regulation of epithelial cell apoptotic process,1/15,36/16992,0.03132536814166276,0.06486246976883196,0.027700120774441662,1,bp,PCR,2625,GATA3
GO:0030425,dendrite,3/15,462/18122,0.005960737692470493,0.06489155877873141,0.04258092715487502,3,cc,PCR,658/4137/5979,BMPR1B/MAPT/RET
GO:0044297,cell body,3/15,483/18122,0.006741980132855212,0.06489155877873141,0.04258092715487502,3,cc,PCR,658/4137/5979,BMPR1B/MAPT/RET
GO:0001101,response to acid chemical,2/15,319/16992,0.031400464436338385,0.06492441351801188,0.027726574428451764,2,bp,PCR,4602/5979,MYB/RET
GO:1901653,cellular response to peptide,2/15,320/16992,0.031581946908050565,0.06511227791516307,0.027806803665926874,2,bp,PCR,3480/3667,IGF1R/IRS1
GO:1903037,regulation of leukocyte cell-cell adhesion,2/15,320/16992,0.031581946908050565,0.06511227791516307,0.027806803665926874,2,bp,PCR,2625/4602,GATA3/MYB
GO:0010959,regulation of metal ion transport,2/15,323/16992,0.032128952920713195,0.06569028927524366,0.028053648791317477,2,bp,PCR,596/776,BCL2/CACNA1D
GO:0030857,negative regulation of epithelial cell differentiation,1/15,37/16992,0.03218229899079439,0.06569028927524366,0.028053648791317477,1,bp,PCR,595,CCND1
GO:0032535,regulation of cellular component size,2/15,323/16992,0.032128952920713195,0.06569028927524366,0.028053648791317477,2,bp,PCR,4137/5979,MAPT/RET
GO:0032881,regulation of polysaccharide metabolic process,1/15,37/16992,0.03218229899079439,0.06569028927524366,0.028053648791317477,1,bp,PCR,3667,IRS1
GO:0046676,negative regulation of insulin secretion,1/15,37/16992,0.03218229899079439,0.06569028927524366,0.028053648791317477,1,bp,PCR,3667,IRS1
GO:0048536,spleen development,1/15,37/16992,0.03218229899079439,0.06569028927524366,0.028053648791317477,1,bp,PCR,596,BCL2
GO:1901030,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,1/15,37/16992,0.03218229899079439,0.06569028927524366,0.028053648791317477,1,bp,PCR,596,BCL2
GO:0016538,cyclin-dependent protein serine/threonine kinase regulator activity,1/15,30/16982,0.026184119407439366,0.06646849570127315,0.031846974346889496,1,mf,PCR,595,CCND1
GO:0031369,translation initiation factor binding,1/15,31/16982,0.027045801699138727,0.06646849570127315,0.031846974346889496,1,mf,PCR,3087,HHEX
GO:0042169,SH2 domain binding,1/15,31/16982,0.027045801699138727,0.06646849570127315,0.031846974346889496,1,mf,PCR,3667,IRS1
GO:0051879,Hsp90 protein binding,1/15,31/16982,0.027045801699138727,0.06646849570127315,0.031846974346889496,1,mf,PCR,4137,MAPT
GO:0002697,regulation of immune effector process,2/15,328/16992,0.033049111290625356,0.06688953933046288,0.028565799677441932,2,bp,PCR,2625/4602,GATA3/MYB
GO:0030890,positive regulation of B cell proliferation,1/15,38/16992,0.03303852225915982,0.06688953933046288,0.028565799677441932,1,bp,PCR,596,BCL2
GO:0042088,T-helper 1 type immune response,1/15,38/16992,0.03303852225915982,0.06688953933046288,0.028565799677441932,1,bp,PCR,51176,LEF1
GO:0042181,ketone biosynthetic process,1/15,38/16992,0.03303852225915982,0.06688953933046288,0.028565799677441932,1,bp,PCR,8912,CACNA1H
GO:0046638,positive regulation of alpha-beta T cell differentiation,1/15,38/16992,0.03303852225915982,0.06688953933046288,0.028565799677441932,1,bp,PCR,4602,MYB
GO:0098930,axonal transport,1/15,38/16992,0.03303852225915982,0.06688953933046288,0.028565799677441932,1,bp,PCR,4137,MAPT
GO:0000266,mitochondrial fission,1/15,39/16992,0.03389403848931882,0.06736615948706937,0.028769344746702882,1,bp,PCR,4137,MAPT
GO:0001666,response to hypoxia,2/15,332/16992,0.033792815336593965,0.06736615948706937,0.028769344746702882,2,bp,PCR,596/4602,BCL2/MYB
GO:0003170,heart valve development,1/15,39/16992,0.03389403848931882,0.06736615948706937,0.028769344746702882,1,bp,PCR,2625,GATA3
GO:0006936,muscle contraction,2/15,331/16992,0.033606260989741225,0.06736615948706937,0.028769344746702882,2,bp,PCR,776/8912,CACNA1D/CACNA1H
GO:0007223,"Wnt signaling pathway, calcium modulating pathway",1/15,39/16992,0.03389403848931882,0.06736615948706937,0.028769344746702882,1,bp,PCR,51176,LEF1
GO:0007520,myoblast fusion,1/15,39/16992,0.03389403848931882,0.06736615948706937,0.028769344746702882,1,bp,PCR,8912,CACNA1H
GO:0010559,regulation of glycoprotein biosynthetic process,1/15,39/16992,0.03389403848931882,0.06736615948706937,0.028769344746702882,1,bp,PCR,596,BCL2
GO:0010718,positive regulation of epithelial to mesenchymal transition,1/15,39/16992,0.03389403848931882,0.06736615948706937,0.028769344746702882,1,bp,PCR,51176,LEF1
GO:0033628,regulation of cell adhesion mediated by integrin,1/15,39/16992,0.03389403848931882,0.06736615948706937,0.028769344746702882,1,bp,PCR,5979,RET
GO:0045843,negative regulation of striated muscle tissue development,1/15,39/16992,0.03389403848931882,0.06736615948706937,0.028769344746702882,1,bp,PCR,51176,LEF1
GO:0051646,mitochondrion localization,1/15,39/16992,0.03389403848931882,0.06736615948706937,0.028769344746702882,1,bp,PCR,4137,MAPT
GO:0070169,positive regulation of biomineral tissue development,1/15,39/16992,0.03389403848931882,0.06736615948706937,0.028769344746702882,1,bp,PCR,658,BMPR1B
GO:1903532,positive regulation of secretion by cell,2/15,331/16992,0.033606260989741225,0.06736615948706937,0.028769344746702882,2,bp,PCR,2625/8912,GATA3/CACNA1H
GO:0051393,alpha-actinin binding,1/15,32/16982,0.027906772318837536,0.0674413664371907,0.032313104790232944,1,mf,PCR,776,CACNA1D
hsa04725,Cholinergic synapse,2/15,112/7430,0.020805884424959318,0.06747854408094914,0.0420261107872578,2,kg,PCR,596/776,BCL2/CACNA1D
hsa05206,MicroRNAs in cancer,3/15,299/7430,0.02048681704261697,0.06747854408094914,0.0420261107872578,3,kg,PCR,596/3667/595,BCL2/IRS1/CCND1
GO:0048871,multicellular organismal homeostasis,2/15,335/16992,0.03435498086901706,0.06818799379665402,0.02912031672962627,2,bp,PCR,596/53832,BCL2/IL20RA
GO:0014706,striated muscle tissue development,2/15,337/16992,0.034731835570640385,0.06840286972204421,0.02921208149137588,2,bp,PCR,596/51176,BCL2/LEF1
GO:0043029,T cell homeostasis,1/15,40/16992,0.03474884822344626,0.06840286972204421,0.02921208149137588,1,bp,PCR,596,BCL2
GO:0045773,positive regulation of axon extension,1/15,40/16992,0.03474884822344626,0.06840286972204421,0.02921208149137588,1,bp,PCR,4137,MAPT
GO:0072210,metanephric nephron development,1/15,40/16992,0.03474884822344626,0.06840286972204421,0.02921208149137588,1,bp,PCR,5979,RET
GO:1901987,regulation of cell cycle phase transition,2/15,337/16992,0.034731835570640385,0.06840286972204421,0.02921208149137588,2,bp,PCR,596/595,BCL2/CCND1
GO:2000351,regulation of endothelial cell apoptotic process,1/15,40/16992,0.03474884822344626,0.06840286972204421,0.02921208149137588,1,bp,PCR,2625,GATA3
GO:0001709,cell fate determination,1/15,41/16992,0.03560295200333308,0.06904378141537063,0.029485788788895784,1,bp,PCR,2625,GATA3
GO:0031103,axon regeneration,1/15,41/16992,0.03560295200333308,0.06904378141537063,0.029485788788895784,1,bp,PCR,596,BCL2
GO:0036293,response to decreased oxygen levels,2/15,340/16992,0.03530021872288021,0.06904378141537063,0.029485788788895784,2,bp,PCR,596/4602,BCL2/MYB
GO:0043551,regulation of phosphatidylinositol 3-kinase activity,1/15,41/16992,0.03560295200333308,0.06904378141537063,0.029485788788895784,1,bp,PCR,3667,IRS1
GO:0046189,phenol-containing compound biosynthetic process,1/15,41/16992,0.03560295200333308,0.06904378141537063,0.029485788788895784,1,bp,PCR,2625,GATA3
GO:0046326,positive regulation of glucose import,1/15,41/16992,0.03560295200333308,0.06904378141537063,0.029485788788895784,1,bp,PCR,3667,IRS1
GO:0048635,negative regulation of muscle organ development,1/15,41/16992,0.03560295200333308,0.06904378141537063,0.029485788788895784,1,bp,PCR,51176,LEF1
GO:0050434,positive regulation of viral transcription,1/15,41/16992,0.03560295200333308,0.06904378141537063,0.029485788788895784,1,bp,PCR,51176,LEF1
GO:0086009,membrane repolarization,1/15,41/16992,0.03560295200333308,0.06904378141537063,0.029485788788895784,1,bp,PCR,776,CACNA1D
GO:1901016,regulation of potassium ion transmembrane transporter activity,1/15,41/16992,0.03560295200333308,0.06904378141537063,0.029485788788895784,1,bp,PCR,776,CACNA1D
GO:1901862,negative regulation of muscle tissue development,1/15,41/16992,0.03560295200333308,0.06904378141537063,0.029485788788895784,1,bp,PCR,51176,LEF1
GO:0001784,phosphotyrosine binding,1/15,35/16982,0.03048541960224893,0.06958208589362487,0.033338785255747676,1,mf,PCR,3667,IRS1
GO:0005261,cation channel activity,2/15,315/16982,0.030712093084082702,0.06958208589362487,0.033338785255747676,2,mf,PCR,776/8912,CACNA1D/CACNA1H
GO:0016248,channel inhibitor activity,1/15,35/16982,0.03048541960224893,0.06958208589362487,0.033338785255747676,1,mf,PCR,596,BCL2
GO:0017046,peptide hormone binding,1/15,35/16982,0.03048541960224893,0.06958208589362487,0.033338785255747676,1,mf,PCR,3480,IGF1R
GO:0005085,guanyl-nucleotide exchange factor activity,2/15,322/16982,0.031980773449189405,0.06968866517930632,0.03338985046703607,2,mf,PCR,5979/3667,RET/IRS1
GO:0030546,receptor activator activity,1/15,37/16982,0.03220096942767947,0.06968866517930632,0.03338985046703607,1,mf,PCR,4137,MAPT
GO:0070888,E-box binding,1/15,37/16982,0.03220096942767947,0.06968866517930632,0.03338985046703607,1,mf,PCR,2625,GATA3
GO:0002437,inflammatory response to antigenic stimulus,1/15,42/16992,0.0364563503703883,0.0701308908731566,0.029950048990257706,1,bp,PCR,2625,GATA3
GO:0003254,regulation of membrane depolarization,1/15,42/16992,0.0364563503703883,0.0701308908731566,0.029950048990257706,1,bp,PCR,596,BCL2
GO:0007595,lactation,1/15,42/16992,0.0364563503703883,0.0701308908731566,0.029950048990257706,1,bp,PCR,595,CCND1
GO:0046850,regulation of bone remodeling,1/15,42/16992,0.0364563503703883,0.0701308908731566,0.029950048990257706,1,bp,PCR,53832,IL20RA
GO:0090278,negative regulation of peptide hormone secretion,1/15,42/16992,0.0364563503703883,0.0701308908731566,0.029950048990257706,1,bp,PCR,3667,IRS1
GO:1903727,positive regulation of phospholipid metabolic process,1/15,42/16992,0.0364563503703883,0.0701308908731566,0.029950048990257706,1,bp,PCR,3667,IRS1
GO:0032259,methylation,2/15,347/16992,0.036640810395849335,0.0703915033941651,0.03006134599040271,2,bp,PCR,2625/4602,GATA3/MYB
GO:0007159,leukocyte cell-cell adhesion,2/15,349/16992,0.03702750274185738,0.07103941447269566,0.030338042440450918,2,bp,PCR,2625/4602,GATA3/MYB
GO:0009101,glycoprotein biosynthetic process,2/15,350/16992,0.0372214561313127,0.07129401068473186,0.0304467701199126,2,bp,PCR,658/596,BMPR1B/BCL2
GO:0045599,negative regulation of fat cell differentiation,1/15,43/16992,0.037309043865635605,0.07129401068473186,0.0304467701199126,1,bp,PCR,2625,GATA3
GO:0048599,oocyte development,1/15,43/16992,0.037309043865635605,0.07129401068473186,0.0304467701199126,1,bp,PCR,596,BCL2
GO:0022836,gated channel activity,2/15,330/16982,0.03345622283512259,0.07134047516312905,0.034181280295945686,2,mf,PCR,776/8912,CACNA1D/CACNA1H
GO:0060537,muscle tissue development,2/15,351/16992,0.037415813319143516,0.07140308597557668,0.030493351736996813,2,bp,PCR,596/51176,BCL2/LEF1
GO:0098802,plasma membrane receptor complex,2/15,169/18122,0.00838213769118754,0.07171384469127118,0.04705761510842128,2,cc,PCR,658/3667,BMPR1B/IRS1
GO:0030331,estrogen receptor binding,1/15,40/16982,0.034768982502327406,0.07202146375482106,0.034507561581257284,1,mf,PCR,51176,LEF1
GO:0042805,actinin binding,1/15,40/16982,0.034768982502327406,0.07202146375482106,0.034507561581257284,1,mf,PCR,776,CACNA1D
GO:0060986,endocrine hormone secretion,1/15,44/16992,0.03816103302971707,0.0724135483658552,0.030924879095552565,1,bp,PCR,2625,GATA3
GO:0070482,response to oxygen levels,2/15,355/16992,0.03819726490001269,0.0724135483658552,0.030924879095552565,2,bp,PCR,596/4602,BCL2/MYB
GO:1903018,regulation of glycoprotein metabolic process,1/15,44/16992,0.03816103302971707,0.0724135483658552,0.030924879095552565,1,bp,PCR,596,BCL2
GO:1903307,positive regulation of regulated secretory pathway,1/15,44/16992,0.03816103302971707,0.0724135483658552,0.030924879095552565,1,bp,PCR,8912,CACNA1H
GO:1904837,beta-catenin-TCF complex assembly,1/15,44/16992,0.03816103302971707,0.0724135483658552,0.030924879095552565,1,bp,PCR,51176,LEF1
GO:0008088,axo-dendritic transport,1/15,45/16992,0.039012318402891544,0.07337788160334444,0.031336706570523246,1,bp,PCR,4137,MAPT
GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,1/15,45/16992,0.039012318402891544,0.07337788160334444,0.031336706570523246,1,bp,PCR,596,BCL2
GO:0010823,negative regulation of mitochondrion organization,1/15,45/16992,0.039012318402891544,0.07337788160334444,0.031336706570523246,1,bp,PCR,4137,MAPT
GO:0010828,positive regulation of glucose transport,1/15,45/16992,0.039012318402891544,0.07337788160334444,0.031336706570523246,1,bp,PCR,3667,IRS1
GO:0031122,cytoplasmic microtubule organization,1/15,45/16992,0.039012318402891544,0.07337788160334444,0.031336706570523246,1,bp,PCR,4137,MAPT
GO:1901028,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,1/15,45/16992,0.039012318402891544,0.07337788160334444,0.031336706570523246,1,bp,PCR,596,BCL2
hsa04722,Neurotrophin signaling pathway,2/15,119/7430,0.02331014950703973,0.07361099844328335,0.045845446398887005,2,kg,PCR,596/3667,BCL2/IRS1
GO:0030900,forebrain development,2/15,361/16992,0.03938142769711385,0.07397530928202954,0.03159184361529739,2,bp,PCR,51176/3087,LEF1/HHEX
GO:0009994,oocyte differentiation,1/15,46/16992,0.03986290052503416,0.07429700136767067,0.03172922521140681,1,bp,PCR,596,BCL2
GO:0014015,positive regulation of gliogenesis,1/15,46/16992,0.03986290052503416,0.07429700136767067,0.03172922521140681,1,bp,PCR,4602,MYB
GO:0035850,epithelial cell differentiation involved in kidney development,1/15,46/16992,0.03986290052503416,0.07429700136767067,0.03172922521140681,1,bp,PCR,2625,GATA3
GO:0072132,mesenchyme morphogenesis,1/15,46/16992,0.03986290052503416,0.07429700136767067,0.03172922521140681,1,bp,PCR,51176,LEF1
GO:0090102,cochlea development,1/15,46/16992,0.03986290052503416,0.07429700136767067,0.03172922521140681,1,bp,PCR,2625,GATA3
GO:2000378,negative regulation of reactive oxygen species metabolic process,1/15,46/16992,0.03986290052503416,0.07429700136767067,0.03172922521140681,1,bp,PCR,596,BCL2
GO:0005978,glycogen biosynthetic process,1/15,47/16992,0.04071277993563982,0.07481363781012075,0.0319498596075892,1,bp,PCR,3667,IRS1
GO:0009250,glucan biosynthetic process,1/15,47/16992,0.04071277993563982,0.07481363781012075,0.0319498596075892,1,bp,PCR,3667,IRS1
GO:0010171,body morphogenesis,1/15,47/16992,0.04071277993563982,0.07481363781012075,0.0319498596075892,1,bp,PCR,51176,LEF1
GO:0032330,regulation of chondrocyte differentiation,1/15,47/16992,0.04071277993563982,0.07481363781012075,0.0319498596075892,1,bp,PCR,658,BMPR1B
GO:0035094,response to nicotine,1/15,47/16992,0.04071277993563982,0.07481363781012075,0.0319498596075892,1,bp,PCR,596,BCL2
GO:0051205,protein insertion into membrane,1/15,47/16992,0.04071277993563982,0.07481363781012075,0.0319498596075892,1,bp,PCR,596,BCL2
GO:0060324,face development,1/15,47/16992,0.04071277993563982,0.07481363781012075,0.0319498596075892,1,bp,PCR,51176,LEF1
GO:0060711,labyrinthine layer development,1/15,47/16992,0.04071277993563982,0.07481363781012075,0.0319498596075892,1,bp,PCR,51176,LEF1
GO:0072577,endothelial cell apoptotic process,1/15,47/16992,0.04071277993563982,0.07481363781012075,0.0319498596075892,1,bp,PCR,2625,GATA3
GO:2000243,positive regulation of reproductive process,1/15,47/16992,0.04071277993563982,0.07481363781012075,0.0319498596075892,1,bp,PCR,8912,CACNA1H
GO:2000677,regulation of transcription regulatory region DNA binding,1/15,47/16992,0.04071277993563982,0.07481363781012075,0.0319498596075892,1,bp,PCR,2625,GATA3
GO:0016303,1-phosphatidylinositol-3-kinase activity,1/15,43/16982,0.03733063461347774,0.07517975026325378,0.03602078778493467,1,mf,PCR,3667,IRS1
GO:0043028,cysteine-type endopeptidase regulator activity involved in apoptotic process,1/15,43/16982,0.03733063461347774,0.07517975026325378,0.03602078778493467,1,mf,PCR,51176,LEF1
GO:0005080,protein kinase C binding,1/15,45/16982,0.03903487604654454,0.07546742702331945,0.03615862202206232,1,mf,PCR,3667,IRS1
GO:0005272,sodium channel activity,1/15,45/16982,0.03903487604654454,0.07546742702331945,0.03615862202206232,1,mf,PCR,8912,CACNA1H
GO:0045309,protein phosphorylated amino acid binding,1/15,44/16982,0.038183107633184,0.07546742702331945,0.03615862202206232,1,mf,PCR,3667,IRS1
GO:0052548,regulation of endopeptidase activity,2/15,370/16992,0.041184318129432,0.07558348039845948,0.032278628042560806,2,bp,PCR,4137/51176,MAPT/LEF1
GO:0000768,syncytium formation by plasma membrane fusion,1/15,48/16992,0.04156195717381994,0.07574621200375717,0.03234812408760242,1,bp,PCR,8912,CACNA1H
GO:0048641,regulation of skeletal muscle tissue development,1/15,48/16992,0.04156195717381994,0.07574621200375717,0.03234812408760242,1,bp,PCR,596,BCL2
GO:0051452,intracellular pH reduction,1/15,48/16992,0.04156195717381994,0.07574621200375717,0.03234812408760242,1,bp,PCR,596,BCL2
GO:0060249,anatomical structure homeostasis,2/15,372/16992,0.04158925627763703,0.07574621200375717,0.03234812408760242,2,bp,PCR,596/53832,BCL2/IL20RA
GO:0071622,regulation of granulocyte chemotaxis,1/15,48/16992,0.04156195717381994,0.07574621200375717,0.03234812408760242,1,bp,PCR,7060,THBS4
GO:0086002,cardiac muscle cell action potential involved in contraction,1/15,48/16992,0.04156195717381994,0.07574621200375717,0.03234812408760242,1,bp,PCR,776,CACNA1D
GO:0043525,positive regulation of neuron apoptotic process,1/15,49/16992,0.04241043277830525,0.07646648921257798,0.03265572516641612,1,bp,PCR,4602,MYB
GO:0045851,pH reduction,1/15,49/16992,0.04241043277830525,0.07646648921257798,0.03265572516641612,1,bp,PCR,596,BCL2
GO:0046626,regulation of insulin receptor signaling pathway,1/15,49/16992,0.04241043277830525,0.07646648921257798,0.03265572516641612,1,bp,PCR,3667,IRS1
GO:0048546,digestive tract morphogenesis,1/15,49/16992,0.04241043277830525,0.07646648921257798,0.03265572516641612,1,bp,PCR,596,BCL2
GO:0051052,regulation of DNA metabolic process,2/15,376/16992,0.042403774424572514,0.07646648921257798,0.03265572516641612,2,bp,PCR,2625/3480,GATA3/IGF1R
GO:0060350,endochondral bone morphogenesis,1/15,49/16992,0.04241043277830525,0.07646648921257798,0.03265572516641612,1,bp,PCR,658,BMPR1B
GO:0060563,neuroepithelial cell differentiation,1/15,49/16992,0.04241043277830525,0.07646648921257798,0.03265572516641612,1,bp,PCR,51176,LEF1
GO:1903829,positive regulation of cellular protein localization,2/15,375/16992,0.0421995665036351,0.07646648921257798,0.03265572516641612,2,bp,PCR,596/4137,BCL2/MAPT
GO:0002763,positive regulation of myeloid leukocyte differentiation,1/15,50/16992,0.04325820728744367,0.07741225886931079,0.03305962489162963,1,bp,PCR,51176,LEF1
GO:0031102,neuron projection regeneration,1/15,50/16992,0.04325820728744367,0.07741225886931079,0.03305962489162963,1,bp,PCR,596,BCL2
GO:0032663,regulation of interleukin-2 production,1/15,50/16992,0.04325820728744367,0.07741225886931079,0.03305962489162963,1,bp,PCR,2625,GATA3
GO:0036092,phosphatidylinositol-3-phosphate biosynthetic process,1/15,50/16992,0.04325820728744367,0.07741225886931079,0.03305962489162963,1,bp,PCR,3667,IRS1
GO:0043550,regulation of lipid kinase activity,1/15,50/16992,0.04325820728744367,0.07741225886931079,0.03305962489162963,1,bp,PCR,3667,IRS1
GO:0046635,positive regulation of alpha-beta T cell activation,1/15,50/16992,0.04325820728744367,0.07741225886931079,0.03305962489162963,1,bp,PCR,4602,MYB
GO:0009948,anterior/posterior axis specification,1/15,51/16992,0.044105281239201544,0.07824603597621312,0.033415697157185835,1,bp,PCR,3087,HHEX
GO:0010676,positive regulation of cellular carbohydrate metabolic process,1/15,51/16992,0.044105281239201544,0.07824603597621312,0.033415697157185835,1,bp,PCR,3667,IRS1
GO:0033059,cellular pigmentation,1/15,51/16992,0.044105281239201544,0.07824603597621312,0.033415697157185835,1,bp,PCR,596,BCL2
GO:0035065,regulation of histone acetylation,1/15,51/16992,0.044105281239201544,0.07824603597621312,0.033415697157185835,1,bp,PCR,2625,GATA3
GO:0043388,positive regulation of DNA binding,1/15,51/16992,0.044105281239201544,0.07824603597621312,0.033415697157185835,1,bp,PCR,2625,GATA3
GO:0043392,negative regulation of DNA binding,1/15,51/16992,0.044105281239201544,0.07824603597621312,0.033415697157185835,1,bp,PCR,51176,LEF1
GO:0045453,bone resorption,1/15,51/16992,0.044105281239201544,0.07824603597621312,0.033415697157185835,1,bp,PCR,53832,IL20RA
GO:0002709,regulation of T cell mediated immunity,1/15,52/16992,0.044951655171166394,0.07906429434634775,0.03376514200191974,1,bp,PCR,2625,GATA3
GO:0006584,catecholamine metabolic process,1/15,52/16992,0.044951655171166394,0.07906429434634775,0.03376514200191974,1,bp,PCR,2625,GATA3
GO:0006949,syncytium formation,1/15,52/16992,0.044951655171166394,0.07906429434634775,0.03376514200191974,1,bp,PCR,8912,CACNA1H
GO:0009712,catechol-containing compound metabolic process,1/15,52/16992,0.044951655171166394,0.07906429434634775,0.03376514200191974,1,bp,PCR,2625,GATA3
GO:0038083,peptidyl-tyrosine autophosphorylation,1/15,52/16992,0.044951655171166394,0.07906429434634775,0.03376514200191974,1,bp,PCR,3480,IGF1R
GO:0048146,positive regulation of fibroblast proliferation,1/15,52/16992,0.044951655171166394,0.07906429434634775,0.03376514200191974,1,bp,PCR,4602,MYB
GO:0060425,lung morphogenesis,1/15,52/16992,0.044951655171166394,0.07906429434634775,0.03376514200191974,1,bp,PCR,3087,HHEX
GO:0001819,positive regulation of cytokine production,2/15,391/16992,0.04551260582944853,0.07995307405491141,0.03414470363990284,2,bp,PCR,2625/4602,GATA3/MYB
GO:0007405,neuroblast proliferation,1/15,53/16992,0.04579732962054239,0.0799644746837417,0.03414957238444231,1,bp,PCR,51176,LEF1
GO:0010830,regulation of myotube differentiation,1/15,53/16992,0.04579732962054239,0.0799644746837417,0.03414957238444231,1,bp,PCR,596,BCL2
GO:0019748,secondary metabolic process,1/15,53/16992,0.04579732962054239,0.0799644746837417,0.03414957238444231,1,bp,PCR,596,BCL2
GO:0086065,cell communication involved in cardiac conduction,1/15,53/16992,0.04579732962054239,0.0799644746837417,0.03414957238444231,1,bp,PCR,776,CACNA1D
GO:0097345,mitochondrial outer membrane permeabilization,1/15,53/16992,0.04579732962054239,0.0799644746837417,0.03414957238444231,1,bp,PCR,596,BCL2
GO:0001933,negative regulation of protein phosphorylation,2/15,396/16992,0.04656767460536328,0.08085041310423473,0.03452792062393792,2,bp,PCR,3480/3087,IGF1R/HHEX
GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,1/15,54/16992,0.046642305124154904,0.08085041310423473,0.03452792062393792,1,bp,PCR,51176,LEF1
GO:0016444,somatic cell DNA recombination,1/15,54/16992,0.046642305124154904,0.08085041310423473,0.03452792062393792,1,bp,PCR,51176,LEF1
GO:0031110,regulation of microtubule polymerization or depolymerization,1/15,54/16992,0.046642305124154904,0.08085041310423473,0.03452792062393792,1,bp,PCR,4137,MAPT
GO:1902110,positive regulation of mitochondrial membrane permeability involved in apoptotic process,1/15,54/16992,0.046642305124154904,0.08085041310423473,0.03452792062393792,1,bp,PCR,596,BCL2
GO:1902686,mitochondrial outer membrane permeabilization involved in programmed cell death,1/15,54/16992,0.046642305124154904,0.08085041310423473,0.03452792062393792,1,bp,PCR,596,BCL2
GO:0052547,regulation of peptidase activity,2/15,397/16992,0.04677980063953277,0.08099105243254047,0.03458798195668688,2,bp,PCR,4137/51176,MAPT/LEF1
GO:0021879,forebrain neuron differentiation,1/15,55/16992,0.04748658221844815,0.08152714294851851,0.03481692439584389,1,bp,PCR,51176,LEF1
GO:0032370,positive regulation of lipid transport,1/15,55/16992,0.04748658221844815,0.08152714294851851,0.03481692439584389,1,bp,PCR,4602,MYB
GO:0033627,cell adhesion mediated by integrin,1/15,55/16992,0.04748658221844815,0.08152714294851851,0.03481692439584389,1,bp,PCR,5979,RET
GO:0045740,positive regulation of DNA replication,1/15,55/16992,0.04748658221844815,0.08152714294851851,0.03481692439584389,1,bp,PCR,3480,IGF1R
GO:0051155,positive regulation of striated muscle cell differentiation,1/15,55/16992,0.04748658221844815,0.08152714294851851,0.03481692439584389,1,bp,PCR,596,BCL2
GO:0051926,negative regulation of calcium ion transport,1/15,55/16992,0.04748658221844815,0.08152714294851851,0.03481692439584389,1,bp,PCR,596,BCL2
GO:2000756,regulation of peptidyl-lysine acetylation,1/15,55/16992,0.04748658221844815,0.08152714294851851,0.03481692439584389,1,bp,PCR,2625,GATA3
GO:0003012,muscle system process,2/15,402/16992,0.047845952643073925,0.08204610256336185,0.035038550924396554,2,bp,PCR,776/8912,CACNA1D/CACNA1H
GO:0001836,release of cytochrome c from mitochondria,1/15,56/16992,0.048330161439485875,0.0821898721757884,0.035099949074083175,1,bp,PCR,596,BCL2
GO:0014910,regulation of smooth muscle cell migration,1/15,56/16992,0.048330161439485875,0.0821898721757884,0.035099949074083175,1,bp,PCR,596,BCL2
GO:0030888,regulation of B cell proliferation,1/15,56/16992,0.048330161439485875,0.0821898721757884,0.035099949074083175,1,bp,PCR,596,BCL2
GO:0033619,membrane protein proteolysis,1/15,56/16992,0.048330161439485875,0.0821898721757884,0.035099949074083175,1,bp,PCR,5979,RET
GO:0035794,positive regulation of mitochondrial membrane permeability,1/15,56/16992,0.048330161439485875,0.0821898721757884,0.035099949074083175,1,bp,PCR,596,BCL2
GO:0050994,regulation of lipid catabolic process,1/15,56/16992,0.048330161439485875,0.0821898721757884,0.035099949074083175,1,bp,PCR,3667,IRS1
GO:0061005,cell differentiation involved in kidney development,1/15,56/16992,0.048330161439485875,0.0821898721757884,0.035099949074083175,1,bp,PCR,2625,GATA3
GO:0097110,scaffold protein binding,1/15,50/16982,0.04328316793349152,0.08257972829416145,0.03956633079792854,1,mf,PCR,8912,CACNA1H
GO:0030673,axolemma,1/15,16/18122,0.013167089407044141,0.08283207314888386,0.0543532400703544,1,cc,PCR,4137,MAPT
GO:0032993,protein-DNA complex,2/15,194/18122,0.010922999470748025,0.08283207314888386,0.0543532400703544,2,cc,PCR,51176/3087,LEF1/HHEX
GO:0034703,cation channel complex,2/15,203/18122,0.01191153183515034,0.08283207314888386,0.0543532400703544,2,cc,PCR,776/8912,CACNA1D/CACNA1H
GO:0046930,pore complex,1/15,17/18122,0.013984635726434935,0.08283207314888386,0.0543532400703544,1,cc,PCR,596,BCL2
GO:0032623,interleukin-2 production,1/15,57/16992,0.04917304332295369,0.08293622447779866,0.035418685763876946,1,bp,PCR,2625,GATA3
GO:0034765,regulation of ion transmembrane transport,2/15,407/16992,0.0489212420682435,0.08293622447779866,0.035418685763876946,2,bp,PCR,776/8912,CACNA1D/CACNA1H
GO:0042116,macrophage activation,1/15,57/16992,0.04917304332295369,0.08293622447779866,0.035418685763876946,1,bp,PCR,4137,MAPT
GO:0045669,positive regulation of osteoblast differentiation,1/15,57/16992,0.04917304332295369,0.08293622447779866,0.035418685763876946,1,bp,PCR,658,BMPR1B
GO:0046785,microtubule polymerization,1/15,57/16992,0.04917304332295369,0.08293622447779866,0.035418685763876946,1,bp,PCR,4137,MAPT
GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,1/15,57/16992,0.04917304332295369,0.08293622447779866,0.035418685763876946,1,bp,PCR,658,BMPR1B
GO:1905710,positive regulation of membrane permeability,1/15,57/16992,0.04917304332295369,0.08293622447779866,0.035418685763876946,1,bp,PCR,596,BCL2
GO:0052742,phosphatidylinositol kinase activity,1/15,51/16982,0.044130720052614536,0.08310330399518322,0.03981719102491538,1,mf,PCR,3667,IRS1
GO:0006979,response to oxidative stress,2/15,409/16992,0.049353896343762076,0.08314366828368829,0.035507276569893616,2,bp,PCR,596/4602,BCL2/MYB
GO:0031667,response to nutrient levels,2/15,411/16992,0.049787992668772096,0.08377675113000645,0.03577764048550984,2,bp,PCR,596/595,BCL2/CCND1
GO:0006801,superoxide metabolic process,1/15,58/16992,0.05001522840415562,0.08386450783753982,0.035815117803381105,1,bp,PCR,4137,MAPT
GO:0048645,animal organ formation,1/15,58/16992,0.05001522840415562,0.08386450783753982,0.035815117803381105,1,bp,PCR,3087,HHEX
GO:0086003,cardiac muscle cell contraction,1/15,58/16992,0.05001522840415562,0.08386450783753982,0.035815117803381105,1,bp,PCR,776,CACNA1D
GO:0098797,plasma membrane protein complex,2/15,232/18122,0.015353970384161076,0.08444683711288592,0.05541282544659636,2,cc,PCR,3480/5979,IGF1R/RET
GO:0002429,immune response-activating cell surface receptor signaling pathway,2/15,414/16992,0.05044182860987738,0.08448124442003939,0.036078500895054,2,bp,PCR,2625/596,GATA3/BCL2
GO:0001658,branching involved in ureteric bud morphogenesis,1/15,59/16992,0.050856717218017544,0.08452468106194738,0.03609705091683356,1,bp,PCR,596,BCL2
GO:0009100,glycoprotein metabolic process,2/15,416/16992,0.050879505301728946,0.08452468106194738,0.03609705091683356,2,bp,PCR,658/596,BMPR1B/BCL2
GO:0030166,proteoglycan biosynthetic process,1/15,59/16992,0.050856717218017544,0.08452468106194738,0.03609705091683356,1,bp,PCR,658,BMPR1B
GO:0051851,modification by host of symbiont morphology or physiology,1/15,59/16992,0.050856717218017544,0.08452468106194738,0.03609705091683356,1,bp,PCR,51176,LEF1
GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,1/15,59/16992,0.050856717218017544,0.08452468106194738,0.03609705091683356,1,bp,PCR,596,BCL2
GO:1901992,positive regulation of mitotic cell cycle phase transition,1/15,59/16992,0.050856717218017544,0.08452468106194738,0.03609705091683356,1,bp,PCR,595,CCND1
GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,1/15,59/16992,0.050856717218017544,0.08452468106194738,0.03609705091683356,1,bp,PCR,596,BCL2
GO:0030545,receptor regulator activity,1/15,53/16982,0.0458237223430914,0.08518512486856734,0.040814651479676556,1,mf,PCR,4137,MAPT
GO:0033692,cellular polysaccharide biosynthetic process,1/15,60/16992,0.05169751029908576,0.08578443683578088,0.036635041332644946,1,bp,PCR,3667,IRS1
GO:0070988,demethylation,1/15,61/16992,0.052537608181528306,0.0870779042178272,0.03718742860417775,1,bp,PCR,2625,GATA3
GO:0022604,regulation of cell morphogenesis,2/15,424/16992,0.05264437872374561,0.08715434588251433,0.03722007372779978,2,bp,PCR,4137/5979,MAPT/RET
GO:0002260,lymphocyte homeostasis,1/15,63/16992,0.054215720485312646,0.08803162749988053,0.03759472499903334,1,bp,PCR,596,BCL2
GO:0002718,regulation of cytokine production involved in immune response,1/15,63/16992,0.054215720485312646,0.08803162749988053,0.03759472499903334,1,bp,PCR,2625,GATA3
GO:0003281,ventricular septum development,1/15,63/16992,0.054215720485312646,0.08803162749988053,0.03759472499903334,1,bp,PCR,2625,GATA3
GO:0010507,negative regulation of autophagy,1/15,62/16992,0.053377011399133645,0.08803162749988053,0.03759472499903334,1,bp,PCR,596,BCL2
GO:0021872,forebrain generation of neurons,1/15,63/16992,0.054215720485312646,0.08803162749988053,0.03759472499903334,1,bp,PCR,51176,LEF1
GO:0043967,histone H4 acetylation,1/15,63/16992,0.054215720485312646,0.08803162749988053,0.03759472499903334,1,bp,PCR,51176,LEF1
GO:0045844,positive regulation of striated muscle tissue development,1/15,63/16992,0.054215720485312646,0.08803162749988053,0.03759472499903334,1,bp,PCR,596,BCL2
GO:0046324,regulation of glucose import,1/15,63/16992,0.054215720485312646,0.08803162749988053,0.03759472499903334,1,bp,PCR,3667,IRS1
GO:0048636,positive regulation of muscle organ development,1/15,63/16992,0.054215720485312646,0.08803162749988053,0.03759472499903334,1,bp,PCR,596,BCL2
GO:0048678,response to axon injury,1/15,63/16992,0.054215720485312646,0.08803162749988053,0.03759472499903334,1,bp,PCR,596,BCL2
GO:0048708,astrocyte differentiation,1/15,63/16992,0.054215720485312646,0.08803162749988053,0.03759472499903334,1,bp,PCR,4137,MAPT
GO:0048857,neural nucleus development,1/15,63/16992,0.054215720485312646,0.08803162749988053,0.03759472499903334,1,bp,PCR,596,BCL2
GO:0050909,sensory perception of taste,1/15,63/16992,0.054215720485312646,0.08803162749988053,0.03759472499903334,1,bp,PCR,51176,LEF1
GO:0051702,interaction with symbiont,1/15,63/16992,0.054215720485312646,0.08803162749988053,0.03759472499903334,1,bp,PCR,51176,LEF1
GO:1901379,regulation of potassium ion transmembrane transport,1/15,63/16992,0.054215720485312646,0.08803162749988053,0.03759472499903334,1,bp,PCR,776,CACNA1D
GO:1901983,regulation of protein acetylation,1/15,62/16992,0.053377011399133645,0.08803162749988053,0.03759472499903334,1,bp,PCR,2625,GATA3
GO:1903725,regulation of phospholipid metabolic process,1/15,62/16992,0.053377011399133645,0.08803162749988053,0.03759472499903334,1,bp,PCR,3667,IRS1
GO:0030971,receptor tyrosine kinase binding,1/15,56/16982,0.04835797897581673,0.08875831584168893,0.04252667038512865,1,mf,PCR,3667,IRS1
GO:0002200,somatic diversification of immune receptors,1/15,64/16992,0.05505373597309815,0.08879036879162969,0.0379187525220819,1,bp,PCR,51176,LEF1
GO:0014909,smooth muscle cell migration,1/15,64/16992,0.05505373597309815,0.08879036879162969,0.0379187525220819,1,bp,PCR,596,BCL2
GO:0046782,regulation of viral transcription,1/15,64/16992,0.05505373597309815,0.08879036879162969,0.0379187525220819,1,bp,PCR,51176,LEF1
GO:0046888,negative regulation of hormone secretion,1/15,64/16992,0.05505373597309815,0.08879036879162969,0.0379187525220819,1,bp,PCR,3667,IRS1
GO:1901863,positive regulation of muscle tissue development,1/15,64/16992,0.05505373597309815,0.08879036879162969,0.0379187525220819,1,bp,PCR,596,BCL2
GO:1904035,regulation of epithelial cell apoptotic process,1/15,64/16992,0.05505373597309815,0.08879036879162969,0.0379187525220819,1,bp,PCR,2625,GATA3
GO:0000979,RNA polymerase II core promoter sequence-specific DNA binding,1/15,59/16982,0.050885952330674056,0.08889714563792456,0.04259318774666441,1,mf,PCR,2625,GATA3
GO:0003707,steroid hormone receptor activity,1/15,59/16982,0.050885952330674056,0.08889714563792456,0.04259318774666441,1,mf,PCR,51176,LEF1
GO:0004869,cysteine-type endopeptidase inhibitor activity,1/15,58/16982,0.05004399179397523,0.08889714563792456,0.04259318774666441,1,mf,PCR,51176,LEF1
GO:0070491,repressing transcription factor binding,1/15,58/16982,0.05004399179397523,0.08889714563792456,0.04259318774666441,1,mf,PCR,3087,HHEX
GO:0042446,hormone biosynthetic process,1/15,65/16992,0.055891058395144744,0.08963778003774887,0.03828064737355426,1,bp,PCR,8912,CACNA1H
GO:0045913,positive regulation of carbohydrate metabolic process,1/15,65/16992,0.055891058395144744,0.08963778003774887,0.03828064737355426,1,bp,PCR,3667,IRS1
GO:0061035,regulation of cartilage development,1/15,65/16992,0.055891058395144744,0.08963778003774887,0.03828064737355426,1,bp,PCR,658,BMPR1B
GO:0071479,cellular response to ionizing radiation,1/15,65/16992,0.055891058395144744,0.08963778003774887,0.03828064737355426,1,bp,PCR,2625,GATA3
GO:0086001,cardiac muscle cell action potential,1/15,65/16992,0.055891058395144744,0.08963778003774887,0.03828064737355426,1,bp,PCR,776,CACNA1D
GO:0001756,somitogenesis,1/15,66/16992,0.056727688283729316,0.09017443369880423,0.03850983030905239,1,bp,PCR,51176,LEF1
GO:0002088,lens development in camera-type eye,1/15,66/16992,0.056727688283729316,0.09017443369880423,0.03850983030905239,1,bp,PCR,2625,GATA3
GO:0009991,response to extracellular stimulus,2/15,442/16992,0.056696697157909585,0.09017443369880423,0.03850983030905239,2,bp,PCR,596/595,BCL2/CCND1
GO:0017158,regulation of calcium ion-dependent exocytosis,1/15,66/16992,0.056727688283729316,0.09017443369880423,0.03850983030905239,1,bp,PCR,8912,CACNA1H
GO:0040014,regulation of multicellular organism growth,1/15,66/16992,0.056727688283729316,0.09017443369880423,0.03850983030905239,1,bp,PCR,596,BCL2
GO:0042440,pigment metabolic process,1/15,66/16992,0.056727688283729316,0.09017443369880423,0.03850983030905239,1,bp,PCR,596,BCL2
GO:1900076,regulation of cellular response to insulin stimulus,1/15,66/16992,0.056727688283729316,0.09017443369880423,0.03850983030905239,1,bp,PCR,3667,IRS1
GO:1901989,positive regulation of cell cycle phase transition,1/15,66/16992,0.056727688283729316,0.09017443369880423,0.03850983030905239,1,bp,PCR,595,CCND1
GO:0002768,immune response-regulating cell surface receptor signaling pathway,2/15,446/16992,0.057612205828329315,0.09147927046995495,0.03906707298390927,2,bp,PCR,2625/596,GATA3/BCL2
GO:0005216,ion channel activity,2/15,427/16982,0.053368055927558375,0.09212342987495196,0.04413899362429641,2,mf,PCR,776/8912,CACNA1D/CACNA1H
GO:0006914,autophagy,2/15,449/16992,0.05830235549551887,0.09221887902041233,0.039382929691902276,2,bp,PCR,596/4137,BCL2/MAPT
GO:0019058,viral life cycle,2/15,449/16992,0.05830235549551887,0.09221887902041233,0.039382929691902276,2,bp,PCR,596/51176,BCL2/LEF1
GO:0030500,regulation of bone mineralization,1/15,68/16992,0.05839887258773502,0.09221887902041233,0.039382929691902276,1,bp,PCR,658,BMPR1B
GO:0032844,regulation of homeostatic process,2/15,449/16992,0.05830235549551887,0.09221887902041233,0.039382929691902276,2,bp,PCR,596/53832,BCL2/IL20RA
GO:0072384,organelle transport along microtubule,1/15,68/16992,0.05839887258773502,0.09221887902041233,0.039382929691902276,1,bp,PCR,4137,MAPT
GO:0022838,substrate-specific channel activity,2/15,437/16982,0.05561816752660767,0.09247448814808086,0.04430719577330917,2,mf,PCR,776/8912,CACNA1D/CACNA1H
GO:0042562,hormone binding,1/15,64/16982,0.05508531769812275,0.09247448814808086,0.04430719577330917,1,mf,PCR,3480,IGF1R
GO:0046873,metal ion transmembrane transporter activity,2/15,440/16982,0.05629988588307868,0.09247448814808086,0.04430719577330917,2,mf,PCR,776/8912,CACNA1D/CACNA1H
GO:0046934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",1/15,66/16982,0.056760203070201354,0.09247448814808086,0.04430719577330917,1,mf,PCR,3667,IRS1
GO:1990782,protein tyrosine kinase binding,1/15,63/16982,0.054246834485006445,0.09247448814808086,0.04430719577330917,1,mf,PCR,3667,IRS1
GO:0090066,regulation of anatomical structure size,2/15,451/16992,0.058764120415677794,0.09269378818587155,0.03958574406648582,2,bp,PCR,4137/5979,MAPT/RET
GO:0000271,polysaccharide biosynthetic process,1/15,69/16992,0.059233428065824434,0.09282272206171178,0.039640806476927797,1,bp,PCR,3667,IRS1
GO:0001707,mesoderm formation,1/15,69/16992,0.059233428065824434,0.09282272206171178,0.039640806476927797,1,bp,PCR,51176,LEF1
GO:0002040,sprouting angiogenesis,1/15,69/16992,0.059233428065824434,0.09282272206171178,0.039640806476927797,1,bp,PCR,51176,LEF1
GO:0019226,transmission of nerve impulse,1/15,69/16992,0.059233428065824434,0.09282272206171178,0.039640806476927797,1,bp,PCR,8912,CACNA1H
GO:0046902,regulation of mitochondrial membrane permeability,1/15,69/16992,0.059233428065824434,0.09282272206171178,0.039640806476927797,1,bp,PCR,596,BCL2
GO:0051051,negative regulation of transport,2/15,453/16992,0.059227211139114416,0.09282272206171178,0.039640806476927797,2,bp,PCR,596/3667,BCL2/IRS1
hsa04550,Signaling pathways regulating pluripotency of stem cells,2/15,139/7430,0.031112466604363585,0.09333739981309075,0.058131187602889864,2,kg,PCR,658/3480,BMPR1B/IGF1R
hsa05418,Fluid shear stress and atherosclerosis,2/15,139/7430,0.031112466604363585,0.09333739981309075,0.058131187602889864,2,kg,PCR,658/596,BMPR1B/BCL2
GO:0001938,positive regulation of endothelial cell proliferation,1/15,70/16992,0.06006729313578918,0.09351755171844968,0.03993753994202554,1,bp,PCR,7060,THBS4
GO:0006635,fatty acid beta-oxidation,1/15,70/16992,0.06006729313578918,0.09351755171844968,0.03993753994202554,1,bp,PCR,3667,IRS1
GO:0007045,cell-substrate adherens junction assembly,1/15,70/16992,0.06006729313578918,0.09351755171844968,0.03993753994202554,1,bp,PCR,596,BCL2
GO:0031571,mitotic G1 DNA damage checkpoint,1/15,70/16992,0.06006729313578918,0.09351755171844968,0.03993753994202554,1,bp,PCR,595,CCND1
GO:0044819,mitotic G1/S transition checkpoint,1/15,70/16992,0.06006729313578918,0.09351755171844968,0.03993753994202554,1,bp,PCR,595,CCND1
GO:0048041,focal adhesion assembly,1/15,70/16992,0.06006729313578918,0.09351755171844968,0.03993753994202554,1,bp,PCR,596,BCL2
GO:0061695,"transferase complex, transferring phosphorus-containing groups",2/15,254/18122,0.018219068589651225,0.09352455209354296,0.061369494196719915,2,cc,PCR,3667/595,IRS1/CCND1
GO:0003208,cardiac ventricle morphogenesis,1/15,71/16992,0.06090046832802187,0.09440558035314717,0.040316780826930965,1,bp,PCR,2625,GATA3
GO:0010595,positive regulation of endothelial cell migration,1/15,71/16992,0.06090046832802187,0.09440558035314717,0.040316780826930965,1,bp,PCR,2625,GATA3
GO:0044783,G1 DNA damage checkpoint,1/15,71/16992,0.06090046832802187,0.09440558035314717,0.040316780826930965,1,bp,PCR,595,CCND1
GO:0048332,mesoderm morphogenesis,1/15,71/16992,0.06090046832802187,0.09440558035314717,0.040316780826930965,1,bp,PCR,51176,LEF1
hsa04261,Adrenergic signaling in cardiomyocytes,2/15,144/7430,0.03320641469645891,0.09487547056131117,0.05908910885836046,2,kg,PCR,596/776,BCL2/CACNA1D
hsa05161,Hepatitis B,2/15,144/7430,0.03320641469645891,0.09487547056131117,0.05908910885836046,2,kg,PCR,596/595,BCL2/CCND1
hsa04310,Wnt signaling pathway,2/15,146/7430,0.03405945377467193,0.09504963844094491,0.0591975818360271,2,kg,PCR,51176/595,LEF1/CCND1
GO:0001570,vasculogenesis,1/15,72/16992,0.06173295417253932,0.0953873711246656,0.04073606370412046,1,bp,PCR,3087,HHEX
GO:0046849,bone remodeling,1/15,72/16992,0.06173295417253932,0.0953873711246656,0.04073606370412046,1,bp,PCR,53832,IL20RA
GO:0048661,positive regulation of smooth muscle cell proliferation,1/15,72/16992,0.06173295417253932,0.0953873711246656,0.04073606370412046,1,bp,PCR,4602,MYB
GO:0052813,phosphatidylinositol bisphosphate kinase activity,1/15,69/16982,0.059267336485317124,0.09548626433745537,0.04575022465533252,1,mf,PCR,3667,IRS1
GO:0002702,positive regulation of production of molecular mediator of immune response,1/15,73/16992,0.0625647511989823,0.0961556657464573,0.04106417106558591,1,bp,PCR,2625,GATA3
GO:0021675,nerve development,1/15,73/16992,0.0625647511989823,0.0961556657464573,0.04106417106558591,1,bp,PCR,5979,RET
GO:0030279,negative regulation of ossification,1/15,73/16992,0.0625647511989823,0.0961556657464573,0.04106417106558591,1,bp,PCR,596,BCL2
GO:0031016,pancreas development,1/15,73/16992,0.0625647511989823,0.0961556657464573,0.04106417106558591,1,bp,PCR,3087,HHEX
GO:0036473,cell death in response to oxidative stress,1/15,73/16992,0.0625647511989823,0.0961556657464573,0.04106417106558591,1,bp,PCR,596,BCL2
GO:0002250,adaptive immune response,2/15,468/16992,0.06274210909101567,0.09622242344054377,0.04109268055952608,2,bp,PCR,2625/51176,GATA3/LEF1
GO:1902532,negative regulation of intracellular signal transduction,2/15,468/16992,0.06274210909101567,0.09622242344054377,0.04109268055952608,2,bp,PCR,596/3480,BCL2/IGF1R
GO:0010717,regulation of epithelial to mesenchymal transition,1/15,74/16992,0.063395859936615,0.09670897104980442,0.04130046523974361,1,bp,PCR,51176,LEF1
GO:0034637,cellular carbohydrate biosynthetic process,1/15,74/16992,0.063395859936615,0.09670897104980442,0.04130046523974361,1,bp,PCR,3667,IRS1
GO:0035050,embryonic heart tube development,1/15,74/16992,0.063395859936615,0.09670897104980442,0.04130046523974361,1,bp,PCR,3087,HHEX
GO:0050772,positive regulation of axonogenesis,1/15,74/16992,0.063395859936615,0.09670897104980442,0.04130046523974361,1,bp,PCR,4137,MAPT
GO:0090559,regulation of membrane permeability,1/15,74/16992,0.063395859936615,0.09670897104980442,0.04130046523974361,1,bp,PCR,596,BCL2
GO:0034702,ion channel complex,2/15,282/18122,0.022168748913863143,0.09736179440266843,0.0638874385690784,2,cc,PCR,776/8912,CACNA1D/CACNA1H
GO:0045121,membrane raft,2/15,285/18122,0.02261149223319204,0.09736179440266843,0.0638874385690784,2,cc,PCR,5979/3667,RET/IRS1
GO:0098857,membrane microdomain,2/15,286/18122,0.02275989999023418,0.09736179440266843,0.0638874385690784,2,cc,PCR,5979/3667,RET/IRS1
GO:0002708,positive regulation of lymphocyte mediated immunity,1/15,75/16992,0.0642262809143288,0.0976647255808365,0.04170862909836112,1,bp,PCR,2625,GATA3
GO:0005977,glycogen metabolic process,1/15,75/16992,0.0642262809143288,0.0976647255808365,0.04170862909836112,1,bp,PCR,3667,IRS1
GO:1905954,positive regulation of lipid localization,1/15,75/16992,0.0642262809143288,0.0976647255808365,0.04170862909836112,1,bp,PCR,4602,MYB
hsa04150,mTOR signaling pathway,2/15,151/7430,0.03623005090824577,0.09778829559073332,0.06090323672756198,2,kg,PCR,3480/3667,IGF1R/IRS1
hsa04921,Oxytocin signaling pathway,2/15,152/7430,0.036670610846524995,0.09778829559073332,0.06090323672756198,2,kg,PCR,776/595,CACNA1D/CCND1
GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1/15,76/16992,0.06505601466063593,0.09809600531724431,0.04189281111962307,1,bp,PCR,2625,GATA3
GO:0006073,cellular glucan metabolic process,1/15,76/16992,0.06505601466063593,0.09809600531724431,0.04189281111962307,1,bp,PCR,3667,IRS1
GO:0021536,diencephalon development,1/15,76/16992,0.06505601466063593,0.09809600531724431,0.04189281111962307,1,bp,PCR,51176,LEF1
GO:0021766,hippocampus development,1/15,76/16992,0.06505601466063593,0.09809600531724431,0.04189281111962307,1,bp,PCR,51176,LEF1
GO:0030516,regulation of axon extension,1/15,76/16992,0.06505601466063593,0.09809600531724431,0.04189281111962307,1,bp,PCR,4137,MAPT
GO:0044042,glucan metabolic process,1/15,76/16992,0.06505601466063593,0.09809600531724431,0.04189281111962307,1,bp,PCR,3667,IRS1
GO:0046323,glucose import,1/15,76/16992,0.06505601466063593,0.09809600531724431,0.04189281111962307,1,bp,PCR,3667,IRS1
GO:0070167,regulation of biomineral tissue development,1/15,76/16992,0.06505601466063593,0.09809600531724431,0.04189281111962307,1,bp,PCR,658,BMPR1B
GO:0002456,T cell mediated immunity,1/15,77/16992,0.0658850617036777,0.09893086067730913,0.0422493438632174,1,bp,PCR,2625,GATA3
GO:0031100,animal organ regeneration,1/15,77/16992,0.0658850617036777,0.09893086067730913,0.0422493438632174,1,bp,PCR,595,CCND1
GO:0044728,DNA methylation or demethylation,1/15,77/16992,0.0658850617036777,0.09893086067730913,0.0422493438632174,1,bp,PCR,2625,GATA3
GO:0045921,positive regulation of exocytosis,1/15,77/16992,0.0658850617036777,0.09893086067730913,0.0422493438632174,1,bp,PCR,8912,CACNA1H
GO:0002367,cytokine production involved in immune response,1/15,78/16992,0.0667134225712177,0.09975774009868871,0.042602470408039786,1,bp,PCR,2625,GATA3
GO:0007492,endoderm development,1/15,78/16992,0.0667134225712177,0.09975774009868871,0.042602470408039786,1,bp,PCR,3087,HHEX
GO:0050848,regulation of calcium-mediated signaling,1/15,78/16992,0.0667134225712177,0.09975774009868871,0.042602470408039786,1,bp,PCR,4137,MAPT
GO:1900034,regulation of cellular response to heat,1/15,78/16992,0.0667134225712177,0.09975774009868871,0.042602470408039786,1,bp,PCR,4137,MAPT
GO:0051259,protein oligomerization,2/15,485/16992,0.06681260838861192,0.09980220192768745,0.04262145824549814,2,bp,PCR,3480/4137,IGF1R/MAPT
GO:0035004,phosphatidylinositol 3-kinase activity,1/15,74/16982,0.06343207524831485,0.09997446642397448,0.047900651789345314,1,mf,PCR,3667,IRS1
GO:0046332,SMAD binding,1/15,74/16982,0.06343207524831485,0.09997446642397448,0.047900651789345314,1,mf,PCR,658,BMPR1B
GO:0050886,endocrine process,1/15,79/16992,0.06754109779064754,0.10078562567514072,0.04304143850024323,1,bp,PCR,2625,GATA3
GO:0002821,positive regulation of adaptive immune response,1/15,80/16992,0.0683680878889823,0.10159766524970792,0.043388227550510736,1,bp,PCR,2625,GATA3
GO:0019217,regulation of fatty acid metabolic process,1/15,80/16992,0.0683680878889823,0.10159766524970792,0.043388227550510736,1,bp,PCR,3667,IRS1
GO:0034333,adherens junction assembly,1/15,80/16992,0.0683680878889823,0.10159766524970792,0.043388227550510736,1,bp,PCR,596,BCL2
GO:0045639,positive regulation of myeloid cell differentiation,1/15,80/16992,0.0683680878889823,0.10159766524970792,0.043388227550510736,1,bp,PCR,51176,LEF1
GO:0044057,regulation of system process,2/15,493/16992,0.06875922834052978,0.10207335860055919,0.04359137681875692,2,bp,PCR,776/8912,CACNA1D/CACNA1H
GO:0050853,B cell receptor signaling pathway,1/15,81/16992,0.06919439339286537,0.10261335738446599,0.04382198832007008,1,bp,PCR,596,BCL2
GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,1/15,82/16992,0.07002001482856435,0.1026722054169867,0.043847119919498405,1,bp,PCR,4137,MAPT
GO:0008015,blood circulation,2/15,496/16992,0.06949424098213261,0.1026722054169867,0.043847119919498405,2,bp,PCR,776/8912,CACNA1D/CACNA1H
GO:0032091,negative regulation of protein binding,1/15,82/16992,0.07002001482856435,0.1026722054169867,0.043847119919498405,1,bp,PCR,51176,LEF1
GO:0042475,odontogenesis of dentin-containing tooth,1/15,82/16992,0.07002001482856435,0.1026722054169867,0.043847119919498405,1,bp,PCR,51176,LEF1
GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,1/15,82/16992,0.07002001482856435,0.1026722054169867,0.043847119919498405,1,bp,PCR,51176,LEF1
GO:0043255,regulation of carbohydrate biosynthetic process,1/15,82/16992,0.07002001482856435,0.1026722054169867,0.043847119919498405,1,bp,PCR,3667,IRS1
GO:0043266,regulation of potassium ion transport,1/15,82/16992,0.07002001482856435,0.1026722054169867,0.043847119919498405,1,bp,PCR,776,CACNA1D
GO:0045069,regulation of viral genome replication,1/15,82/16992,0.07002001482856435,0.1026722054169867,0.043847119919498405,1,bp,PCR,596,BCL2
GO:0045778,positive regulation of ossification,1/15,82/16992,0.07002001482856435,0.1026722054169867,0.043847119919498405,1,bp,PCR,658,BMPR1B
GO:0051640,organelle localization,2/15,496/16992,0.06949424098213261,0.1026722054169867,0.043847119919498405,2,bp,PCR,4137/3087,MAPT/HHEX
GO:0070301,cellular response to hydrogen peroxide,1/15,82/16992,0.07002001482856435,0.1026722054169867,0.043847119919498405,1,bp,PCR,4602,MYB
GO:0051219,phosphoprotein binding,1/15,77/16982,0.06592265169351719,0.10278262898451604,0.04924612350619282,1,mf,PCR,3667,IRS1
GO:0007507,heart development,2/15,499/16992,0.07023197036845127,0.10287802387305248,0.04393501660476109,2,bp,PCR,2625/3087,GATA3/HHEX
GO:0003013,circulatory system process,2/15,500/16992,0.07047848090059759,0.10313398885352215,0.044044328829508414,2,bp,PCR,776/8912,CACNA1D/CACNA1H
GO:0008013,beta-catenin binding,1/15,79/16982,0.06757960030738552,0.10314781099548317,0.04942109274556726,1,mf,PCR,51176,LEF1
GO:0035591,signaling adaptor activity,1/15,79/16982,0.06757960030738552,0.10314781099548317,0.04942109274556726,1,mf,PCR,3667,IRS1
GO:0001776,leukocyte homeostasis,1/15,83/16992,0.07084495272197477,0.10345954985922536,0.04418336268390169,1,bp,PCR,596,BCL2
GO:0051897,positive regulation of protein kinase B signaling,1/15,83/16992,0.07084495272197477,0.10345954985922536,0.04418336268390169,1,bp,PCR,2625,GATA3
GO:0005667,transcription factor complex,2/15,307/18122,0.025970625726875345,0.10380862588171053,0.06811775861000827,2,cc,PCR,2625/51176,GATA3/LEF1
GO:0032589,neuron projection membrane,1/15,37/18122,0.030203405931210625,0.10380862588171053,0.06811775861000827,1,cc,PCR,4137,MAPT
GO:1902495,transmembrane transporter complex,2/15,318/18122,0.027722867207786113,0.10380862588171053,0.06811775861000827,2,cc,PCR,776/8912,CACNA1D/CACNA1H
GO:1904115,axon cytoplasm,1/15,38/18122,0.03100777136726418,0.10380862588171053,0.06811775861000827,1,cc,PCR,4137,MAPT
GO:1990351,transporter complex,2/15,325/18122,0.02886259318556355,0.10380862588171053,0.06811775861000827,2,cc,PCR,776/8912,CACNA1D/CACNA1H
GO:0006029,proteoglycan metabolic process,1/15,84/16992,0.07166920759861883,0.10413412671305891,0.04447144700121844,1,bp,PCR,658,BMPR1B
GO:0021782,glial cell development,1/15,84/16992,0.07166920759861883,0.10413412671305891,0.04447144700121844,1,bp,PCR,4137,MAPT
GO:0031109,microtubule polymerization or depolymerization,1/15,84/16992,0.07166920759861883,0.10413412671305891,0.04447144700121844,1,bp,PCR,4137,MAPT
GO:0048145,regulation of fibroblast proliferation,1/15,84/16992,0.07166920759861883,0.10413412671305891,0.04447144700121844,1,bp,PCR,4602,MYB
GO:0051781,positive regulation of cell division,1/15,84/16992,0.07166920759861883,0.10413412671305891,0.04447144700121844,1,bp,PCR,7060,THBS4
GO:0000307,cyclin-dependent protein kinase holoenzyme complex,1/15,40/18122,0.0326146345523215,0.10463861918869814,0.06866238853120316,1,cc,PCR,595,CCND1
GO:0048144,fibroblast proliferation,1/15,85/16992,0.07249277998364467,0.10501222261743688,0.044846446021291224,1,bp,PCR,4602,MYB
GO:0061053,somite development,1/15,85/16992,0.07249277998364467,0.10501222261743688,0.044846446021291224,1,bp,PCR,51176,LEF1
GO:2000379,positive regulation of reactive oxygen species metabolic process,1/15,85/16992,0.07249277998364467,0.10501222261743688,0.044846446021291224,1,bp,PCR,4137,MAPT
hsa04218,Cellular senescence,2/15,160/7430,0.04027084531783119,0.10505437908999442,0.06542860452096144,2,kg,PCR,776/595,CACNA1D/CCND1
GO:0002690,positive regulation of leukocyte chemotaxis,1/15,86/16992,0.07331567040182929,0.10588403856022983,0.045218763125381096,1,bp,PCR,7060,THBS4
GO:0007044,cell-substrate junction assembly,1/15,86/16992,0.07331567040182929,0.10588403856022983,0.045218763125381096,1,bp,PCR,596,BCL2
GO:0043467,regulation of generation of precursor metabolites and energy,1/15,86/16992,0.07331567040182929,0.10588403856022983,0.045218763125381096,1,bp,PCR,3667,IRS1
GO:0030315,T-tubule,1/15,44/18122,0.035820902698653345,0.10608498106908876,0.06961147083139112,1,cc,PCR,776,CACNA1D
GO:0098589,membrane region,2/15,361/18122,0.035017898834354334,0.10608498106908876,0.06961147083139112,2,cc,PCR,5979/3667,RET/IRS1
hsa04022,cGMP-PKG signaling pathway,2/15,163/7430,0.04165505938896389,0.10635334312075888,0.0662376084348586,2,kg,PCR,776/3667,CACNA1D/IRS1
GO:0001942,hair follicle development,1/15,87/16992,0.07413787937757577,0.10674963192943525,0.04558842282156595,1,bp,PCR,596,BCL2
GO:0060349,bone morphogenesis,1/15,87/16992,0.07413787937757577,0.10674963192943525,0.04558842282156595,1,bp,PCR,658,BMPR1B
GO:2000117,negative regulation of cysteine-type endopeptidase activity,1/15,87/16992,0.07413787937757577,0.10674963192943525,0.04558842282156595,1,bp,PCR,51176,LEF1
GO:0001892,embryonic placenta development,1/15,88/16992,0.07495940743491591,0.10750166515366684,0.045909585602012797,1,bp,PCR,51176,LEF1
GO:0010522,regulation of calcium ion transport into cytosol,1/15,88/16992,0.07495940743491591,0.10750166515366684,0.045909585602012797,1,bp,PCR,596,BCL2
GO:0030593,neutrophil chemotaxis,1/15,88/16992,0.07495940743491591,0.10750166515366684,0.045909585602012797,1,bp,PCR,7060,THBS4
GO:0060021,palate development,1/15,88/16992,0.07495940743491591,0.10750166515366684,0.045909585602012797,1,bp,PCR,51176,LEF1
GO:0002705,positive regulation of leukocyte mediated immunity,1/15,89/16992,0.0757802550975093,0.10792490245304347,0.04609033302576592,1,bp,PCR,2625,GATA3
GO:0006112,energy reserve metabolic process,1/15,89/16992,0.0757802550975093,0.10792490245304347,0.04609033302576592,1,bp,PCR,3667,IRS1
GO:0009798,axis specification,1/15,89/16992,0.0757802550975093,0.10792490245304347,0.04609033302576592,1,bp,PCR,3087,HHEX
GO:0022404,molting cycle process,1/15,89/16992,0.0757802550975093,0.10792490245304347,0.04609033302576592,1,bp,PCR,596,BCL2
GO:0022405,hair cycle process,1/15,89/16992,0.0757802550975093,0.10792490245304347,0.04609033302576592,1,bp,PCR,596,BCL2
GO:1904019,epithelial cell apoptotic process,1/15,89/16992,0.0757802550975093,0.10792490245304347,0.04609033302576592,1,bp,PCR,2625,GATA3
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,1/15,89/16992,0.0757802550975093,0.10792490245304347,0.04609033302576592,1,bp,PCR,596,BCL2
GO:0001158,enhancer sequence-specific DNA binding,1/15,84/16982,0.07170997774777199,0.10831194555653062,0.05189537863325606,1,mf,PCR,2625,GATA3
GO:0002027,regulation of heart rate,1/15,90/16992,0.0766004228886431,0.1083413461525395,0.046268179179526456,1,bp,PCR,776,CACNA1D
GO:0007589,body fluid secretion,1/15,90/16992,0.0766004228886431,0.1083413461525395,0.046268179179526456,1,bp,PCR,595,CCND1
GO:0033273,response to vitamin,1/15,90/16992,0.0766004228886431,0.1083413461525395,0.046268179179526456,1,bp,PCR,595,CCND1
GO:0044264,cellular polysaccharide metabolic process,1/15,90/16992,0.0766004228886431,0.1083413461525395,0.046268179179526456,1,bp,PCR,3667,IRS1
GO:0051149,positive regulation of muscle cell differentiation,1/15,90/16992,0.0766004228886431,0.1083413461525395,0.046268179179526456,1,bp,PCR,596,BCL2
GO:0051453,regulation of intracellular pH,1/15,90/16992,0.0766004228886431,0.1083413461525395,0.046268179179526456,1,bp,PCR,596,BCL2
GO:0061387,regulation of extent of cell growth,1/15,90/16992,0.0766004228886431,0.1083413461525395,0.046268179179526456,1,bp,PCR,4137,MAPT
GO:0051153,regulation of striated muscle cell differentiation,1/15,91/16992,0.07741991133123372,0.10939273606979631,0.046717185019002495,1,bp,PCR,596,BCL2
GO:0035258,steroid hormone receptor binding,1/15,86/16982,0.07335734214916889,0.10965788259411845,0.05254025590716384,1,mf,PCR,51176,LEF1
GO:0014013,regulation of gliogenesis,1/15,92/16992,0.07823872094782669,0.11011659353773452,0.047026315080759794,1,bp,PCR,4602,MYB
GO:0030641,regulation of cellular pH,1/15,92/16992,0.07823872094782669,0.11011659353773452,0.047026315080759794,1,bp,PCR,596,BCL2
GO:0032649,regulation of interferon-gamma production,1/15,92/16992,0.07823872094782669,0.11011659353773452,0.047026315080759794,1,bp,PCR,2625,GATA3
GO:0048010,vascular endothelial growth factor receptor signaling pathway,1/15,92/16992,0.07823872094782669,0.11011659353773452,0.047026315080759794,1,bp,PCR,3087,HHEX
GO:0007569,cell aging,1/15,93/16992,0.079056852260595,0.11105053440711146,0.04742516321235467,1,bp,PCR,596,BCL2
GO:0009062,fatty acid catabolic process,1/15,93/16992,0.079056852260595,0.11105053440711146,0.04742516321235467,1,bp,PCR,3667,IRS1
hsa04530,Tight junction,2/15,170/7430,0.044955411627451015,0.11126894924364347,0.06929908242367269,2,kg,PCR,776/595,CACNA1D/CCND1
hsa05010,Alzheimer's disease,2/15,171/7430,0.04543482094115442,0.11126894924364347,0.06929908242367269,2,kg,PCR,4137/776,MAPT/CACNA1D
GO:0006081,cellular aldehyde metabolic process,1/15,94/16992,0.07987430579134158,0.11197988041186131,0.04782204906428975,1,bp,PCR,8912,CACNA1H
GO:0051817,modification of morphology or physiology of other organism involved in symbiotic interaction,1/15,94/16992,0.07987430579134158,0.11197988041186131,0.04782204906428975,1,bp,PCR,51176,LEF1
GO:0030424,axon,2/15,385/18122,0.039384450468505326,0.11231861800277444,0.07370189561357722,2,cc,PCR,4137/5979,MAPT/RET
GO:0009953,dorsal/ventral pattern formation,1/15,95/16992,0.08069108206149966,0.11279482969102628,0.04817008073095874,1,bp,PCR,658,BMPR1B
GO:1903902,positive regulation of viral life cycle,1/15,95/16992,0.08069108206149966,0.11279482969102628,0.04817008073095874,1,bp,PCR,51176,LEF1
GO:1990266,neutrophil migration,1/15,95/16992,0.08069108206149966,0.11279482969102628,0.04817008073095874,1,bp,PCR,7060,THBS4
GO:0001952,regulation of cell-matrix adhesion,1/15,96/16992,0.08150718159213122,0.11305581076051406,0.04828153512315841,1,bp,PCR,596,BCL2
GO:0002062,chondrocyte differentiation,1/15,96/16992,0.08150718159213122,0.11305581076051406,0.04828153512315841,1,bp,PCR,658,BMPR1B
GO:0003279,cardiac septum development,1/15,96/16992,0.08150718159213122,0.11305581076051406,0.04828153512315841,1,bp,PCR,2625,GATA3
GO:0010906,regulation of glucose metabolic process,1/15,96/16992,0.08150718159213122,0.11305581076051406,0.04828153512315841,1,bp,PCR,3667,IRS1
GO:0019395,fatty acid oxidation,1/15,96/16992,0.08150718159213122,0.11305581076051406,0.04828153512315841,1,bp,PCR,3667,IRS1
GO:0030218,erythrocyte differentiation,1/15,96/16992,0.08150718159213122,0.11305581076051406,0.04828153512315841,1,bp,PCR,2625,GATA3
GO:0035282,segmentation,1/15,96/16992,0.08150718159213122,0.11305581076051406,0.04828153512315841,1,bp,PCR,51176,LEF1
GO:0042472,inner ear morphogenesis,1/15,96/16992,0.08150718159213122,0.11305581076051406,0.04828153512315841,1,bp,PCR,2625,GATA3
GO:0001936,regulation of endothelial cell proliferation,1/15,97/16992,0.08232260490392751,0.11385715423189974,0.048623756303115086,1,bp,PCR,7060,THBS4
GO:0042035,regulation of cytokine biosynthetic process,1/15,97/16992,0.08232260490392751,0.11385715423189974,0.048623756303115086,1,bp,PCR,2625,GATA3
GO:0098773,skin epidermis development,1/15,97/16992,0.08232260490392751,0.11385715423189974,0.048623756303115086,1,bp,PCR,596,BCL2
GO:0006304,DNA modification,1/15,98/16992,0.08313735251721222,0.11443330993030072,0.04886980895093237,1,bp,PCR,2625,GATA3
GO:0007613,memory,1/15,98/16992,0.08313735251721222,0.11443330993030072,0.04886980895093237,1,bp,PCR,4137,MAPT
GO:0034440,lipid oxidation,1/15,98/16992,0.08313735251721222,0.11443330993030072,0.04886980895093237,1,bp,PCR,3667,IRS1
GO:0044773,mitotic DNA damage checkpoint,1/15,98/16992,0.08313735251721222,0.11443330993030072,0.04886980895093237,1,bp,PCR,595,CCND1
GO:0051928,positive regulation of calcium ion transport,1/15,98/16992,0.08313735251721222,0.11443330993030072,0.04886980895093237,1,bp,PCR,776,CACNA1D
GO:0004896,cytokine receptor activity,1/15,91/16982,0.07746382350071779,0.11461484089391917,0.054915277669681795,1,mf,PCR,53832,IL20RA
GO:0004702,"signal transducer, downstream of receptor, with serine/threonine kinase activity",1/15,92/16982,0.07828307888213282,0.11465703472635616,0.05493549395237391,1,mf,PCR,658,BMPR1B
GO:0006885,regulation of pH,1/15,99/16992,0.08395142495193719,0.11500304828973665,0.04911312101447934,1,bp,PCR,596,BCL2
GO:0022037,metencephalon development,1/15,99/16992,0.08395142495193719,0.11500304828973665,0.04911312101447934,1,bp,PCR,596,BCL2
GO:0030282,bone mineralization,1/15,99/16992,0.08395142495193719,0.11500304828973665,0.04911312101447934,1,bp,PCR,658,BMPR1B
GO:0032368,regulation of lipid transport,1/15,99/16992,0.08395142495193719,0.11500304828973665,0.04911312101447934,1,bp,PCR,4602,MYB
GO:0046854,phosphatidylinositol phosphorylation,1/15,99/16992,0.08395142495193719,0.11500304828973665,0.04911312101447934,1,bp,PCR,3667,IRS1
GO:0003705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",1/15,95/16982,0.08073677266733148,0.11590922808676302,0.055535455925418226,1,mf,PCR,51176,LEF1
GO:0019955,cytokine binding,1/15,95/16982,0.08073677266733148,0.11590922808676302,0.055535455925418226,1,mf,PCR,53832,IL20RA
GO:0031072,heat shock protein binding,1/15,96/16982,0.08155331488382866,0.11593363390348194,0.05554714945647774,1,mf,PCR,4137,MAPT
GO:0048675,axon extension,1/15,100/16992,0.0847648227276856,0.11600671453303257,0.04954174601527891,1,bp,PCR,4137,MAPT
GO:0032609,interferon-gamma production,1/15,101/16992,0.0855775463636721,0.11678531255897132,0.04987425354128139,1,bp,PCR,2625,GATA3
GO:0050715,positive regulation of cytokine secretion,1/15,101/16992,0.0855775463636721,0.11678531255897132,0.04987425354128139,1,bp,PCR,2625,GATA3
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,1/15,101/16992,0.0855775463636721,0.11678531255897132,0.04987425354128139,1,bp,PCR,596,BCL2
GO:0021761,limbic system development,1/15,102/16992,0.0863895963787421,0.11755857007220873,0.05020448035168127,1,bp,PCR,51176,LEF1
GO:0031929,TOR signaling,1/15,102/16992,0.0863895963787421,0.11755857007220873,0.05020448035168127,1,bp,PCR,2625,GATA3
GO:1905477,positive regulation of protein localization to membrane,1/15,102/16992,0.0863895963787421,0.11755857007220873,0.05020448035168127,1,bp,PCR,596,BCL2
GO:0002688,regulation of leukocyte chemotaxis,1/15,103/16992,0.08720097329137222,0.11821490435820932,0.050484774010794445,1,bp,PCR,7060,THBS4
GO:0005976,polysaccharide metabolic process,1/15,103/16992,0.08720097329137222,0.11821490435820932,0.050484774010794445,1,bp,PCR,3667,IRS1
GO:0010827,regulation of glucose transport,1/15,103/16992,0.08720097329137222,0.11821490435820932,0.050484774010794445,1,bp,PCR,3667,IRS1
GO:0030010,establishment of cell polarity,1/15,103/16992,0.08720097329137222,0.11821490435820932,0.050484774010794445,1,bp,PCR,2625,GATA3
GO:0002065,columnar/cuboidal epithelial cell differentiation,1/15,104/16992,0.08801167761967033,0.1188653954318292,0.050762572271733086,1,bp,PCR,51176,LEF1
GO:0034101,erythrocyte homeostasis,1/15,104/16992,0.08801167761967033,0.1188653954318292,0.050762572271733086,1,bp,PCR,2625,GATA3
GO:0050728,negative regulation of inflammatory response,1/15,104/16992,0.08801167761967033,0.1188653954318292,0.050762572271733086,1,bp,PCR,2625,GATA3
GO:0070252,actin-mediated cell contraction,1/15,104/16992,0.08801167761967033,0.1188653954318292,0.050762572271733086,1,bp,PCR,776,CACNA1D
GO:0007006,mitochondrial membrane organization,1/15,105/16992,0.08882170988137694,0.11962211536976444,0.05108573655684187,1,bp,PCR,596,BCL2
GO:0017156,calcium ion regulated exocytosis,1/15,105/16992,0.08882170988137694,0.11962211536976444,0.05108573655684187,1,bp,PCR,8912,CACNA1H
GO:0044774,mitotic DNA integrity checkpoint,1/15,105/16992,0.08882170988137694,0.11962211536976444,0.05108573655684187,1,bp,PCR,595,CCND1
GO:0030004,cellular monovalent inorganic cation homeostasis,1/15,106/16992,0.08963107059386455,0.12048629414722484,0.05145479213846983,1,bp,PCR,596,BCL2
GO:0050709,negative regulation of protein secretion,1/15,106/16992,0.08963107059386455,0.12048629414722484,0.05145479213846983,1,bp,PCR,3667,IRS1
hsa04020,Calcium signaling pathway,2/15,182/7430,0.0508355534894865,0.12063667809027333,0.07513336968780181,2,kg,PCR,776/8912,CACNA1D/CACNA1H
hsa04950,Maturity onset diabetes of the young,1/15,26/7430,0.05127058818836616,0.12063667809027333,0.07513336968780181,1,kg,PCR,3087,HHEX
GO:0008543,fibroblast growth factor receptor signaling pathway,1/15,107/16992,0.09043976027413769,0.12123314880031331,0.05177374336196217,1,bp,PCR,2625,GATA3
GO:0050871,positive regulation of B cell activation,1/15,107/16992,0.09043976027413769,0.12123314880031331,0.05177374336196217,1,bp,PCR,596,BCL2
GO:0072089,stem cell proliferation,1/15,107/16992,0.09043976027413769,0.12123314880031331,0.05177374336196217,1,bp,PCR,51176,LEF1
GO:0001948,glycoprotein binding,1/15,102/16982,0.08643836969983942,0.121646891076849,0.0582845358335538,1,mf,PCR,658,BMPR1B
GO:0005178,integrin binding,1/15,103/16982,0.08725018394477446,0.121646891076849,0.0582845358335538,1,mf,PCR,7060,THBS4
GO:0042089,cytokine biosynthetic process,1/15,108/16992,0.09124777943883389,0.12197493865451563,0.052090531616000156,1,bp,PCR,2625,GATA3
GO:0048524,positive regulation of viral process,1/15,108/16992,0.09124777943883389,0.12197493865451563,0.052090531616000156,1,bp,PCR,51176,LEF1
GO:0071621,granulocyte chemotaxis,1/15,108/16992,0.09124777943883389,0.12197493865451563,0.052090531616000156,1,bp,PCR,7060,THBS4
hsa05202,Transcriptional misregulation in cancer,2/15,186/7430,0.05285592266094138,0.12197520614063394,0.07596701435074571,2,kg,PCR,3480/3087,IGF1R/HHEX
GO:0042303,molting cycle,1/15,109/16992,0.09205512860422183,0.12248446278172848,0.05230812863183365,1,bp,PCR,596,BCL2
GO:0042633,hair cycle,1/15,109/16992,0.09205512860422183,0.12248446278172848,0.05230812863183365,1,bp,PCR,596,BCL2
GO:0045667,regulation of osteoblast differentiation,1/15,109/16992,0.09205512860422183,0.12248446278172848,0.05230812863183365,1,bp,PCR,658,BMPR1B
GO:0071156,regulation of cell cycle arrest,1/15,109/16992,0.09205512860422183,0.12248446278172848,0.05230812863183365,1,bp,PCR,595,CCND1
GO:1903305,regulation of regulated secretory pathway,1/15,109/16992,0.09205512860422183,0.12248446278172848,0.05230812863183365,1,bp,PCR,8912,CACNA1H
GO:0002761,regulation of myeloid leukocyte differentiation,1/15,110/16992,0.09286180828620594,0.12321552955427326,0.05262033749415179,1,bp,PCR,51176,LEF1
GO:0019079,viral genome replication,1/15,110/16992,0.09286180828620594,0.12321552955427326,0.05262033749415179,1,bp,PCR,596,BCL2
GO:0042107,cytokine metabolic process,1/15,110/16992,0.09286180828620594,0.12321552955427326,0.05262033749415179,1,bp,PCR,2625,GATA3
GO:0002700,regulation of production of molecular mediator of immune response,1/15,111/16992,0.09366781900032228,0.12348684027840652,0.05273620326140791,1,bp,PCR,2625,GATA3
GO:0006406,mRNA export from nucleus,1/15,111/16992,0.09366781900032228,0.12348684027840652,0.05273620326140791,1,bp,PCR,3087,HHEX
GO:0010634,positive regulation of epithelial cell migration,1/15,111/16992,0.09366781900032228,0.12348684027840652,0.05273620326140791,1,bp,PCR,2625,GATA3
GO:0032963,collagen metabolic process,1/15,111/16992,0.09366781900032228,0.12348684027840652,0.05273620326140791,1,bp,PCR,4602,MYB
GO:0034754,cellular hormone metabolic process,1/15,111/16992,0.09366781900032228,0.12348684027840652,0.05273620326140791,1,bp,PCR,8912,CACNA1H
GO:0046834,lipid phosphorylation,1/15,111/16992,0.09366781900032228,0.12348684027840652,0.05273620326140791,1,bp,PCR,3667,IRS1
GO:0071427,mRNA-containing ribonucleoprotein complex export from nucleus,1/15,111/16992,0.09366781900032228,0.12348684027840652,0.05273620326140791,1,bp,PCR,3087,HHEX
GO:0002792,negative regulation of peptide secretion,1/15,112/16992,0.0944731612617401,0.12397984724485893,0.052946746470170135,1,bp,PCR,3667,IRS1
GO:0003014,renal system process,1/15,112/16992,0.0944731612617401,0.12397984724485893,0.052946746470170135,1,bp,PCR,596,BCL2
GO:0018107,peptidyl-threonine phosphorylation,1/15,112/16992,0.0944731612617401,0.12397984724485893,0.052946746470170135,1,bp,PCR,596,BCL2
GO:0032273,positive regulation of protein polymerization,1/15,112/16992,0.0944731612617401,0.12397984724485893,0.052946746470170135,1,bp,PCR,4137,MAPT
GO:0045598,regulation of fat cell differentiation,1/15,112/16992,0.0944731612617401,0.12397984724485893,0.052946746470170135,1,bp,PCR,2625,GATA3
GO:0001935,endothelial cell proliferation,1/15,113/16992,0.09527783558526337,0.1248078849006595,0.05330036764977072,1,bp,PCR,7060,THBS4
GO:0048660,regulation of smooth muscle cell proliferation,1/15,113/16992,0.09527783558526337,0.1248078849006595,0.05330036764977072,1,bp,PCR,4602,MYB
GO:0010389,regulation of G2/M transition of mitotic cell cycle,1/15,114/16992,0.0960818424853298,0.12551782513765358,0.05360355422865768,1,bp,PCR,595,CCND1
GO:0034605,cellular response to heat,1/15,114/16992,0.0960818424853298,0.12551782513765358,0.05360355422865768,1,bp,PCR,4137,MAPT
GO:0035821,modification of morphology or physiology of other organism,1/15,114/16992,0.0960818424853298,0.12551782513765358,0.05360355422865768,1,bp,PCR,51176,LEF1
GO:0002687,positive regulation of leukocyte migration,1/15,115/16992,0.09688518247601119,0.1259945766678987,0.05380715540225247,1,bp,PCR,7060,THBS4
GO:0006275,regulation of DNA replication,1/15,115/16992,0.09688518247601119,0.1259945766678987,0.05380715540225247,1,bp,PCR,3480,IGF1R
GO:0051592,response to calcium ion,1/15,115/16992,0.09688518247601119,0.1259945766678987,0.05380715540225247,1,bp,PCR,595,CCND1
GO:0072329,monocarboxylic acid catabolic process,1/15,115/16992,0.09688518247601119,0.1259945766678987,0.05380715540225247,1,bp,PCR,3667,IRS1
GO:1903749,positive regulation of establishment of protein localization to mitochondrion,1/15,115/16992,0.09688518247601119,0.1259945766678987,0.05380715540225247,1,bp,PCR,596,BCL2
GO:0008637,apoptotic mitochondrial changes,1/15,116/16992,0.09768785607101382,0.12623871328601338,0.053911416214881734,1,bp,PCR,596,BCL2
GO:0018210,peptidyl-threonine modification,1/15,116/16992,0.09768785607101382,0.12623871328601338,0.053911416214881734,1,bp,PCR,596,BCL2
GO:0042471,ear morphogenesis,1/15,116/16992,0.09768785607101382,0.12623871328601338,0.053911416214881734,1,bp,PCR,2625,GATA3
GO:0042476,odontogenesis,1/15,116/16992,0.09768785607101382,0.12623871328601338,0.053911416214881734,1,bp,PCR,51176,LEF1
GO:0044259,multicellular organismal macromolecule metabolic process,1/15,116/16992,0.09768785607101382,0.12623871328601338,0.053911416214881734,1,bp,PCR,4602,MYB
GO:0048659,smooth muscle cell proliferation,1/15,116/16992,0.09768785607101382,0.12623871328601338,0.053911416214881734,1,bp,PCR,4602,MYB
GO:0050680,negative regulation of epithelial cell proliferation,1/15,116/16992,0.09768785607101382,0.12623871328601338,0.053911416214881734,1,bp,PCR,2625,GATA3
GO:0003231,cardiac ventricle development,1/15,117/16992,0.09848986378367863,0.1270466196204185,0.05425644012650916,1,bp,PCR,2625,GATA3
GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,1/15,117/16992,0.09848986378367863,0.1270466196204185,0.05425644012650916,1,bp,PCR,4137,MAPT
GO:0002706,regulation of lymphocyte mediated immunity,1/15,118/16992,0.09929120612698195,0.1277363144176124,0.05455098070209723,1,bp,PCR,2625,GATA3
GO:0010594,regulation of endothelial cell migration,1/15,118/16992,0.09929120612698195,0.1277363144176124,0.05455098070209723,1,bp,PCR,2625,GATA3
GO:0097530,granulocyte migration,1/15,118/16992,0.09929120612698195,0.1277363144176124,0.05455098070209723,1,bp,PCR,7060,THBS4
GO:0001046,core promoter sequence-specific DNA binding,1/15,111/16982,0.09372050098344709,0.12820257209999839,0.06142555178656911,1,mf,PCR,2625,GATA3
GO:0002020,protease binding,1/15,111/16982,0.09372050098344709,0.12820257209999839,0.06142555178656911,1,mf,PCR,596,BCL2
GO:0001704,formation of primary germ layer,1/15,119/16992,0.10009188361353516,0.12842146138629468,0.054843579085235905,1,bp,PCR,51176,LEF1
GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1/15,119/16992,0.10009188361353516,0.12842146138629468,0.054843579085235905,1,bp,PCR,2625,GATA3
GO:0003206,cardiac chamber morphogenesis,1/15,119/16992,0.10009188361353516,0.12842146138629468,0.054843579085235905,1,bp,PCR,2625,GATA3
GO:0016529,sarcoplasmic reticulum,1/15,60/18122,0.04854705513440283,0.12865866925960992,0.08442400716966884,1,cc,PCR,7060,THBS4
GO:0032838,cell projection cytoplasm,1/15,62/18122,0.05012675425699087,0.12865866925960992,0.08442400716966884,1,cc,PCR,4137,MAPT
GO:0044304,main axon,1/15,61/18122,0.04933721094068,0.12865866925960992,0.08442400716966884,1,cc,PCR,4137,MAPT
GO:0022612,gland morphogenesis,1/15,120/16992,0.10089189675558419,0.12910209762936284,0.05513425112106255,1,bp,PCR,596,BCL2
GO:0034332,adherens junction organization,1/15,120/16992,0.10089189675558419,0.12910209762936284,0.05513425112106255,1,bp,PCR,596,BCL2
GO:0045995,regulation of embryonic development,1/15,120/16992,0.10089189675558419,0.12910209762936284,0.05513425112106255,1,bp,PCR,2625,GATA3
GO:0030048,actin filament-based movement,1/15,121/16992,0.10169124606501223,0.1300091820243973,0.05552162994559106,1,bp,PCR,776,CACNA1D
GO:0001085,RNA polymerase II transcription factor binding,1/15,114/16982,0.09613581375015567,0.13027750461469695,0.06241971182990925,1,mf,PCR,2625,GATA3
GO:0010675,regulation of cellular carbohydrate metabolic process,1/15,122/16992,0.10248993205333701,0.13079754206096383,0.055858306428994565,1,bp,PCR,3667,IRS1
GO:1902749,regulation of cell cycle G2/M phase transition,1/15,122/16992,0.10248993205333701,0.13079754206096383,0.055858306428994565,1,bp,PCR,595,CCND1
GO:0051053,negative regulation of DNA metabolic process,1/15,123/16992,0.10328795523171286,0.13158226211699592,0.05619342842486805,1,bp,PCR,2625,GATA3
GO:0071901,negative regulation of protein serine/threonine kinase activity,1/15,123/16992,0.10328795523171286,0.13158226211699592,0.05619342842486805,1,bp,PCR,3087,HHEX
GO:0001837,epithelial to mesenchymal transition,1/15,125/16992,0.10488201520141749,0.132322612681683,0.05650960201693675,1,bp,PCR,51176,LEF1
GO:0009267,cellular response to starvation,1/15,125/16992,0.10488201520141749,0.132322612681683,0.05650960201693675,1,bp,PCR,596,BCL2
GO:0010970,transport along microtubule,1/15,125/16992,0.10488201520141749,0.132322612681683,0.05650960201693675,1,bp,PCR,4137,MAPT
GO:0030326,embryonic limb morphogenesis,1/15,125/16992,0.10488201520141749,0.132322612681683,0.05650960201693675,1,bp,PCR,51176,LEF1
GO:0030968,endoplasmic reticulum unfolded protein response,1/15,125/16992,0.10488201520141749,0.132322612681683,0.05650960201693675,1,bp,PCR,595,CCND1
GO:0035113,embryonic appendage morphogenesis,1/15,125/16992,0.10488201520141749,0.132322612681683,0.05650960201693675,1,bp,PCR,51176,LEF1
GO:0043271,negative regulation of ion transport,1/15,124/16992,0.10408531611093041,0.132322612681683,0.05650960201693675,1,bp,PCR,596,BCL2
GO:0051896,regulation of protein kinase B signaling,1/15,125/16992,0.10488201520141749,0.132322612681683,0.05650960201693675,1,bp,PCR,2625,GATA3
GO:0060048,cardiac muscle contraction,1/15,124/16992,0.10408531611093041,0.132322612681683,0.05650960201693675,1,bp,PCR,776,CACNA1D
GO:0099111,microtubule-based transport,1/15,125/16992,0.10488201520141749,0.132322612681683,0.05650960201693675,1,bp,PCR,4137,MAPT
GO:2000241,regulation of reproductive process,1/15,125/16992,0.10488201520141749,0.132322612681683,0.05650960201693675,1,bp,PCR,8912,CACNA1H
GO:0002262,myeloid cell homeostasis,1/15,126/16992,0.1056780530132383,0.13286033436572478,0.05673924106158119,1,bp,PCR,2625,GATA3
GO:0032355,response to estradiol,1/15,126/16992,0.1056780530132383,0.13286033436572478,0.05673924106158119,1,bp,PCR,595,CCND1
GO:0045834,positive regulation of lipid metabolic process,1/15,126/16992,0.1056780530132383,0.13286033436572478,0.05673924106158119,1,bp,PCR,3667,IRS1
GO:2001056,positive regulation of cysteine-type endopeptidase activity,1/15,126/16992,0.1056780530132383,0.13286033436572478,0.05673924106158119,1,bp,PCR,4137,MAPT
GO:0007498,mesoderm development,1/15,127/16992,0.106473430056094,0.13339347775990154,0.056966924904972065,1,bp,PCR,51176,LEF1
GO:0050671,positive regulation of lymphocyte proliferation,1/15,127/16992,0.106473430056094,0.13339347775990154,0.056966924904972065,1,bp,PCR,596,BCL2
GO:0050921,positive regulation of chemotaxis,1/15,127/16992,0.106473430056094,0.13339347775990154,0.056966924904972065,1,bp,PCR,7060,THBS4
GO:1905952,regulation of lipid localization,1/15,127/16992,0.106473430056094,0.13339347775990154,0.056966924904972065,1,bp,PCR,4602,MYB
GO:0032946,positive regulation of mononuclear cell proliferation,1/15,128/16992,0.10726814683932273,0.13392209123206497,0.057192674203050124,1,bp,PCR,596,BCL2
GO:0045931,positive regulation of mitotic cell cycle,1/15,128/16992,0.10726814683932273,0.13392209123206497,0.057192674203050124,1,bp,PCR,595,CCND1
GO:0060402,calcium ion transport into cytosol,1/15,128/16992,0.10726814683932273,0.13392209123206497,0.057192674203050124,1,bp,PCR,596,BCL2
GO:0071426,ribonucleoprotein complex export from nucleus,1/15,128/16992,0.10726814683932273,0.13392209123206497,0.057192674203050124,1,bp,PCR,3087,HHEX
GO:0016528,sarcoplasm,1/15,67/18122,0.054065298909743764,0.13429122632420226,0.08812001180535486,1,cc,PCR,7060,THBS4
GO:0002819,regulation of adaptive immune response,1/15,130/16992,0.10885560166244446,0.1354333329774309,0.05783806404119857,1,bp,PCR,2625,GATA3
GO:0031214,biomineral tissue development,1/15,130/16992,0.10885560166244446,0.1354333329774309,0.05783806404119857,1,bp,PCR,658,BMPR1B
GO:0034620,cellular response to unfolded protein,1/15,130/16992,0.10885560166244446,0.1354333329774309,0.05783806404119857,1,bp,PCR,595,CCND1
GO:0071166,ribonucleoprotein complex localization,1/15,130/16992,0.10885560166244446,0.1354333329774309,0.05783806404119857,1,bp,PCR,3087,HHEX
GO:0017124,SH3 domain binding,1/15,121/16982,0.10174819939475388,0.13660637881703067,0.06545205809019257,1,mf,PCR,4137,MAPT
GO:0002526,acute inflammatory response,1/15,132/16992,0.11044042155006784,0.13716757628992868,0.05857868877195064,1,bp,PCR,2625,GATA3
GO:0070507,regulation of microtubule cytoskeleton organization,1/15,132/16992,0.11044042155006784,0.13716757628992868,0.05857868877195064,1,bp,PCR,4137,MAPT
hsa05205,Proteoglycans in cancer,2/15,201/7430,0.06068860892684987,0.1374081711551318,0.08557877326328385,2,kg,PCR,3480/595,IGF1R/CCND1
GO:0010770,positive regulation of cell morphogenesis involved in differentiation,1/15,133/16992,0.11123184466256775,0.13779324205181884,0.058845885152701456,1,bp,PCR,4137,MAPT
GO:0060078,regulation of postsynaptic membrane potential,1/15,133/16992,0.11123184466256775,0.13779324205181884,0.058845885152701456,1,bp,PCR,8912,CACNA1H
GO:0070665,positive regulation of leukocyte proliferation,1/15,133/16992,0.11123184466256775,0.13779324205181884,0.058845885152701456,1,bp,PCR,596,BCL2
GO:0044344,cellular response to fibroblast growth factor stimulus,1/15,135/16992,0.11281271976078244,0.13951108287112252,0.0595795050462326,1,bp,PCR,2625,GATA3
GO:0051302,regulation of cell division,1/15,135/16992,0.11281271976078244,0.13951108287112252,0.0595795050462326,1,bp,PCR,7060,THBS4
GO:0005901,caveola,1/15,72/18122,0.05798859732159245,0.13953506230508184,0.0915609431393565,1,cc,PCR,3667,IRS1
GO:0001764,neuron migration,1/15,136/16992,0.11360217275974949,0.1400054221747513,0.059790617241973425,1,bp,PCR,2625,GATA3
GO:0007338,single fertilization,1/15,136/16992,0.11360217275974949,0.1400054221747513,0.059790617241973425,1,bp,PCR,8912,CACNA1H
GO:0043524,negative regulation of neuron apoptotic process,1/15,136/16992,0.11360217275974949,0.1400054221747513,0.059790617241973425,1,bp,PCR,596,BCL2
GO:0044236,multicellular organism metabolic process,1/15,136/16992,0.11360217275974949,0.1400054221747513,0.059790617241973425,1,bp,PCR,4602,MYB
GO:0007605,sensory perception of sound,1/15,137/16992,0.11439097006685672,0.1407361506730078,0.060102681641111634,1,bp,PCR,776,CACNA1D
GO:0061337,cardiac conduction,1/15,137/16992,0.11439097006685672,0.1407361506730078,0.060102681641111634,1,bp,PCR,776,CACNA1D
GO:0051100,negative regulation of binding,1/15,139/16992,0.11596659962803302,0.14243077236366108,0.06082638558987247,1,bp,PCR,51176,LEF1
GO:0060401,cytosolic calcium ion transport,1/15,139/16992,0.11596659962803302,0.14243077236366108,0.06082638558987247,1,bp,PCR,596,BCL2
GO:0016247,channel regulator activity,1/15,129/16982,0.1081225205771631,0.14252514076080589,0.06828790773294513,1,mf,PCR,596,BCL2
GO:0019838,growth factor binding,1/15,128/16982,0.1073280457157495,0.14252514076080589,0.06828790773294513,1,mf,PCR,3480,IGF1R
GO:0006661,phosphatidylinositol biosynthetic process,1/15,140/16992,0.11675343289247153,0.14290858864265893,0.06103044147432163,1,bp,PCR,3667,IRS1
GO:0010950,positive regulation of endopeptidase activity,1/15,140/16992,0.11675343289247153,0.14290858864265893,0.06103044147432163,1,bp,PCR,4137,MAPT
GO:0043279,response to alkaloid,1/15,140/16992,0.11675343289247153,0.14290858864265893,0.06103044147432163,1,bp,PCR,596,BCL2
GO:1990138,neuron projection extension,1/15,140/16992,0.11675343289247153,0.14290858864265893,0.06103044147432163,1,bp,PCR,4137,MAPT
GO:0070851,growth factor receptor binding,1/15,131/16982,0.10970949086820203,0.14331419978278642,0.06866596867995577,1,mf,PCR,2625,GATA3
GO:0006405,RNA export from nucleus,1/15,141/16992,0.11753961248579026,0.1433823625993893,0.06123277104746289,1,bp,PCR,3087,HHEX
GO:0048592,eye morphogenesis,1/15,141/16992,0.11753961248579026,0.1433823625993893,0.06123277104746289,1,bp,PCR,596,BCL2
GO:0071774,response to fibroblast growth factor,1/15,141/16992,0.11753961248579026,0.1433823625993893,0.06123277104746289,1,bp,PCR,2625,GATA3
GO:1905475,regulation of protein localization to membrane,1/15,141/16992,0.11753961248579026,0.1433823625993893,0.06123277104746289,1,bp,PCR,596,BCL2
hsa04215,Apoptosis - multiple species,1/15,33/7430,0.06464890768335019,0.14366423929633376,0.089475096403857,1,kg,PCR,596,BCL2
GO:0030705,cytoskeleton-dependent intracellular transport,1/15,142/16992,0.11832513891227603,0.14409595306520392,0.061537516490505734,1,bp,PCR,4137,MAPT
GO:0051262,protein tetramerization,1/15,142/16992,0.11832513891227603,0.14409595306520392,0.061537516490505734,1,bp,PCR,3480,IGF1R
GO:0016234,inclusion body,1/15,77/18122,0.06189670431079619,0.1444256433918578,0.09477007358590804,1,cc,PCR,4137,MAPT
GO:0035265,organ growth,1/15,143/16992,0.11911001267585541,0.14468392917599682,0.06178861715533542,1,bp,PCR,596,BCL2
GO:0055067,monovalent inorganic cation homeostasis,1/15,143/16992,0.11911001267585541,0.14468392917599682,0.06178861715533542,1,bp,PCR,596,BCL2
GO:1903828,negative regulation of cellular protein localization,1/15,143/16992,0.11911001267585541,0.14468392917599682,0.06178861715533542,1,bp,PCR,4137,MAPT
GO:0050864,regulation of B cell activation,1/15,144/16992,0.11989423428009693,0.14551352589569197,0.062142904147667606,1,bp,PCR,596,BCL2
GO:0017053,transcriptional repressor complex,1/15,85/18122,0.06811821363860504,0.1456972902825719,0.09560451036997199,1,cc,PCR,595,CCND1
GO:0044853,plasma membrane raft,1/15,85/18122,0.06811821363860504,0.1456972902825719,0.09560451036997199,1,cc,PCR,3667,IRS1
GO:1902554,serine/threonine protein kinase complex,1/15,82/18122,0.06578967451362527,0.1456972902825719,0.09560451036997199,1,cc,PCR,595,CCND1
GO:0001890,placenta development,1/15,145/16992,0.1206778042282095,0.14584861621188988,0.06228600758270651,1,bp,PCR,51176,LEF1
GO:0006109,regulation of carbohydrate metabolic process,1/15,145/16992,0.1206778042282095,0.14584861621188988,0.06228600758270651,1,bp,PCR,3667,IRS1
GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,1/15,145/16992,0.1206778042282095,0.14584861621188988,0.06228600758270651,1,bp,PCR,3667,IRS1
GO:0046425,regulation of JAK-STAT cascade,1/15,145/16992,0.1206778042282095,0.14584861621188988,0.06228600758270651,1,bp,PCR,5979,RET
GO:1904892,regulation of STAT cascade,1/15,145/16992,0.1206778042282095,0.14584861621188988,0.06228600758270651,1,bp,PCR,5979,RET
GO:0035257,nuclear hormone receptor binding,1/15,135/16982,0.11287552796589184,0.1461334960272707,0.07001677486606074,1,mf,PCR,51176,LEF1
GO:0035725,sodium ion transmembrane transport,1/15,146/16992,0.121460723023044,0.1465483282822118,0.06258482612791963,1,bp,PCR,8912,CACNA1H
GO:0035967,cellular response to topologically incorrect protein,1/15,146/16992,0.121460723023044,0.1465483282822118,0.06258482612791963,1,bp,PCR,595,CCND1
GO:0034614,cellular response to reactive oxygen species,1/15,147/16992,0.12224299116709325,0.14712158987195392,0.06282964281972615,1,bp,PCR,4602,MYB
GO:0043409,negative regulation of MAPK cascade,1/15,147/16992,0.12224299116709325,0.14712158987195392,0.06282964281972615,1,bp,PCR,3480,IGF1R
GO:0071248,cellular response to metal ion,1/15,147/16992,0.12224299116709325,0.14712158987195392,0.06282964281972615,1,bp,PCR,8912,CACNA1H
GO:0031330,negative regulation of cellular catabolic process,1/15,148/16992,0.12302460916249236,0.14793837938619375,0.06317846037589346,1,bp,PCR,596,BCL2
GO:0043491,protein kinase B signaling,1/15,149/16992,0.12380557751101762,0.14875302247770258,0.06352636128227714,1,bp,PCR,2625,GATA3
GO:0051028,mRNA transport,1/15,150/16992,0.12458589671408904,0.14956552512794147,0.06387334809331567,1,bp,PCR,3087,HHEX
GO:0000077,DNA damage checkpoint,1/15,151/16992,0.12536556727276948,0.14975088958517851,0.0639525097082072,1,bp,PCR,595,CCND1
GO:0007093,mitotic cell cycle checkpoint,1/15,151/16992,0.12536556727276948,0.14975088958517851,0.0639525097082072,1,bp,PCR,595,CCND1
GO:0019722,calcium-mediated signaling,1/15,151/16992,0.12536556727276948,0.14975088958517851,0.0639525097082072,1,bp,PCR,4137,MAPT
GO:0031348,negative regulation of defense response,1/15,151/16992,0.12536556727276948,0.14975088958517851,0.0639525097082072,1,bp,PCR,2625,GATA3
GO:0035567,non-canonical Wnt signaling pathway,1/15,151/16992,0.12536556727276948,0.14975088958517851,0.0639525097082072,1,bp,PCR,51176,LEF1
GO:0050707,regulation of cytokine secretion,1/15,151/16992,0.12536556727276948,0.14975088958517851,0.0639525097082072,1,bp,PCR,2625,GATA3
GO:0007188,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,1/15,152/16992,0.126144589687763,0.15055629184494634,0.06429646423147913,1,bp,PCR,776,CACNA1D
GO:0007519,skeletal muscle tissue development,1/15,153/16992,0.12692296445941886,0.1512340795424419,0.06458591976943459,1,bp,PCR,596,BCL2
GO:0050954,sensory perception of mechanical stimulus,1/15,153/16992,0.12692296445941886,0.1512340795424419,0.06458591976943459,1,bp,PCR,776,CACNA1D
GO:0015758,glucose transport,1/15,154/16992,0.1277006920877286,0.15190885308780297,0.06487408808569692,1,bp,PCR,3667,IRS1
GO:0030177,positive regulation of Wnt signaling pathway,1/15,154/16992,0.1277006920877286,0.15190885308780297,0.06487408808569692,1,bp,PCR,3087,HHEX
GO:0002703,regulation of leukocyte mediated immunity,1/15,155/16992,0.12847777307232755,0.15232884480605172,0.06505344945385355,1,bp,PCR,2625,GATA3
GO:0003205,cardiac chamber development,1/15,155/16992,0.12847777307232755,0.15232884480605172,0.06505344945385355,1,bp,PCR,2625,GATA3
GO:0032886,regulation of microtubule-based process,1/15,155/16992,0.12847777307232755,0.15232884480605172,0.06505344945385355,1,bp,PCR,4137,MAPT
GO:0051099,positive regulation of binding,1/15,155/16992,0.12847777307232755,0.15232884480605172,0.06505344945385355,1,bp,PCR,2625,GATA3
GO:0005057,"signal transducer activity, downstream of receptor",1/15,143/16982,0.11917610186192207,0.1529250864599885,0.07327082182474949,1,mf,PCR,658,BMPR1B
GO:0008645,hexose transport,1/15,156/16992,0.1292542079124961,0.1529969495636383,0.06533876980229361,1,bp,PCR,3667,IRS1
GO:0043542,endothelial cell migration,1/15,156/16992,0.1292542079124961,0.1529969495636383,0.06533876980229361,1,bp,PCR,2625,GATA3
GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,1/15,157/16992,0.13002999710715735,0.15378856447982314,0.0656768363123004,1,bp,PCR,5979,RET
GO:0002685,regulation of leukocyte migration,1/15,158/16992,0.1308051411548785,0.15419769305952455,0.06585155847614022,1,bp,PCR,7060,THBS4
GO:0010952,positive regulation of peptidase activity,1/15,158/16992,0.1308051411548785,0.15419769305952455,0.06585155847614022,1,bp,PCR,4137,MAPT
GO:0015749,monosaccharide transport,1/15,158/16992,0.1308051411548785,0.15419769305952455,0.06585155847614022,1,bp,PCR,3667,IRS1
GO:0030308,negative regulation of cell growth,1/15,158/16992,0.1308051411548785,0.15419769305952455,0.06585155847614022,1,bp,PCR,596,BCL2
GO:0005604,basement membrane,1/15,93/18122,0.07430119555785064,0.15462681237714865,0.10146393703490272,1,cc,PCR,7060,THBS4
GO:0010565,regulation of cellular ketone metabolic process,1/15,160/16992,0.13235349580199884,0.15589506021923963,0.06657643490298994,1,bp,PCR,3667,IRS1
GO:0009408,response to heat,1/15,161/16992,0.13312670739675692,0.15629336481138864,0.06674653458230932,1,bp,PCR,4137,MAPT
GO:0031570,DNA integrity checkpoint,1/15,161/16992,0.13312670739675692,0.15629336481138864,0.06674653458230932,1,bp,PCR,595,CCND1
GO:0042594,response to starvation,1/15,161/16992,0.13312670739675692,0.15629336481138864,0.06674653458230932,1,bp,PCR,596,BCL2
GO:0060538,skeletal muscle organ development,1/15,161/16992,0.13312670739675692,0.15629336481138864,0.06674653458230932,1,bp,PCR,596,BCL2
GO:0001076,"transcription factor activity, RNA polymerase II transcription factor binding",1/15,148/16982,0.1230927253338,0.15656530853860526,0.07501495726713575,1,mf,PCR,4602,MYB
GO:0007219,Notch signaling pathway,1/15,162/16992,0.13389927583529582,0.1569439309749756,0.06702436491111656,1,bp,PCR,3087,HHEX
GO:0021543,pallium development,1/15,162/16992,0.13389927583529582,0.1569439309749756,0.06702436491111656,1,bp,PCR,51176,LEF1
hsa04960,Aldosterone-regulated sodium reabsorption,1/15,37/7430,0.07221439417736708,0.15755867820516453,0.09812865046111126,1,kg,PCR,3667,IRS1
GO:0008201,heparin binding,1/15,152/16982,0.1262143144486505,0.15776789306081312,0.0755911502142553,1,mf,PCR,7060,THBS4
GO:0015081,sodium ion transmembrane transporter activity,1/15,152/16982,0.1262143144486505,0.15776789306081312,0.0755911502142553,1,mf,PCR,8912,CACNA1H
GO:0017157,regulation of exocytosis,1/15,164/16992,0.1354424852305347,0.15836521666092623,0.06763133817772407,1,bp,PCR,8912,CACNA1H
GO:0046328,regulation of JNK cascade,1/15,164/16992,0.1354424852305347,0.15836521666092623,0.06763133817772407,1,bp,PCR,3480,IGF1R
GO:0090090,negative regulation of canonical Wnt signaling pathway,1/15,164/16992,0.1354424852305347,0.15836521666092623,0.06763133817772407,1,bp,PCR,51176,LEF1
GO:0006694,steroid biosynthetic process,1/15,165/16992,0.13621312717975875,0.15874960564258989,0.06779549506620511,1,bp,PCR,8912,CACNA1H
GO:0006941,striated muscle contraction,1/15,165/16992,0.13621312717975875,0.15874960564258989,0.06779549506620511,1,bp,PCR,776,CACNA1D
GO:0051147,regulation of muscle cell differentiation,1/15,165/16992,0.13621312717975875,0.15874960564258989,0.06779549506620511,1,bp,PCR,596,BCL2
GO:2001020,regulation of response to DNA damage stimulus,1/15,165/16992,0.13621312717975875,0.15874960564258989,0.06779549506620511,1,bp,PCR,4137,MAPT
GO:0007163,establishment or maintenance of cell polarity,1/15,166/16992,0.13698312795781198,0.15900222526282376,0.06790337862376022,1,bp,PCR,2625,GATA3
GO:0007259,JAK-STAT cascade,1/15,166/16992,0.13698312795781198,0.15900222526282376,0.06790337862376022,1,bp,PCR,5979,RET
GO:0033002,muscle cell proliferation,1/15,166/16992,0.13698312795781198,0.15900222526282376,0.06790337862376022,1,bp,PCR,4602,MYB
GO:0097529,myeloid leukocyte migration,1/15,166/16992,0.13698312795781198,0.15900222526282376,0.06790337862376022,1,bp,PCR,7060,THBS4
GO:0097696,STAT cascade,1/15,166/16992,0.13698312795781198,0.15900222526282376,0.06790337862376022,1,bp,PCR,5979,RET
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,1/15,167/16992,0.13775248806007234,0.15963735914703545,0.06817461845417842,1,bp,PCR,7060,THBS4
GO:0071478,cellular response to radiation,1/15,167/16992,0.13775248806007234,0.15963735914703545,0.06817461845417842,1,bp,PCR,2625,GATA3
GO:1902905,positive regulation of supramolecular fiber organization,1/15,168/16992,0.13852120798156387,0.16039885243312432,0.06849982124199647,1,bp,PCR,4137,MAPT
GO:0016363,nuclear matrix,1/15,100/18122,0.07967987449110114,0.16145658778459968,0.10594553948955276,1,cc,PCR,4602,MYB
GO:0010822,positive regulation of mitochondrion organization,1/15,170/16992,0.1400567292605739,0.1620463123570408,0.06920338431978522,1,bp,PCR,596,BCL2
GO:0051427,hormone receptor binding,1/15,158/16982,0.13087725726386812,0.162198310284281,0.07771389095290415,1,mf,PCR,51176,LEF1
GO:1903531,negative regulation of secretion by cell,1/15,171/16992,0.14082353160637695,0.16280242551758944,0.06952628947496953,1,bp,PCR,3667,IRS1
GO:0001047,core promoter binding,1/15,163/16982,0.13474529088875697,0.16281722649058133,0.0780104315671751,1,mf,PCR,2625,GATA3
GO:0008083,growth factor activity,1/15,162/16982,0.1339729718981788,0.16281722649058133,0.0780104315671751,1,mf,PCR,7060,THBS4
GO:0030674,"protein binding, bridging",1/15,162/16982,0.1339729718981788,0.16281722649058133,0.0780104315671751,1,mf,PCR,3667,IRS1
GO:0006575,cellular modified amino acid metabolic process,1/15,172/16992,0.14158969574797986,0.16303236601750565,0.06962448770333356,1,bp,PCR,2625,GATA3
GO:0007584,response to nutrient,1/15,172/16992,0.14158969574797986,0.16303236601750565,0.06962448770333356,1,bp,PCR,595,CCND1
GO:0030324,lung development,1/15,172/16992,0.14158969574797986,0.16303236601750565,0.06962448770333356,1,bp,PCR,3087,HHEX
GO:0050920,regulation of chemotaxis,1/15,172/16992,0.14158969574797986,0.16303236601750565,0.06962448770333356,1,bp,PCR,7060,THBS4
GO:0071241,cellular response to inorganic substance,1/15,172/16992,0.14158969574797986,0.16303236601750565,0.06962448770333356,1,bp,PCR,8912,CACNA1H
GO:0021953,central nervous system neuron differentiation,1/15,173/16992,0.1423552221786446,0.16365156341656983,0.06988892170959984,1,bp,PCR,51176,LEF1
GO:0050852,T cell receptor signaling pathway,1/15,173/16992,0.1423552221786446,0.16365156341656983,0.06988892170959984,1,bp,PCR,2625,GATA3
GO:0009566,fertilization,1/15,174/16992,0.14312011139128022,0.16413695137212264,0.07009621114891955,1,bp,PCR,8912,CACNA1H
GO:0031669,cellular response to nutrient levels,1/15,174/16992,0.14312011139128022,0.16413695137212264,0.07009621114891955,1,bp,PCR,596,BCL2
GO:0050663,cytokine secretion,1/15,174/16992,0.14312011139128022,0.16413695137212264,0.07009621114891955,1,bp,PCR,2625,GATA3
GO:0005923,bicellular tight junction,1/15,114/18122,0.09034983913617167,0.16473183585605217,0.10809471115639786,1,cc,PCR,595,CCND1
GO:0030018,Z disc,1/15,118/18122,0.09337712642654183,0.16473183585605217,0.10809471115639786,1,cc,PCR,776,CACNA1D
GO:0042383,sarcolemma,1/15,118/18122,0.09337712642654183,0.16473183585605217,0.10809471115639786,1,cc,PCR,776,CACNA1D
GO:0044420,extracellular matrix component,1/15,119/18122,0.09413247763202981,0.16473183585605217,0.10809471115639786,1,cc,PCR,7060,THBS4
GO:0070160,occluding junction,1/15,117/18122,0.0926211873991043,0.16473183585605217,0.10809471115639786,1,cc,PCR,595,CCND1
GO:0090575,RNA polymerase II transcription factor complex,1/15,116/18122,0.09186466012496641,0.16473183585605217,0.10809471115639786,1,cc,PCR,51176,LEF1
GO:0010632,regulation of epithelial cell migration,1/15,176/16992,0.1446479801323438,0.16536129470976776,0.0706190783546091,1,bp,PCR,2625,GATA3
GO:0019083,viral transcription,1/15,176/16992,0.1446479801323438,0.16536129470976776,0.0706190783546091,1,bp,PCR,51176,LEF1
GO:0030323,respiratory tube development,1/15,176/16992,0.1446479801323438,0.16536129470976776,0.0706190783546091,1,bp,PCR,3087,HHEX
GO:0032271,regulation of protein polymerization,1/15,176/16992,0.1446479801323438,0.16536129470976776,0.0706190783546091,1,bp,PCR,4137,MAPT
GO:0006611,protein export from nucleus,1/15,179/16992,0.1469350164112454,0.16731031583435788,0.07145142594691473,1,bp,PCR,3087,HHEX
GO:0007187,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",1/15,179/16992,0.1469350164112454,0.16731031583435788,0.07145142594691473,1,bp,PCR,776,CACNA1D
GO:0010810,regulation of cell-substrate adhesion,1/15,179/16992,0.1469350164112454,0.16731031583435788,0.07145142594691473,1,bp,PCR,596,BCL2
GO:0048839,inner ear development,1/15,179/16992,0.1469350164112454,0.16731031583435788,0.07145142594691473,1,bp,PCR,2625,GATA3
GO:1905330,regulation of morphogenesis of an epithelium,1/15,179/16992,0.1469350164112454,0.16731031583435788,0.07145142594691473,1,bp,PCR,2625,GATA3
GO:0004866,endopeptidase inhibitor activity,1/15,171/16982,0.14090074111505868,0.16884799555110339,0.08089994705170835,1,mf,PCR,51176,LEF1
GO:1901654,response to ketone,1/15,181/16992,0.1484565351055045,0.16890897937182103,0.07213415007418354,1,bp,PCR,595,CCND1
GO:0051216,cartilage development,1/15,182/16992,0.1492163442764891,0.16963915089028073,0.07244597660992101,1,bp,PCR,658,BMPR1B
GO:0032845,negative regulation of homeostatic process,1/15,183/16992,0.14997552064982944,0.16996437158817423,0.07258486513270013,1,bp,PCR,596,BCL2
GO:0043401,steroid hormone mediated signaling pathway,1/15,183/16992,0.14997552064982944,0.16996437158817423,0.07258486513270013,1,bp,PCR,51176,LEF1
GO:0060348,bone development,1/15,183/16992,0.14997552064982944,0.16996437158817423,0.07258486513270013,1,bp,PCR,658,BMPR1B
GO:1901215,negative regulation of neuron death,1/15,183/16992,0.14997552064982944,0.16996437158817423,0.07258486513270013,1,bp,PCR,596,BCL2
GO:0007565,female pregnancy,1/15,184/16992,0.15073406471492856,0.1706894018875905,0.07289449606304454,1,bp,PCR,596,BCL2
hsa05219,Bladder cancer,1/15,41/7430,0.07972273672316388,0.17083443583535116,0.10639688547640293,1,kg,PCR,595,CCND1
GO:0045637,regulation of myeloid cell differentiation,1/15,185/16992,0.1514919769608395,0.17141257550608374,0.07320333408053828,1,bp,PCR,51176,LEF1
GO:0048588,developmental cell growth,1/15,186/16992,0.15224925787626697,0.1719985719875752,0.07345358932626916,1,bp,PCR,4137,MAPT
GO:0071456,cellular response to hypoxia,1/15,186/16992,0.15224925787626697,0.1719985719875752,0.07345358932626916,1,bp,PCR,596,BCL2
GO:0008643,carbohydrate transport,1/15,187/16992,0.1530059079495657,0.1725820170514332,0.07370275496537786,1,bp,PCR,3667,IRS1
GO:0019080,viral gene expression,1/15,187/16992,0.1530059079495657,0.1725820170514332,0.07370275496537786,1,bp,PCR,51176,LEF1
GO:0030414,peptidase inhibitor activity,1/15,180/16982,0.14777675870741847,0.17280346784335224,0.08279512796850273,1,mf,PCR,51176,LEF1
GO:0060090,"binding, bridging",1/15,180/16982,0.14777675870741847,0.17280346784335224,0.08279512796850273,1,mf,PCR,3667,IRS1
GO:0061135,endopeptidase regulator activity,1/15,177/16982,0.14549048080522053,0.17280346784335224,0.08279512796850273,1,mf,PCR,51176,LEF1
GO:0019887,protein kinase regulator activity,1/15,182/16982,0.14929777079421236,0.17318541412128632,0.0829781294519412,1,mf,PCR,595,CCND1
GO:0031674,I band,1/15,132/18122,0.10389874425287093,0.17391746320589266,0.11412219048370263,1,cc,PCR,776,CACNA1D
GO:0043296,apical junction complex,1/15,131/18122,0.10315099620902324,0.17391746320589266,0.11412219048370263,1,cc,PCR,595,CCND1
GO:0044242,cellular lipid catabolic process,1/15,190/16992,0.15527207799501086,0.17500076555202398,0.074735704000901,1,bp,PCR,3667,IRS1
GO:0031256,leading edge membrane,1/15,136/18122,0.1068839215811519,0.17510770131380204,0.1149032079707792,1,cc,PCR,4137,MAPT
GO:0030595,leukocyte chemotaxis,1/15,191/16992,0.15602620957637436,0.1751637993447265,0.07480532909788344,1,bp,PCR,7060,THBS4
GO:0032412,regulation of ion transmembrane transporter activity,1/15,191/16992,0.15602620957637436,0.1751637993447265,0.07480532909788344,1,bp,PCR,776,CACNA1D
GO:0051495,positive regulation of cytoskeleton organization,1/15,191/16992,0.15602620957637436,0.1751637993447265,0.07480532909788344,1,bp,PCR,4137,MAPT
GO:0071804,cellular potassium ion transport,1/15,191/16992,0.15602620957637436,0.1751637993447265,0.07480532909788344,1,bp,PCR,776,CACNA1D
GO:0071805,potassium ion transmembrane transport,1/15,191/16992,0.15602620957637436,0.1751637993447265,0.07480532909788344,1,bp,PCR,776,CACNA1D
GO:0016051,carbohydrate biosynthetic process,1/15,192/16992,0.15677971275215896,0.17587232414118065,0.07510791119972775,1,bp,PCR,3667,IRS1
GO:0042393,histone binding,1/15,187/16982,0.1530892234937521,0.1761741064015401,0.08441009816698113,1,mf,PCR,51176,LEF1
GO:0036294,cellular response to decreased oxygen levels,1/15,193/16992,0.15753258800863035,0.17630399452367743,0.07529226005003402,1,bp,PCR,596,BCL2
GO:0050657,nucleic acid transport,1/15,193/16992,0.15753258800863035,0.17630399452367743,0.07529226005003402,1,bp,PCR,3087,HHEX
GO:0050658,RNA transport,1/15,193/16992,0.15753258800863035,0.17630399452367743,0.07529226005003402,1,bp,PCR,3087,HHEX
GO:0006006,glucose metabolic process,1/15,194/16992,0.15828483583170694,0.17659573687124444,0.07541685133204082,1,bp,PCR,3667,IRS1
GO:0007254,JNK cascade,1/15,194/16992,0.15828483583170694,0.17659573687124444,0.07541685133204082,1,bp,PCR,3480,IGF1R
GO:0034329,cell junction assembly,1/15,194/16992,0.15828483583170694,0.17659573687124444,0.07541685133204082,1,bp,PCR,596,BCL2
GO:0050670,regulation of lymphocyte proliferation,1/15,194/16992,0.15828483583170694,0.17659573687124444,0.07541685133204082,1,bp,PCR,596,BCL2
GO:0032944,regulation of mononuclear cell proliferation,1/15,195/16992,0.15903645670696154,0.17688497545503384,0.0755403733584476,1,bp,PCR,596,BCL2
GO:0051048,negative regulation of secretion,1/15,195/16992,0.15903645670696154,0.17688497545503384,0.0755403733584476,1,bp,PCR,3667,IRS1
GO:0051224,negative regulation of protein transport,1/15,195/16992,0.15903645670696154,0.17688497545503384,0.0755403733584476,1,bp,PCR,3667,IRS1
GO:2000021,regulation of ion homeostasis,1/15,195/16992,0.15903645670696154,0.17688497545503384,0.0755403733584476,1,bp,PCR,596,BCL2
GO:0005875,microtubule associated complex,1/15,144/18122,0.11282645225069532,0.17729871067966407,0.11634091746580828,1,cc,PCR,4137,MAPT
GO:0044798,nuclear transcription factor complex,1/15,141/18122,0.11060234132208224,0.17729871067966407,0.11634091746580828,1,cc,PCR,51176,LEF1
GO:0051236,establishment of RNA localization,1/15,196/16992,0.15978745111961812,0.17758280530463358,0.07583838808380133,1,bp,PCR,3087,HHEX
GO:0007160,cell-matrix adhesion,1/15,197/16992,0.1605378195545556,0.17814119436285436,0.0760768533227441,1,bp,PCR,596,BCL2
GO:0051168,nuclear export,1/15,197/16992,0.1605378195545556,0.17814119436285436,0.0760768533227441,1,bp,PCR,3087,HHEX
GO:0030426,growth cone,1/15,148/18122,0.11578385915005052,0.1783071430910778,0.1170026366147879,1,cc,PCR,4137,MAPT
hsa04973,Carbohydrate digestion and absorption,1/15,44/7430,0.08531673424597364,0.17961417735994448,0.11186497011014089,1,kg,PCR,776,CACNA1D
GO:0030427,site of polarized growth,1/15,153/18122,0.11946767865323948,0.18037276973136157,0.11835807173076357,1,cc,PCR,4137,MAPT
GO:0032872,regulation of stress-activated MAPK cascade,1/15,202/16992,0.16428028900994607,0.18187270824906973,0.07767043102165158,1,bp,PCR,3480,IGF1R
GO:0070663,regulation of leukocyte proliferation,1/15,202/16992,0.16428028900994607,0.18187270824906973,0.07767043102165158,1,bp,PCR,596,BCL2
GO:0071453,cellular response to oxygen levels,1/15,202/16992,0.16428028900994607,0.18187270824906973,0.07767043102165158,1,bp,PCR,596,BCL2
GO:0031668,cellular response to extracellular stimulus,1/15,203/16992,0.1650269117416232,0.18227799552091664,0.07784351271925752,1,bp,PCR,596,BCL2
GO:0070302,regulation of stress-activated protein kinase signaling cascade,1/15,203/16992,0.1650269117416232,0.18227799552091664,0.07784351271925752,1,bp,PCR,3480,IGF1R
GO:2001234,negative regulation of apoptotic signaling pathway,1/15,203/16992,0.1650269117416232,0.18227799552091664,0.07784351271925752,1,bp,PCR,596,BCL2
GO:0002440,production of molecular mediator of immune response,1/15,204/16992,0.16577291188003984,0.18296134744363843,0.07813534451132932,1,bp,PCR,2625,GATA3
GO:0060560,developmental growth involved in morphogenesis,1/15,205/16992,0.16651828990730866,0.1836429643874156,0.07842643536451181,1,bp,PCR,4137,MAPT
GO:0009895,negative regulation of catabolic process,1/15,207/16992,0.16800718155513572,0.18514288335485432,0.07906698970507277,1,bp,PCR,596,BCL2
GO:0005741,mitochondrial outer membrane,1/15,161/18122,0.1253320084639611,0.1855877817639424,0.12178008919575167,1,cc,PCR,596,BCL2
GO:0005539,glycosaminoglycan binding,1/15,201/16982,0.16362155669775302,0.1861994488936547,0.08921352905249519,1,mf,PCR,7060,THBS4
GO:0019207,kinase regulator activity,1/15,202/16982,0.16436916867853657,0.1861994488936547,0.08921352905249519,1,mf,PCR,595,CCND1
GO:0048705,skeletal system morphogenesis,1/15,209/16992,0.16949359053511726,0.18663776980763488,0.07970539486345905,1,bp,PCR,658,BMPR1B
GO:0051054,positive regulation of DNA metabolic process,1/15,210/16992,0.17023586522629142,0.18731159137073564,0.07999315662684606,1,bp,PCR,3480,IGF1R
GO:0043209,myelin sheath,1/15,167/18122,0.12970631164432955,0.18844124521912028,0.12365249173640155,1,cc,PCR,596,BCL2
GO:0044706,multi-multicellular organism process,1/15,212/16992,0.1717185574112483,0.1887984445294291,0.0806281310923028,1,bp,PCR,596,BCL2
hsa04913,Ovarian steroidogenesis,1/15,49/7430,0.09456959140469778,0.18913918280939557,0.11779721034620252,1,kg,PCR,3480,IGF1R
hsa05144,Malaria,1/15,49/7430,0.09456959140469778,0.18913918280939557,0.11779721034620252,1,kg,PCR,7060,THBS4
hsa05166,HTLV-I infection,2/15,255/7430,0.09187865735742654,0.18913918280939557,0.11779721034620252,2,kg,PCR,4602/595,MYB/CCND1
GO:0033500,carbohydrate homeostasis,1/15,213/16992,0.17245897586409886,0.18917828115779395,0.08079034385598204,1,bp,PCR,3667,IRS1
GO:0042593,glucose homeostasis,1/15,213/16992,0.17245897586409886,0.18917828115779395,0.08079034385598204,1,bp,PCR,3667,IRS1
GO:0044033,multi-organism metabolic process,1/15,213/16992,0.17245897586409886,0.18917828115779395,0.08079034385598204,1,bp,PCR,51176,LEF1
GO:0030336,negative regulation of cell migration,1/15,214/16992,0.17319877652933768,0.1898448831980612,0.08107502245501937,1,bp,PCR,596,BCL2
GO:0015850,organic hydroxy compound transport,1/15,215/16992,0.1739379598856411,0.1905097929540139,0.08135897834830613,1,bp,PCR,4602,MYB
GO:0046488,phosphatidylinositol metabolic process,1/15,216/16992,0.1746765264113438,0.191027525458981,0.08158008082817707,1,bp,PCR,3667,IRS1
GO:0050714,positive regulation of protein secretion,1/15,216/16992,0.1746765264113438,0.191027525458981,0.08158008082817707,1,bp,PCR,2625,GATA3
GO:0019867,outer membrane,1/15,186/18122,0.14342394686330506,0.1913586838296422,0.125566873873176,1,cc,PCR,596,BCL2
GO:0030017,sarcomere,1/15,187/18122,0.14414030730024996,0.1913586838296422,0.125566873873176,1,cc,PCR,776,CACNA1D
GO:0031968,organelle outer membrane,1/15,183/18122,0.14127150636382657,0.1913586838296422,0.125566873873176,1,cc,PCR,596,BCL2
GO:0033267,axon part,1/15,175/18122,0.1355069594139683,0.1913586838296422,0.125566873873176,1,cc,PCR,4137,MAPT
GO:0036464,cytoplasmic ribonucleoprotein granule,1/15,181/18122,0.13983374264469917,0.1913586838296422,0.125566873873176,1,cc,PCR,4137,MAPT
GO:0035770,ribonucleoprotein granule,1/15,192/18122,0.14771372975999253,0.1927789354494818,0.12649882298804,1,cc,PCR,4137,MAPT
hsa05014,Amyotrophic lateral sclerosis (ALS),1/15,51/7430,0.09824621353963048,0.19327123975009275,0.12037068440575953,1,kg,PCR,596,BCL2
GO:0009636,response to toxic substance,1/15,220/16992,0.17762463376286453,0.19410387735151052,0.0828938655063038,1,bp,PCR,596,BCL2
GO:0000075,cell cycle checkpoint,1/15,221/16992,0.17836012329861217,0.19446395840675698,0.08304764146880514,1,bp,PCR,595,CCND1
GO:0009266,response to temperature stimulus,1/15,221/16992,0.17836012329861217,0.19446395840675698,0.08304764146880514,1,bp,PCR,4137,MAPT
GO:0045926,negative regulation of growth,1/15,221/16992,0.17836012329861217,0.19446395840675698,0.08304764146880514,1,bp,PCR,596,BCL2
GO:0007611,learning or memory,1/15,222/16992,0.17909499886658808,0.19467436714923378,0.08313749847855789,1,bp,PCR,4137,MAPT
GO:0043270,positive regulation of ion transport,1/15,222/16992,0.17909499886658808,0.19467436714923378,0.08313749847855789,1,bp,PCR,776,CACNA1D
GO:0045216,cell-cell junction organization,1/15,222/16992,0.17909499886658808,0.19467436714923378,0.08313749847855789,1,bp,PCR,596,BCL2
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,1/15,222/16992,0.17909499886658808,0.19467436714923378,0.08313749847855789,1,bp,PCR,7060,THBS4
GO:0006814,sodium ion transport,1/15,223/16992,0.17982926094273588,0.19517722656700262,0.08335224926825809,1,bp,PCR,8912,CACNA1H
GO:0009755,hormone-mediated signaling pathway,1/15,223/16992,0.17982926094273588,0.19517722656700262,0.08335224926825809,1,bp,PCR,51176,LEF1
GO:0008017,microtubule binding,1/15,217/16982,0.17550876808768268,0.1957597797901076,0.09379415946386283,1,mf,PCR,4137,MAPT
GO:0061134,peptidase regulator activity,1/15,217/16982,0.17550876808768268,0.1957597797901076,0.09379415946386283,1,mf,PCR,51176,LEF1
GO:0006403,RNA localization,1/15,225/16992,0.18129594652162195,0.1966205850200534,0.08396864891527754,1,bp,PCR,3087,HHEX
GO:0003714,transcription corepressor activity,1/15,222/16982,0.17919106094412207,0.19683866543104317,0.09431108470743269,1,mf,PCR,595,CCND1
GO:1901681,sulfur compound binding,1/15,221/16982,0.17845583258595665,0.19683866543104317,0.09431108470743269,1,mf,PCR,7060,THBS4
GO:0006813,potassium ion transport,1/15,226/16992,0.18202837097454605,0.19711738439368703,0.08418081170678646,1,bp,PCR,776,CACNA1D
GO:0031334,positive regulation of protein complex assembly,1/15,226/16992,0.18202837097454605,0.19711738439368703,0.08418081170678646,1,bp,PCR,4137,MAPT
GO:0003007,heart morphogenesis,1/15,230/16992,0.18495195761242345,0.19938181777123218,0.0851478590342661,1,bp,PCR,2625,GATA3
GO:0010631,epithelial cell migration,1/15,230/16992,0.18495195761242345,0.19938181777123218,0.0851478590342661,1,bp,PCR,2625,GATA3
GO:0016054,organic acid catabolic process,1/15,230/16992,0.18495195761242345,0.19938181777123218,0.0851478590342661,1,bp,PCR,3667,IRS1
GO:0019932,second-messenger-mediated signaling,1/15,230/16992,0.18495195761242345,0.19938181777123218,0.0851478590342661,1,bp,PCR,4137,MAPT
GO:0046395,carboxylic acid catabolic process,1/15,230/16992,0.18495195761242345,0.19938181777123218,0.0851478590342661,1,bp,PCR,3667,IRS1
GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,1/15,230/16992,0.18495195761242345,0.19938181777123218,0.0851478590342661,1,bp,PCR,5979,RET
GO:0015931,nucleobase-containing compound transport,1/15,231/16992,0.1856813288471102,0.2000180431434013,0.08541956499476466,1,bp,PCR,3087,HHEX
GO:0044449,contractile fiber part,1/15,204/18122,0.15623320881732283,0.20049928464889766,0.13156480742511398,1,cc,PCR,776,CACNA1D
GO:0046474,glycerophospholipid biosynthetic process,1/15,232/16992,0.18641009085816507,0.20065265959789005,0.08569058385200887,1,bp,PCR,3667,IRS1
GO:0000086,G2/M transition of mitotic cell cycle,1/15,233/16992,0.1871382441181365,0.20068481850579267,0.08570431761262655,1,bp,PCR,595,CCND1
GO:0010951,negative regulation of endopeptidase activity,1/15,233/16992,0.1871382441181365,0.20068481850579267,0.08570431761262655,1,bp,PCR,51176,LEF1
GO:0019318,hexose metabolic process,1/15,233/16992,0.1871382441181365,0.20068481850579267,0.08570431761262655,1,bp,PCR,3667,IRS1
GO:0046777,protein autophosphorylation,1/15,233/16992,0.1871382441181365,0.20068481850579267,0.08570431761262655,1,bp,PCR,3480,IGF1R
GO:0090132,epithelium migration,1/15,233/16992,0.1871382441181365,0.20068481850579267,0.08570431761262655,1,bp,PCR,2625,GATA3
hsa04923,Regulation of lipolysis in adipocytes,1/15,54/7430,0.10373502852436589,0.20077747456328882,0.12504562012275006,1,kg,PCR,3667,IRS1
GO:0051607,defense response to virus,1/15,234/16992,0.1878657890992349,0.20131479413542175,0.08597335456246631,1,bp,PCR,596,BCL2
GO:0030016,myofibril,1/15,209/18122,0.15975947768645193,0.20166360298125902,0.13232881672044336,1,cc,PCR,776,CACNA1D
GO:0002793,positive regulation of peptide secretion,1/15,235/16992,0.188592726273332,0.20194318007062453,0.08624171261852112,1,bp,PCR,2625,GATA3
GO:0021537,telencephalon development,1/15,236/16992,0.18931905611196076,0.20241925865542235,0.08644502640450591,1,bp,PCR,51176,LEF1
GO:0061448,connective tissue development,1/15,236/16992,0.18931905611196076,0.20241925865542235,0.08644502640450591,1,bp,PCR,658,BMPR1B
GO:0031647,regulation of protein stability,1/15,238/16992,0.19076989566726044,0.20381884020360838,0.0870427307172865,1,bp,PCR,596,BCL2
GO:0060828,regulation of canonical Wnt signaling pathway,1/15,239/16992,0.191494406325312,0.2042891328058451,0.08724357354562334,1,bp,PCR,51176,LEF1
GO:0090130,tissue migration,1/15,239/16992,0.191494406325312,0.2042891328058451,0.08724357354562334,1,bp,PCR,2625,GATA3
GO:0051258,protein polymerization,1/15,241/16992,0.1929416117531385,0.2056803383451484,0.08783770080593453,1,bp,PCR,4137,MAPT
GO:0044839,cell cycle G2/M phase transition,1/15,242/16992,0.1936643074622726,0.2062977092833845,0.08810135480512264,1,bp,PCR,595,CCND1
GO:0043292,contractile fiber,1/15,219/18122,0.16677079024423946,0.20711856207752322,0.13590828407000838,1,cc,PCR,776,CACNA1D
GO:0010466,negative regulation of peptidase activity,1/15,244/16992,0.19510788721685446,0.207681506615274,0.08869231832157985,1,bp,PCR,51176,LEF1
GO:0007050,cell cycle arrest,1/15,246/16992,0.1965490545437648,0.2089060587125666,0.08921527468001783,1,bp,PCR,595,CCND1
GO:0071383,cellular response to steroid hormone stimulus,1/15,246/16992,0.1965490545437648,0.2089060587125666,0.08921527468001783,1,bp,PCR,51176,LEF1
GO:0044262,cellular carbohydrate metabolic process,1/15,248/16992,0.19798781318699654,0.21012443689048302,0.0897355944087841,1,bp,PCR,3667,IRS1
GO:0050808,synapse organization,1/15,248/16992,0.19798781318699654,0.21012443689048302,0.0897355944087841,1,bp,PCR,4137,MAPT
GO:0042277,peptide binding,1/15,242/16982,0.19376728764296858,0.21125005043782288,0.1012159951281039,1,mf,PCR,3480,IGF1R
GO:0034330,cell junction organization,1/15,250/16992,0.19942416688517817,0.21133667242920431,0.09025329086637082,1,bp,PCR,596,BCL2
GO:0090068,positive regulation of cell cycle process,1/15,250/16992,0.19942416688517817,0.21133667242920431,0.09025329086637082,1,bp,PCR,595,CCND1
GO:0051403,stress-activated MAPK cascade,1/15,251/16992,0.2001414430467311,0.21194049643194737,0.09051115952080381,1,bp,PCR,3480,IGF1R
GO:0006470,protein dephosphorylation,1/15,252/16992,0.20085811937158005,0.21238639995361336,0.0907015867655251,1,bp,PCR,596,BCL2
GO:1904062,regulation of cation transmembrane transport,1/15,252/16992,0.20085811937158005,0.21238639995361336,0.0907015867655251,1,bp,PCR,776,CACNA1D
GO:0007018,microtubule-based movement,1/15,254/16992,0.2022896743741246,0.21358579138546438,0.09121379802785463,1,bp,PCR,4137,MAPT
GO:0032102,negative regulation of response to external stimulus,1/15,254/16992,0.2022896743741246,0.21358579138546438,0.09121379802785463,1,bp,PCR,2625,GATA3
hsa05416,Viral myocarditis,1/15,59/7430,0.11281381306345384,0.21488345345419776,0.13383092276533373,1,kg,PCR,595,CCND1
hsa04730,Long-term depression,1/15,60/7430,0.1146192387592957,0.21491107267367943,0.13384812420904596,1,kg,PCR,3480,IGF1R
GO:0050890,cognition,1/15,256/16992,0.20371883561538906,0.21493683317130258,0.09179077298382551,1,bp,PCR,4137,MAPT
hsa04060,Cytokine-cytokine receptor interaction,2/15,294/7430,0.1168389972808707,0.21493711422366543,0.13386434306912498,2,kg,PCR,658/53832,BMPR1B/IL20RA
hsa04924,Renin secretion,1/15,65/7430,0.12359504448754033,0.21493711422366543,0.13386434306912498,1,kg,PCR,776,CACNA1D
hsa05217,Basal cell carcinoma,1/15,63/7430,0.12001496259457745,0.21493711422366543,0.13386434306912498,1,kg,PCR,51176,LEF1
hsa05223,Non-small cell lung cancer,1/15,66/7430,0.12537998329713818,0.21493711422366543,0.13386434306912498,1,kg,PCR,595,CCND1
hsa05230,Central carbon metabolism in cancer,1/15,65/7430,0.12359504448754033,0.21493711422366543,0.13386434306912498,1,kg,PCR,5979,RET
hsa05321,Inflammatory bowel disease (IBD),1/15,65/7430,0.12359504448754033,0.21493711422366543,0.13386434306912498,1,kg,PCR,2625,GATA3
GO:0031098,stress-activated protein kinase signaling cascade,1/15,257/16992,0.20443251973738785,0.21553157069891882,0.092044761174574,1,bp,PCR,3480,IGF1R
hsa04917,Prolactin signaling pathway,1/15,70/7430,0.13248586420251307,0.21681498241086128,0.1350338925541329,1,kg,PCR,595,CCND1
hsa04920,Adipocytokine signaling pathway,1/15,69/7430,0.1307144631629047,0.21681498241086128,0.1350338925541329,1,kg,PCR,3667,IRS1
hsa05031,Amphetamine addiction,1/15,68/7430,0.1289396866483331,0.21681498241086128,0.1350338925541329,1,kg,PCR,776,CACNA1D
hsa05165,Human papillomavirus infection,2/15,319/7430,0.13370257248669778,0.21681498241086128,0.1350338925541329,2,kg,PCR,7060/595,THBS4/CCND1
GO:0045017,glycerolipid biosynthetic process,1/15,259/16992,0.20585809730489557,0.2168754294920344,0.09261866856671873,1,bp,PCR,3667,IRS1
GO:0015980,energy derivation by oxidation of organic compounds,1/15,260/16992,0.20656999167771717,0.2174659912387396,0.09287087345140475,1,bp,PCR,3667,IRS1
GO:0032103,positive regulation of response to external stimulus,1/15,261/16992,0.20728129039423826,0.21805506171048342,0.09312244147325338,1,bp,PCR,7060,THBS4
GO:0007204,positive regulation of cytosolic calcium ion concentration,1/15,264/16992,0.20941161723259405,0.2201349626651336,0.09401068251384309,1,bp,PCR,596,BCL2
hsa01524,Platinum drug resistance,1/15,73/7430,0.13777987404412362,0.2204477984705978,0.13729643588958285,1,kg,PCR,596,BCL2
GO:0006310,DNA recombination,1/15,267/16992,0.21153659980605344,0.22220620900679738,0.09489522752149059,1,bp,PCR,51176,LEF1
hsa05212,Pancreatic cancer,1/15,75/7430,0.14129244561019938,0.22292527584108954,0.1388394261817312,1,kg,PCR,595,CCND1
hsa05220,Chronic myeloid leukemia,1/15,76/7430,0.14304371866469912,0.22292527584108954,0.1388394261817312,1,kg,PCR,595,CCND1
GO:0030258,lipid modification,1/15,269/16992,0.2129502919689814,0.22352780829760868,0.09545962878621828,1,bp,PCR,3667,IRS1
GO:0071356,cellular response to tumor necrosis factor,1/15,270/16992,0.213656250566151,0.22410513289310877,0.09570618062240957,1,bp,PCR,2625,GATA3
GO:0008654,phospholipid biosynthetic process,1/15,272/16992,0.21506639509112835,0.22541970076291132,0.09626757905342073,1,bp,PCR,3667,IRS1
hsa04260,Cardiac muscle contraction,1/15,78/7430,0.14653626883664095,0.22544041359483225,0.14040587162485169,1,kg,PCR,776,CACNA1D
GO:0005996,monosaccharide metabolic process,1/15,273/16992,0.21577058193763754,0.22599294915771512,0.09651239011020615,1,bp,PCR,3667,IRS1
GO:0010721,negative regulation of cell development,1/15,274/16992,0.21647417911874478,0.22639985108707153,0.0966861613623138,1,bp,PCR,596,BCL2
GO:0071496,cellular response to external stimulus,1/15,274/16992,0.21647417911874478,0.22639985108707153,0.0966861613623138,1,bp,PCR,596,BCL2
GO:0005126,cytokine receptor binding,1/15,264/16982,0.20952190958367523,0.2267214693256187,0.10862879837016942,1,mf,PCR,2625,GATA3
GO:0007568,aging,1/15,280/16992,0.22068340488642413,0.23063422023403016,0.0984944880756251,1,bp,PCR,596,BCL2
GO:0019216,regulation of lipid metabolic process,1/15,282/16992,0.22208178356728736,0.23192697891438366,0.09904657268951082,1,bp,PCR,3667,IRS1
hsa04350,TGF-beta signaling pathway,1/15,84/7430,0.15693437503990437,0.23217929852334593,0.14460289644875055,1,kg,PCR,658,BMPR1B
hsa04512,ECM-receptor interaction,1/15,82/7430,0.15348155013809917,0.23217929852334593,0.14460289644875055,1,kg,PCR,7060,THBS4
hsa04911,Insulin secretion,1/15,85/7430,0.15865585399095306,0.23217929852334593,0.14460289644875055,1,kg,PCR,776,CACNA1D
hsa05410,Hypertrophic cardiomyopathy (HCM),1/15,83/7430,0.1552096090313938,0.23217929852334593,0.14460289644875055,1,kg,PCR,776,CACNA1D
GO:0071103,DNA conformation change,1/15,283/16992,0.22278009435403145,0.23231857444611262,0.09921380720220024,1,bp,PCR,3087,HHEX
GO:1902903,regulation of supramolecular fiber organization,1/15,283/16992,0.22278009435403145,0.23231857444611262,0.09921380720220024,1,bp,PCR,4137,MAPT
GO:0033218,amide binding,1/15,274/16982,0.21658769421831203,0.2326312271233722,0.11146033386673371,1,mf,PCR,3480,IGF1R
GO:0048562,embryonic organ morphogenesis,1/15,284/16992,0.22347782004585526,0.23287717723415086,0.0994523637164487,1,bp,PCR,2625,GATA3
GO:0050727,regulation of inflammatory response,1/15,285/16992,0.22417496109800483,0.23343436166509635,0.09969031450811351,1,bp,PCR,2625,GATA3
GO:0000209,protein polyubiquitination,1/15,287/16992,0.22556749110262453,0.23471432636819073,0.10023693533505859,1,bp,PCR,596,BCL2
GO:0034612,response to tumor necrosis factor,1/15,288/16992,0.2262628809639513,0.23526755422952103,0.10047319643688295,1,bp,PCR,2625,GATA3
GO:0016579,protein deubiquitination,1/15,289/16992,0.22695768800331528,0.23581937647199136,0.10070885725610446,1,bp,PCR,2625,GATA3
hsa04727,GABAergic synapse,1/15,88/7430,0.16380062662981487,0.23682018307925043,0.14749327191777878,1,kg,PCR,776,CACNA1D
GO:0006260,DNA replication,1/15,291/16992,0.22834555543028012,0.23709000227840504,0.10125148982039346,1,bp,PCR,3480,IGF1R
GO:0008202,steroid metabolic process,1/15,292/16992,0.22903861672412784,0.23763790052893266,0.10148547486237244,1,bp,PCR,8912,CACNA1H
GO:0071214,cellular response to abiotic stimulus,1/15,293/16992,0.22973109700850747,0.2381844057728898,0.101718865007944,1,bp,PCR,2625,GATA3
hsa05414,Dilated cardiomyopathy (DCM),1/15,90/7430,0.16721414617486863,0.23887735167838375,0.14877449095758988,1,kg,PCR,776,CACNA1D
hsa04658,Th1 and Th2 cell differentiation,1/15,92/7430,0.17061465653862207,0.24043262466149348,0.149743125885667,1,kg,PCR,2625,GATA3
hsa04912,GnRH signaling pathway,1/15,93/7430,0.17231004767407032,0.24043262466149348,0.149743125885667,1,kg,PCR,776,CACNA1D
GO:0051480,regulation of cytosolic calcium ion concentration,1/15,298/16992,0.23318479910786072,0.24159088415140295,0.10317363327126536,1,bp,PCR,596,BCL2
GO:0015631,tubulin binding,1/15,289/16982,0.2270759211462986,0.2418053945203236,0.11585594220211515,1,mf,PCR,4137,MAPT
GO:0031625,ubiquitin protein ligase binding,1/15,291/16982,0.22846440723644368,0.2418053945203236,0.11585594220211515,1,mf,PCR,596,BCL2
GO:0016042,lipid catabolic process,1/15,299/16992,0.23387380282257153,0.24213015465132223,0.10340393375213046,1,bp,PCR,3667,IRS1
hsa04064,NF-kappa B signaling pathway,1/15,95/7430,0.17569113056286845,0.24233259387981856,0.1509264400479572,1,kg,PCR,596,BCL2
GO:0003713,transcription coactivator activity,1/15,297/16982,0.2326159103304114,0.24265688487704787,0.11626391580315908,1,mf,PCR,2625,GATA3
GO:0044389,ubiquitin-like protein ligase binding,1/15,296/16982,0.2319254441709101,0.24265688487704787,0.11626391580315908,1,mf,PCR,596,BCL2
GO:0002449,lymphocyte mediated immunity,1/15,300/16992,0.23456222868716514,0.24266805084482096,0.10363364732266096,1,bp,PCR,2625,GATA3
GO:0071902,positive regulation of protein serine/threonine kinase activity,1/15,302/16992,0.2359373486658336,0.24391508635453443,0.1041662054314131,1,bp,PCR,595,CCND1
GO:0070646,protein modification by small protein removal,1/15,304/16992,0.23731016264029636,0.2451579465953313,0.10469698045275477,1,bp,PCR,2625,GATA3
GO:0031589,cell-substrate adhesion,1/15,305/16992,0.23799570599842168,0.24568953270095686,0.10492399924159093,1,bp,PCR,596,BCL2
hsa04914,Progesterone-mediated oocyte maturation,1/15,99/7430,0.1824146590012765,0.24874726227446795,0.15492154053936164,1,kg,PCR,3480,IGF1R
GO:0006839,mitochondrial transport,1/15,311/16992,0.24209690357005687,0.2497438983705468,0.10665545379630721,1,bp,PCR,596,BCL2
hsa04916,Melanogenesis,1/15,101/7430,0.1857571957509514,0.2504591403383614,0.15598771021073388,1,kg,PCR,51176,LEF1
GO:0045861,negative regulation of proteolysis,1/15,315/16992,0.24481957989980607,0.25237140338308556,0.10777755424117416,1,bp,PCR,51176,LEF1
GO:0006869,lipid transport,1/15,318/16992,0.24685559335998453,0.2542878047729733,0.10859597127249272,1,bp,PCR,4602,MYB
GO:0010639,negative regulation of organelle organization,1/15,323/16992,0.2502375679485803,0.2575869521075286,0.1100049028155801,1,bp,PCR,4137,MAPT
hsa04659,Th17 cell differentiation,1/15,107/7430,0.19570844019455935,0.25807706399282554,0.1607322065218475,1,kg,PCR,2625,GATA3
hsa04931,Insulin resistance,1/15,107/7430,0.19570844019455935,0.25807706399282554,0.1607322065218475,1,kg,PCR,3667,IRS1
GO:0043405,regulation of MAP kinase activity,1/15,325/16992,0.2515863847168688,0.25879000346323583,0.11051867708242061,1,bp,PCR,3480,IGF1R
GO:0000790,nuclear chromatin,1/15,305/18122,0.2248536435449947,0.26215795688014054,0.17202435994869097,1,cc,PCR,2625,GATA3
GO:0005769,early endosome,1/15,310/18122,0.22811146897362877,0.26215795688014054,0.17202435994869097,1,cc,PCR,5979,RET
GO:0031253,cell projection membrane,1/15,299/18122,0.2209273137344535,0.26215795688014054,0.17202435994869097,1,cc,PCR,4137,MAPT
GO:0031965,nuclear membrane,1/15,300/18122,0.22158298844095536,0.26215795688014054,0.17202435994869097,1,cc,PCR,596,BCL2
GO:0099568,cytoplasmic region,1/15,292/18122,0.21632313742157938,0.26215795688014054,0.17202435994869097,1,cc,PCR,4137,MAPT
hsa04724,Glutamatergic synapse,1/15,114/7430,0.20717472788236335,0.2657970660096296,0.16554027795336582,1,kg,PCR,776,CACNA1D
hsa04726,Serotonergic synapse,1/15,115/7430,0.20880025810130354,0.2657970660096296,0.16554027795336582,1,kg,PCR,776,CACNA1D
hsa04919,Thyroid hormone signaling pathway,1/15,116/7430,0.21042267725762343,0.2657970660096296,0.16554027795336582,1,kg,PCR,595,CCND1
hsa05145,Toxoplasmosis,1/15,113/7430,0.20554608106207217,0.2657970660096296,0.16554027795336582,1,kg,PCR,596,BCL2
hsa04071,Sphingolipid signaling pathway,1/15,118/7430,0.2136582044919043,0.2670727556148804,0.16633478639172378,1,kg,PCR,596,BCL2
GO:0045787,positive regulation of cell cycle,1/15,341/16992,0.2622956743907986,0.2696129356935462,0.11514071091772879,1,bp,PCR,595,CCND1
GO:0006631,fatty acid metabolic process,1/15,342/16992,0.2629602329689107,0.2701028268594172,0.11534992349488353,1,bp,PCR,3667,IRS1
hsa04270,Vascular smooth muscle contraction,1/15,121/7430,0.2184883003201611,0.27029480451978694,0.16834150106056905,1,kg,PCR,776,CACNA1D
GO:0007015,actin filament organization,1/15,343/16992,0.26362423275902847,0.2705914446248028,0.1155585922545215,1,bp,PCR,596,BCL2
hsa04110,Cell cycle,1/15,124/7430,0.2232906939090743,0.2706553865564537,0.16856607408340538,1,kg,PCR,595,CCND1
hsa04114,Oocyte meiosis,1/15,124/7430,0.2232906939090743,0.2706553865564537,0.16856607408340538,1,kg,PCR,3480,IGF1R
GO:0006650,glycerophospholipid metabolic process,1/15,345/16992,0.2649505577202381,0.27175870909634703,0.11605708339975118,1,bp,PCR,3667,IRS1
GO:0044282,small molecule catabolic process,1/15,346/16992,0.2656128837630203,0.2722437332150215,0.11626421745914921,1,bp,PCR,3667,IRS1
GO:0007596,blood coagulation,1/15,348/16992,0.26693586514981127,0.2734047314470982,0.11676003254855383,1,bp,PCR,2625,GATA3
GO:0010876,lipid localization,1/15,351/16992,0.26891616700426624,0.2752368461432554,0.11754245416365815,1,bp,PCR,4602,MYB
GO:0050817,coagulation,1/15,352/16992,0.2695751572990166,0.275714947358496,0.11774663173277893,1,bp,PCR,2625,GATA3
GO:0007599,hemostasis,1/15,353/16992,0.27023359315481654,0.2761918018232371,0.11795027686550726,1,bp,PCR,2625,GATA3
GO:0006091,generation of precursor metabolites and energy,1/15,355/16992,0.2715488032819804,0.2773387564436431,0.11844009449997725,1,bp,PCR,3667,IRS1
hsa04210,Apoptosis,1/15,136/7430,0.24222618686933606,0.278610899639139,0.1735208234594638,1,kg,PCR,596,BCL2
hsa04371,Apelin signaling pathway,1/15,137/7430,0.24378453718424664,0.278610899639139,0.1735208234594638,1,kg,PCR,595,CCND1
hsa04728,Dopaminergic synapse,1/15,131/7430,0.23438937573465457,0.278610899639139,0.1735208234594638,1,kg,PCR,776,CACNA1D
hsa04910,Insulin signaling pathway,1/15,137/7430,0.24378453718424664,0.278610899639139,0.1735208234594638,1,kg,PCR,3667,IRS1
hsa04915,Estrogen signaling pathway,1/15,137/7430,0.24378453718424664,0.278610899639139,0.1735208234594638,1,kg,PCR,596,BCL2
hsa05162,Measles,1/15,132/7430,0.23596276378287795,0.278610899639139,0.1735208234594638,1,kg,PCR,595,CCND1
GO:0031331,positive regulation of cellular catabolic process,1/15,358/16992,0.27351747099998946,0.27915099845666536,0.11921402930098225,1,bp,PCR,3667,IRS1
GO:0034504,protein localization to nucleus,1/15,359/16992,0.27417258930797317,0.27962101549720186,0.11941475444813296,1,bp,PCR,3087,HHEX
GO:0045862,positive regulation of proteolysis,1/15,367/16992,0.2793937210601797,0.28474381359111933,0.12160249300342274,1,bp,PCR,4137,MAPT
GO:0015077,monovalent inorganic cation transmembrane transporter activity,1/15,361/16982,0.2756201878692708,0.28546376600745904,0.1367739278148261,1,mf,PCR,8912,CACNA1H
GO:0090150,establishment of protein localization to membrane,1/15,371/16992,0.2819911218151362,0.2871872728903974,0.12264599501527429,1,bp,PCR,596,BCL2
GO:0005578,proteinaceous extracellular matrix,1/15,359/18122,0.2593688701149357,0.28874018922971173,0.18946724652120525,1,cc,PCR,7060,THBS4
GO:0016607,nuclear speck,1/15,364/18122,0.26249108111791974,0.28874018922971173,0.18946724652120525,1,cc,PCR,4137,MAPT
GO:0031252,cell leading edge,1/15,355/18122,0.2568622236647181,0.28874018922971173,0.18946724652120525,1,cc,PCR,4137,MAPT
GO:0043254,regulation of protein complex assembly,1/15,377/16992,0.2858708436236098,0.29093229623734224,0.12424534205499072,1,bp,PCR,4137,MAPT
GO:0016050,vesicle organization,1/15,379/16992,0.28715973005996376,0.2920371777042943,0.12471719195810249,1,bp,PCR,596,BCL2
hsa04723,Retrograde endocannabinoid signaling,1/15,148/7430,0.26073012155734343,0.2941154289065927,0.18317715309094815,1,kg,PCR,776,CACNA1D
hsa04932,Non-alcoholic fatty liver disease (NAFLD),1/15,149/7430,0.2622529241083785,0.2941154289065927,0.18317715309094815,1,kg,PCR,3667,IRS1
hsa04145,Phagosome,1/15,152/7430,0.26680378428218365,0.2964486492024263,0.18463029906466902,1,kg,PCR,7060,THBS4
GO:0006874,cellular calcium ion homeostasis,1/15,392/16992,0.2954847153791399,0.3002910438471174,0.12824208223482364,1,bp,PCR,596,BCL2
GO:0005874,microtubule,1/15,389/18122,0.27791871216156294,0.30140480051324436,0.19777758611942212,1,cc,PCR,4137,MAPT
GO:0004857,enzyme inhibitor activity,1/15,389/16982,0.2937179621998959,0.30205038665946743,0.14472105640308422,1,mf,PCR,51176,LEF1
GO:0051346,negative regulation of hydrolase activity,1/15,398/16992,0.299296330979388,0.30394970149638206,0.12980454600035948,1,bp,PCR,51176,LEF1
GO:0043588,skin development,1/15,402/16992,0.30182670578658743,0.3063029493046089,0.13080952235621504,1,bp,PCR,596,BCL2
GO:0003779,actin binding,1/15,400/16982,0.3007116362924308,0.30706469903100325,0.1471235581564154,1,mf,PCR,4137,MAPT
GO:0055074,calcium ion homeostasis,1/15,405/16992,0.3037188872608456,0.3080056746604341,0.13153668705053154,1,bp,PCR,596,BCL2
GO:0005911,cell-cell junction,1/15,406/18122,0.28823687397617037,0.30825332355784885,0.20227149050959325,1,cc,PCR,595,CCND1
hsa04217,Necroptosis,1/15,162/7430,0.2817847980654766,0.31022179603538713,0.193208311565899,1,kg,PCR,596,BCL2
hsa04141,Protein processing in endoplasmic reticulum,1/15,165/7430,0.28622308326023704,0.3122433635566222,0.194467358004563,1,kg,PCR,596,BCL2
GO:0009896,positive regulation of catabolic process,1/15,412/16992,0.308115380086431,0.31224386543314625,0.13334664582465244,1,bp,PCR,3667,IRS1
GO:0010008,endosome membrane,1/15,421/18122,0.29722668984262235,0.31351308380660164,0.20572287112394913,1,cc,PCR,5979,RET
hsa04621,NOD-like receptor signaling pathway,1/15,168/7430,0.2906357595129848,0.3142008210951187,0.19568647629608274,1,kg,PCR,596,BCL2
GO:0072503,cellular divalent inorganic cation homeostasis,1/15,416/16992,0.31061601468323974,0.3145561755460292,0.13433413935709268,1,bp,PCR,596,BCL2
GO:0016311,dephosphorylation,1/15,418/16992,0.3118631663050285,0.31559673942276484,0.13477852183530886,1,bp,PCR,596,BCL2
GO:0005635,nuclear envelope,1/15,436/18122,0.3061104414325475,0.3185203241933265,0.20900855176048763,1,cc,PCR,596,BCL2
GO:0051493,regulation of cytoskeleton organization,1/15,426/16992,0.316830745402512,0.3201728418730026,0.13673278893305538,1,bp,PCR,4137,MAPT
GO:0051656,establishment of organelle localization,1/15,426/16992,0.316830745402512,0.3201728418730026,0.13673278893305538,1,bp,PCR,4137,MAPT
hsa04360,Axon guidance,1/15,175/7430,0.30083318356211364,0.3223212681022646,0.20074394767772621,1,kg,PCR,658,BMPR1B
GO:0046486,glycerolipid metabolic process,1/15,432/16992,0.3205344431772489,0.32368797951209183,0.13823396114386663,1,bp,PCR,3667,IRS1
hsa05152,Tuberculosis,1/15,179/7430,0.3065986846885448,0.32559152356305643,0.2027806857278685,1,kg,PCR,596,BCL2
GO:0044440,endosomal part,1/15,455/18122,0.31721274896793195,0.3256717556070768,0.21370122035734365,1,cc,PCR,5979,RET
GO:0072507,divalent inorganic cation homeostasis,1/15,436/16992,0.3229931544621142,0.3259418279227936,0.13919648806284196,1,bp,PCR,596,BCL2
GO:0000226,microtubule cytoskeleton organization,1/15,443/16992,0.3272759287032011,0.3300319365238596,0.14094320696876547,1,bp,PCR,4137,MAPT
GO:0008544,epidermis development,1/15,445/16992,0.32849492592547425,0.33102889800484325,0.14136896863848195,1,bp,PCR,596,BCL2
GO:0000785,chromatin,1/15,472/18122,0.3270056375706796,0.3313083433281885,0.21739986985308338,1,cc,PCR,2625,GATA3
GO:0006644,phospholipid metabolic process,1/15,448/16992,0.3303195567966758,0.33263433995572744,0.14205458755022463,1,bp,PCR,3667,IRS1
hsa05167,Kaposi's sarcoma-associated herpesvirus infection,1/15,186/7430,0.31658166874636806,0.33324386183828214,0.20754661570629857,1,kg,PCR,595,CCND1
GO:0060627,regulation of vesicle-mediated transport,1/15,450/16992,0.3315334054575022,0.3336229017103856,0.14247676203871723,1,bp,PCR,8912,CACNA1H
GO:0004674,protein serine/threonine kinase activity,1/15,446/16982,0.32926350175315267,0.3338685856937562,0.15996607372622804,1,mf,PCR,658,BMPR1B
GO:0044723,single-organism carbohydrate metabolic process,1/15,451/16992,0.3321395594242619,0.33399898312992604,0.14263737110555388,1,bp,PCR,3667,IRS1
GO:0050839,cell adhesion molecule binding,1/15,451/16982,0.33230051908236913,0.3346081615759967,0.16032042587307285,1,mf,PCR,7060,THBS4
GO:0044454,nuclear chromosome part,1/15,493/18122,0.3389217518815463,0.3389217518815463,0.22239568134400847,1,cc,PCR,2625,GATA3
GO:0051222,positive regulation of protein transport,1/15,460/16992,0.3375719067581665,0.3392243566513883,0.1448689154508731,1,bp,PCR,2625,GATA3
GO:0006913,nucleocytoplasmic transport,1/15,464/16992,0.33997302105195326,0.3413984844525904,0.14579739694235813,1,bp,PCR,3087,HHEX
GO:0044089,positive regulation of cellular component biogenesis,1/15,466/16992,0.3411705296887293,0.34236176757172065,0.14620877595452014,1,bp,PCR,4137,MAPT
GO:0051169,nuclear transport,1/15,472/16992,0.3447508998775598,0.3457132192072948,0.14764004453565752,1,bp,PCR,3087,HHEX
hsa04024,cAMP signaling pathway,1/15,198/7430,0.3333838948251229,0.3461782403095195,0.2156022373857534,1,kg,PCR,776,CACNA1D
hsa05169,Epstein-Barr virus infection,1/15,201/7430,0.33752378430178154,0.3461782403095195,0.2156022373857534,1,kg,PCR,596,BCL2
hsa05203,Viral carcinogenesis,1/15,201/7430,0.33752378430178154,0.3461782403095195,0.2156022373857534,1,kg,PCR,595,CCND1
GO:0045860,positive regulation of protein kinase activity,1/15,478/16992,0.3483131033235065,0.3490417918241833,0.14906154241914726,1,bp,PCR,595,CCND1
GO:0046982,protein heterodimerization activity,1/15,480/16982,0.3496636316346423,0.3496636316346423,0.16753393602821343,1,mf,PCR,596,BCL2
hsa04015,Rap1 signaling pathway,1/15,206/7430,0.34437031748658764,0.35020710252873316,0.21811144104859703,1,kg,PCR,3480,IGF1R
GO:0001501,skeletal system development,1/15,485/16992,0.35244616081089597,0.3529373749723049,0.15072518742178792,1,bp,PCR,658,BMPR1B
GO:0006875,cellular metal ion homeostasis,1/15,488/16992,0.3542099709191636,0.35445663524431625,0.1513740016462926,1,bp,PCR,596,BCL2
GO:0098542,defense response to other organism,1/15,496/16992,0.35889156758914453,0.35889156758914453,0.1532679807379931,1,bp,PCR,596,BCL2
hsa04014,Ras signaling pathway,1/15,232/7430,0.37892027696822284,0.38210448097635913,0.23797735218703076,1,kg,PCR,3480,IGF1R
hsa04144,Endocytosis,1/15,244/7430,0.3942864132509408,0.3942864132509408,0.2455643450948842,1,kg,PCR,3480,IGF1R
